Synthesis of Heterocyclic Steroids Containing Vicinal Methoxyl (and Hydroxyl) Groups in the a Ring and Related Model Systems- Possible Potentiators of Drug Activity in Cancer Chemotherapy by Hasem, Mohamed Mohamed
SYNTHESIS. OF HETEROCYCLIC STEROIDS CONTAINING 
VICINAL METHOXYL (AND HYDROXYL) GROUPS IN 
THE A RING AND RELATED MODEL SYSTEMS~ 
POSSIBLE POTENTIATORS OF DRUG 
ACTIVITY IN CANCER 
CHEMOTHERAPY 
By 
MOHAMED MOHAMED HASHEM 
I\ 
Bachelor of Science 
Alexandria University 
Alexandria, Egypt 
1963 
Master of Science 
Alexandria University 
Alexandria, Egypt 
1967 
Submitted to the Faculty of the Graduate College 
of the Oklahoma State University 
in partial fulfillment of the requirements 
for the Degree of 
DOCTOR OF PHILOSOPHY 
May, 1975 
T~ 
19'7'5]) 
H 3 'I 'is 
~· :;_, 
SYNTHESIS OF HETEROCYCLIC STEROIDS CONTAINING 
VICINAL METHOXYL (AND HYDROXYL) GROUPS IN 
THE A RING AND RELATED MODEL SYSTEMS~ 
POSSIBLE POTENTIATORS OF DRUG 
ACTIVITY IN CANCER 
CHEMOTHERAPY 
Thesis Approved: 
Thesis Adviser 
~·---"--
/G<GC ~ /[f;~dc~ 
~"'11 17 &~ 
/]~~'V l] LL~-~ 
Dean of the Graduate College 
938941 
ii 
OKLAHOMA 
STATE UNIVERSITY 
LIBRARY 
Ml\Y 1 2 1976 
ACKNOWLEDGEMENTS 
Gratitude is specially extended to Professor K. D. Berlin without 
whom this work would never have been undertaken nor accomplished. His 
continuous guidance, encouragement and faith during the course of this 
study are much appreciated. The author is also grateful to Professor 
0. C. Dermer for his advice and concern about the progress of this re-
search; and to Dr. N. Purdie for his guidance and friendly attitude. 
Appreciation is also extended to Dean N. N. Durham for his cooperation 
and invaluable suggestions in the joint meetings held during the course 
of this study. 
The author is particularly indebted to his wife, Samia, for her 
encouragement, sacrifice, patience, love, and understanding for many 
·years. He also thanks his wife for typing most of the manuscript. 
The author thanks Mr. Stan Sigle for his help in obtaining 100 MHz 
NMR spectra, Mr. Norman Perreira in obtaining mass spectral data, and 
Mrs. Janet Saliee for her help in typing the final draft. 
Appreciation is expressed to the USPHS (National Cancer Institute 
of NIH) for.a Research Assistantship (Grant CA 14343-01). The help, 
cooperation, and friendship of all members of Professor Berlin's re-
search group are gratefully acknowledged. 
The author sincerely thanks the faculty of the Chemistry Depart-
ment of Oklahoma State University for a pleasant association. 
iii 
TABLE OF CONTENTS 
Chapter Page 
L HISTORICAL. • • • . . 1 
II. 
Pyrazoles •• 
A. Synthesis of Pyrazoles. 
B. The General Character of Pyrazoles. 
C. Pyrazolosteroids. . 
D. Tetrahydroindazoles • 
Pyrazolones ••• 
Isoxazoles • • 
. Thiazoles. • • 
Polymethoxy Cyclic 
Nucleoside Analogs 
RESULTS AND DISCUSSION. 
Ketones and Polymethoxy Steroids. 
and Related Compounds 
Biological Activity •• 
1 
2 
10 
16 
21 
28 
38 
54 
60 
63 
70 
147 
III. EXPERIMENTAL. • 161 
Preparation of 3-Carbomethoxypropanoic Acid (252) 
and 3-Carbomethoxypropanoyl Chloride (253) :-: . 161 
-Preparation of Methyl 4-(3 ,4 -Dimethoxyphenyl)-4-
oxobutanoate (222) . . • . . 162 
-
Method A. . 
Method B. • 
Preparation of Methyl 4-(3 ,4·-Dimethoxyphenyl)-
butanoate (~). ·. • 
Preparation of 4-(3 ,4 -Dimethoxyphenyl)butanoic 
Acid (224) . . 
_.... 
Method A. 
Method B. 
162 
162 
163 
163 
163 
164 
Preparation of 3,4-Dihydro-6,7-dimethoxy-1(2!!)-naph-
thalenone q,.§.~). . . . . . . . . . . . . . . . . . 165 
Attempted Synthesis of 6,7-Dimethoxy-3,4-dihydro-l-
[2~]-naphthalenone Using (A) AlC13 or (B) PPA in 
One Step • • . • . . . • . • • . . • . • . . • . . 165 
iv 
Chapter 
TABLE OF CONTENTS (Continued) 
Method A •• 
Method B. • . 
Preparation of 4-(3 -Hydroxy-4 -methoxyphenyl)-
butanoic Acid CW) ..••••.••. • • • • 
Reduction of 4-(3. ,4·-Dimethoxyphenyl)-4-oxobutanoic 
Acid ():.2§) to 4-(3·,4·-Dimethoxyphenyl)butartoic 
Acid (~) by Clemmensen Reduction . . • • • • • . 
Attempted Cyclization of the Mixture Resulting From 
Clemniensen Reduction of Acid ]:3..4 Using 105% PPA; 
Attempted Preparation of Ketone 182 .••••. 
Cyclization of Acid 224 to Ketone 182 Using 95% 
-- --
H2 SO 4• • • • • • • • • . • • • • • • • • • • • 
Catalytic Hydrogenation of the Keto Acid 3l:J to Give 
Acid 226 Using 10% Pd-C. · • . • • . • • • • . • • • 
Preparati(;'n of 6-(3 ,4 -Dimethoxyphenyl)-4,5-dihy-
dro-3 (2!!)-pyridazinone C3l.4) ...• • •.•.. 
Attempted Reaction of 3-Carbomethoxypropanoic Acid 
(,12.2) With Veratrole Using 105% PPA. • • . • . • 
Preparation of 3-Protocatechuoylpropanoic Acid 
<w). . . . . . . . . . . . . . . . . . . . . . . 
Preparation of 3,4-Dihydro-1-(hydroxymethylene)-6,7-
dimethoxy--1-flH)-naphthalenone (232) . . • . . • • 
Preparation of 4-;5-Dihydro-7,8-dim;t°hoxy-lH-benz[g]-
indazole (193) . • • • • • . . . • . . .-. • • -: • 
Preparation ~4,5-Dihydro-lH-benz[g]indazole-7,8-
diol (194) . . . . . . . .-. . . : . . . . . . . . 
Preparation of 4,5-Dihydro-7,8-dimethoxy-1-phenyl-
lH-benz [g]indazole ( 195) . • • • . . • . • • • . • 
Preparation of 4,5-DihYclr-o-1-phenyl-lH-benz[g]inda-
zole-7, 8-diol (.!.2.§) • • • • • • • • -:- • • • - • • • • 
Preparation of 4,5-Dihydro-7,8-dimethoxy-1-(p-
methoxyphenyl)-lH-benz[g]indazole (197) .• - .... 
Preparation of 4,5-:Dihydro-1-(p-hydro~henyl)benz­
[g]indazole-7, 8-diol (198) .-•••..••••.• 
Preparation of 4,5-Dihyd?c;":7,8-dimethoxy-l-(p-tolyl-
sulfonyl)-1H-benz[g]indazole (199) .•.• - ..•. 
Preparation of 4,5-Dihydro-7-met~y-1-phenyl-lH­
benz [g]indazole ( 203). • . . . • • . • . • • -:- . . 
Preparation of 4,5-Dih.ydro-1-phenyl-lH-benz[g]inda-
zol-7-ol (204) •••.....•. -:- ... - •... 
Preparation ;r-Methyl 1,2,3,4-Tetrahydro-6-methoxy-
1-oxo-2-naphthoate (241) ..•.••..... 
Preparation of 2,3a,4,:f-:Tetrahydro-7-methoxy-3H-
benz [g]indazol-3-one ( 233) • • . • . . • • . -. . 
- -Preparation of Methyl 1,2,3,4-Tetrahydro-6,7-di-
methoxy-1-oxo-2-naphthoate (230) .••...... 
~ 
v 
Page 
165 
166 
167 
167 
169 
169 
170 
170 
171 
171 
172 
173 
173 
174 
174 
175 
176 
177 
177· 
178 
179 
179 
180 
TABLE OF CONTENTS (Continued,) 
Chapter Page 
Preparation of 2,3a,4,5-Tetrahydro-7,8-dimethoxy-
3H-benz[g]indazol-3-one (207). • . • . . • • . 181 
- - . ,...._.,. Preparation of 2,3a,4,5-Tetrahydro-7,8-dimethoxy-2-
phenyl-3H-benz[g]indazol-3-one (208). . • • . . • 182 
- - -Preparation of 2-(p-Fluorophenyl)-2,3a,4-5-tetra-
hydro-7 ,8-dimethoxy-3H-benz[g]indazol-3-one (209). 182 
- ' - . ~ Preparation of 2,3a,4,5-Tetrahydro-7,8-dimethoxy-
3a-methyl-3H-benz[g]indazol-3-one (210). • . . • • 183 
Preparation of 2-Methyl-6,7-dimethoxy=r.::tetralone 
( 231) . . . . . . . . . . . . . . . . . . . . . 185 
-Preparation of 4,5-Dihydro-7,8-dimethoxyna:phth-
[2,1-d]isoxazole (185) • • • . . . . . . . . . 185 
- -Preparation of 4,5-Dihydro-7,8-dimethoxynaphth-
[1,2-c]isoxazole (186) • . . • • • • • • • . . 186 
Attempted Cleavage o~the Methoxyl Groups of 4,5-
Dihydro-7 ,8-dimethoxynaphth[2,l-d]isoxazole (185) 
- -by 48% Aqueous HBr . • . • . • . . . . . . • • . . 187 
Preparation of 2-Bromo-3,4-dihydro-6,7-dimethoxy-
1(2H)naphthalenone ( 229) . . • • • . . . . . . . . 188 
- --Preparation of 2-Amino-4,5-dihydro-7,8-dimethoxy-
naphtho[l,2-d]thiazole (211) • . • . • . • • . 189 
Preparation of-2-Anilino-4:S:dihydro-7,8-dimethoxy-
naphtho[l,2-d]thiazole (212) • . • . . . • . . • . 189 
Preparation of-2-(allylam~-4,5-dihydro-7,8-di-
methoxynaphtho[l,2-d]thiazole (213). . • . . . • . 190 
- __, . 
Preparation of 4,5-Dihydro~7,8-dimethoxy-2-methyl-
naphtho[l,2-d]thiazole (214) . . . • • . . • • • • 191 
- -Preparation of Methyl 3,4-dihydro-6,7-dimethoxy-
~l(2.!!),Y_naphthalenecrotonate (235) . • • . . • . 191 
Preparation of 6,7-Dimethoxy-1-naphthalenebutanoic 
Acid ( 236) . • . . • • . • • . • . . . . • • . • . 194 
-Preparation of 3,4-Dihydro-6,7-dimethoxy-1[2H]-
phenanthrone (188) .••.•.•..... -. • . 195 
- . Preparation of 3,4-Dihydro-2-(hydroxymethylene)-6,7-
dimethoxy-1(2H)-phenanthrone (237) . . • . • . . . 196 
- -Preparation of 10,11-Dihydro-7,8-dimethoxy-3H-phen-
anthro [1, 2-c ]pyrazole ( 215) . • . . . . . • - . • . . 197 
Preparation of 10,11-Dihya;;-3H-phenanthro[l,2-c]-
pyrazole-7 ,8-diol ( 216) ... - .•..•.•. :- . . 198 
-Preparation of 10;ll-Dihydro-l-(p-fluorophenyl)-7,8-
dimethoxy-3H-phenanthro[l,2-c]pyrazole (217) . • . 199 
- - -Preparation of 10,11-Dihydro-l-(p-fluorophenyl)-
phenanthro[l,2-c]pyrazole-7 ,8-diol (218) • . . . . 199 
- -Preparation of 10,11-Dihydro-7,8-dimethoxyphenanthro-
[2,l-~]isoxazole (l2,9) • • • • • • • • • • • . • . 200 
Preparation of l-S-D-Glucopyranosyl-4,5-dihydro-7-
methoxy-lH-benz[~]indazole tetraacetate (ester) 
( 206) . . . . .. . . . . . . . . . . . . . . . . . . 201 
- . 
vi 
Chapter 
BIBLIOGRAPHY. 
TABLE OF CONTENTS (Continued) 
B_-Glucosidation Using Hg(CN) 2 ••...• · . · · · · 
Preparation of 1-13-D-Glucopyranosyl-4,5-dihydro-7,8-
dimethoxy-lH-benzTg]indazole (202) . . . • • . • . 
- - -Preparation of l-f3-D-Glucopyranosyl-10,11-dihydro-7-
methoxy-3H-phenanthro[l,2-c]pyrazole tetraacetate 
(ester) (Z20). • • . . . . - . . . . . . . . . • . . 
Attempted C~ensation of D-Glucose with 7-Methoxy-
4, 5-dihydro-lH"-benz[g]indazole (247) Using Poly-
phosphate Ester (PPE) .•.•. . --: . •.•. 
An Attempted One-Step Synthesis of N-Glycoside of 7-
Methoxy-4, 5-dihydro-lH-benz [g]indazole (247) with 
Acetobromoglucose 161-in Dry-Dioxane .. -:-' •... 
The Reaction of 6,7-Dimethoxy-l-tetralone (182) and 
_... 
95% Hydrazine in Methanolic Sodium Methoxide Med-
ium; the Isolation of an Unknown Compound ..•. 
Reaction of Veratrole and 3-Carbomethoxypropionic 
Acid with 115% PPA at l00°c •..••••... 
Condensation of Hydroxymethylene Ketone 232 with 
-Methylhydrazine; Formation of Isomers •..•.. 
Attempted Bromination of the Allylic Position of 
Alkene 242 by Bromine in the Presence of Light ,.._ . 
Preparation of 6-Methoxy-l-methyl-3,4-dihydronaph-
thalene ( 242) . . 
__, 
vii 
Page 
204 
205 
207 
209 
210 
211 
212 
213 
214 
215 
311 
LIST OF TABLES 
Table Page 
I. NMR Spectra of Isomeric !!_-Methyl-3(5).!!_-pyrazoles. . . . . • 25 
II. 7,8-Dimethoxy-(and 7,8-dihydroxy)-4,5-dihydro-lH-benz[g]-
indazoles and Derivatives ....••.... - ... : . 74 
III. 1-N-Substituted-7-methoxy-(and 7-hydroxy)-4,5-dihydro-lH-
benz[~]indazoles .•....•.•.•........ -. 76 
IV. 2,3a,4,5-Tetrahydro-7,8-dimethoxy-3H-benz[g]indazol-3-ones 
and the 2-aryl Analogs ..••.. -. . - . . . . . . 77 
V. 4,5-Dihydro-7,8-dimethoxynaphth[2,l-g]- and [l,2-£]is-
oxazoles and 4,5-dihydro-7,8-dimethoxyphenanthro[2,l-g]-
isoxazole . . • • . . • • . . • . . . . . . • . . . 78 
VI. 2-Substituted 4,5-Dihydro-7,8-dimethoxynaphth[l,2-g]-
VII. 
VIII. 
IX. 
x. 
XI. 
thiazoles . 79 
10(11-Dihydro-7,8-dimethoxy(and 7,8-dihydroxy)phenanthro-
1,2-c]pyrazoles. . . . . . . . . • . . . . . . . . . . 80 
NMR Data of Starting Materials, Intermediates, and Products 82 
Intense Ions in Mass Spectra (70 eV) of Some Model Hetero-
steroids and Their Precursors . . . . . . . . . . . . . . 156 
Intense Ions in Mass Spectra (70 eV) of Some Heterosteroids 
and Their Precursors. . • . . . . . . . . . . . . . . . 159 
Intense Ions in Mass Spectra (70 eV) of Some Pyrazolo-!!_-
glucosides. • • . . . • • . . . . • . . . . . . . . . . 160 
viii 
LIST OF FIGURES 
Figure Page 
1. Synthesis of Some Phenanthropyrazoles .. 13 
2. Preparation of 6,7-Dimethoxy-l-tetralone 104 
3. Reaction of Keto Acid 226 with Hydrazine 105 
--
4. Synthesis of Model Steroidal Pyrazoles 106 
5. Preparation of Isomeric Isoxazoles ... 107 
6. Synthesis of Model Steroidal Pyrazolones . . 109 
7. Synthesis of Thiazoles as Models to Steroid Systems. 109 
8. Synthesis of Some Pyrazoles and Pyrazolones From 6-Methoxy-
1-tetralone. • . . . . . . . • • • • . . . . . . . . . . . 110 
9. Synthesis of 3,4-Dihydro-6,7-dimethoxy-1(2!!)-phenanthrone. 111 
10. Synthesis of Heterocyclic Steroids • . . . . . . . . . . 112 
11. Synthesis of N-Glucosides From 6,7-Dimethoxy-l-tetralone . 113 
12. Synthesis of N-Glucosides From 6-Methoxy-1-tetralone . . 114 
13. Synthesis of N-Glucosi<les From 7-Methoxy-3,4-dihydro-1(2!!)-
phenanthrone . . . . . . . . . . . . . . . . . . . . . . . 115 
ix 
LIST OF ILLUSTRATIONS 
Infrared Spectra 
Plate Page 
I. 4-(3 ,4·-Dimethoxyphenyl)-4-oxobutanoic Acid (226). . 216 
-
II. Methyl 4-(3' ,4 -Dimethoxyphenyl)-4-oxobutanoate (222) 217 
-
III. Methyl 4-(3 ,4·-Dimethoxyphenyl)butanoate (223) . 
-
IV. 4-(3 ,4 -Dimethoxyphenyl)butanoic Acid (224) •. 
-
V. 6-(3,4-Dimethoxyphenyl)-4,5-dihydro-3(2H)-pyridazin-
one (234) . . • . . . . . . . -
-
VI. 3-Protocatechuoylpropionic Acid (227) 
-
VII. 4-(3-Hydroxy-4-methoxyphenyl)butanoic Acid (225). 
--
218 
219 
220 
221 
222 
VIII. 3,4-Dihydro-6,7-dimethoxy-1(2H)-naphthalenone (182) . 223 
- -
IX. 3,4-Dihydro-2-(hydroxymethylene)-6,7-dimethoxy-1(2H)-
naphthalenone (232) . . . . • • . . . . • . . . -: . 224 
-
X. 3,4-Dihydro-6,7-dimethoxy-2-methyl-1(2H)-naphthalen-
one (231) • . • . • . . . . . . . . -: . . . . . . • 225 
-
XI. 2-Bromo-3,4-dihydro-6,7-dimethoxy-1(2H)-naphthalenone 
(229) • . . . • . . . . . . . . . .-. . . . . . . . 226 
-
XII. Ethyl 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-l-
oxo-2-naphthoate (228). . . . . . . . . . . . . . 227 
-
XIII. Methyl 1,2,3,4-Tetrahydro-6,7-dimethoxy-l-oxo-2-
naphthoate (230). • . . . . . . . . . . . . . . 228 
-
XIV. 4,5-Dihydro-7,8-dimethoxy-lH-benz[g]indazole (193). 229 
- - -
XV. 4,5-Dihydro-lH-benz[g]indazole-7 ,8-diol (194) . . . 230 
- - .............. 
XVI. 4,5-Dihydro-7,8-dimethoxy-l-phenyl-lH-benz[g]indazole 
( 19 5) . . . . • . . . • . . . . . -: . . . - . . . . . 231 
--
x 
LIST OF ILLUSTRATIONS (Continued) 
Plate Page 
XVII. 4,5-Dihydro-l-phenyl-lH-benz[g]indazole-7,8-diol 
(196) •...••. -: .•• -. . . . . . . . . . 232 
-
XVIII. 4,5-Dihydro-7,8-dimethoxy-l-(p-methoxyphenyl)-lH-
benz[g]indazole (197) ... - .•....... -. · 233 
- ...._ 
XIX. 4,5-Dihydro-l-(p-hydroxyphenyl)-lH-benz[g]indazole-
7 ,8-diol (198) .....••.. - ... : . • • . . • 234 
_..._. 
XX. 4,5-Dihydro-7,8-dimethoxy-l-(p-tolylsulfonyl)-lH-
benz[g]indazole (199) ... - ......... -. 235 
- -
XXI. 4,5-Dihydro-7-methoxy-1-phenyl-lH-benz[g]indazole 
(203) ...•.......• -: ... -. . 236 
-
XXII. 4,5-Dihydro-l-phenyl-l_!!.-benz[~]indazol-7-ol ~) 237 
XXIII. 4,5-Dihydro-7,8-dimethoxynaphth[2,l-~]isoxazole (~) 238 
XXIV. 4,5-Dihydro-7,8-dimethoxynaphth[l,2-~]isoxazole ~) 239 
XXV. 2,3a,4,5-Tetrahydro-7-methoxy-3_!!.-benz[g]indazol-3-one 
(233) . . . . • . • . . . . . . . . . . . . • . . . 240 
-
XXVI. 2,3a,4,5-Tetrahydro-7,8-dimethoxy-3H-benz[g]indazol-
3-one (207) . . • . . • . . • . .-. . . : . . . . 241 
-
XXVII. 2,3a,4,5-Tetrahydro-7,8-dimethoxy-2-phenyl-3H-benz-
[g]indazol-3-one (208) •.•....... -: . . . 242 
- --
XXVIII. 2-(p-Fluorophenyl)-2,3a,4,5~tetrahydro-7,8-dimethoxy-
3H-benz[g]indazol-3-one (209) . . . . . . . . . . . 243 
- - -
XXIX. 2,3a,4,5-Tetrahydro-7,8-dimethoxy-3a-methyl-3H-benz-
[g]indazol-3-one (210) ... , ....... -. . . . 244 
- --
XXX. 2-Amino-4,5-dihydro-7,8-dimethoxynaphtho[l,2-d]thia-
zole (211) ..•.............. -. . . 245 
-
XXXI. ·2-Anilino-4,5-dihydro-7,8-dimethoxynaphtho[l,2-d]-
thiazole (212) •............... -. . 246 
-
XXXII. 2-(Allylamino)-4,5-dihydro-7,8-dimethoxynaphtho-
[l,2-d]thiazole (213) . . . . . . . . . . . . . 247 
- --
XXXIII. 4,5-Dihydro-7,8-dimethoxy-2-methylnaphtho[l,2-d]thia-
zole (~ ..•.....•...•.... :... 248 
xi 
LIST OF ILLUSTRATIONS (Continued) 
Plate 
XXXIV. Methyl 3, 4-dihydro-6, 7-dimethoxy-l'i 1 C2!D 'Y -naphthalene-
crotonate (235) .••.....••....• 
-
XXXV. 6,7-Dimethoxy-l-naphthalenebutyric Acid (236) ... 
-
XXXVI. 3,4-Dihydro-6,7-dimethoxy-1(2H)-phenanthrone (188) 
- -
XXXVII. 3,4-Dihydro-2-(hydroxymethylene)-6,7-dimethoxy-1(2H)-
phenanthrone (237) .•............. - .. 
-
XXXVIII. 10,ll-Dihydro-7,8-dimethoxy-3H-phenanthro[l,2-c]pyra-
zole (215) • . . . . . . . -: . . . . . . . . - . . . 
-
XXXIX. 10,ll-Dihydro-3H-phenanthro[l,2-c]pyrazole-7,8-diol 
(216) . ... -: ........ - ......... . 
-
XL. 10,ll-Dihydro-7,8-dimethoxyphenanthro[2,l-d]isoxazole 
(190) . .......... ·• ...... - ... . 
-
XLI. 10,ll-Dihydro-l-(p-fluorophenyl)-7,8-dimethoxy-3H-
phenanthro[l,2-c]pyrazole (217) ....••.. -. 
- -
XLII. 10,ll-Dihydro-l-(p-fluorophenyl)-3H-phenanthro[l,2-c]-
pyrazole-7,8-diol (218) .••.• - •....... : . 
-
XLIII. l-S-D-Glucopyranosyl-4,5-dihydro-7-methoxy-lH-benz[g]-
indazole Tetraacetate (ester) (206) .... - ... -
-
XLIV. l-S-D-Glucopyranosyl-4,5-dihydro-7,8-dimethoxy-lH-
be;z[g]indazole Tetraacetate (ester) (201) . .-. 
- -
XLV. l-S-D-Glucopyranosyl-4,5-dihydro-7,8-dimethoxy-lH-
be~z[g]indazole (202) .•...••...... -. 
- -
XLVI. 3-S-D-Glucopyranosyl-10,ll-dihydro-7-methoxy-3H-phen-
anthro[l,2-c]pyrazole tetraacetate (ester) (Z20) . 
- -
XLVII. 3-S-D-Glucopyranosyl-10,ll-dihydro-7-methoxy-3H-phen-
anthro[l,2-c]pyrazole (221) ......... - .. . 
- -
Proton Magnetic Resonance Spectra 
Page 
249 
250 
251 
252 
253 
254 
255 
256 
257 
258 
259 
260 
261 
262 
XLVIII. 4-(3 , 4 -Dimethoxyphenyl)-4-oxobutanoic Acid (226) . . 263 
-XLIX. Methyl 4-(3 ,4 -Dimethoxyphenyl)-4-oxobutanoate (222). 264 
-
L. Methyl 4-(3 ,4 -Dimethoxyphenyl)butanoate (223). 265 
-
xii 
LIST OF ILLUSTRATIONS (Continued) 
Plate Page 
LI. 4-(3 ,4 -Dimethoxyphenyl)butanoic Acid (;224). 
-
266 
LII. 6-(3,4-Dimethoxyphenyl)-4,5-dihydro-3(2_!:')-pyridazinone 
(234) . • • . . . • . . • . . . . . . 267 
-
LIII. 3-Protocatechuoylpropionic Acid (227) 268 
-
LIV. 4-(3-Hydroxy-4-methoxyphenyl)butanoic Acid (225). 269 
-
LV. 3,4-Dihydro-6,7-dimethoxy-1(2H)-naphthalenone (182) 270 
- -
LVI. 3,4-Dihydro-2-(hydroxymethylene)-6,7-dimethoxy-1(2H)-
naphthalenone (232) . . . . • • . • . . . . . . -:-- . 271 
- ' 
LVII. 3,4-Dihydro-6,7-dimethoxy-2-methyl-1(2H)-naphthalenone 
(231) . . • . • . • . . • . . . . . -:-- . . . . . . . . 272 
-
LVIII. 2-Bromo-3,4-dihydro-6,7-dimethoxy-1(2H)-naphthalenone 
(229) •.•.••...•..... -. . . . . . . . 273 
-
LIX. Ethyl 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-l-oxo-
2-naphthoate (228). . . . . . • . . . . . . . . . . 274 
-
LX. Methyl 1,2,3,4-Tetrahydro-6,7-dimethoxy-l-oxo-2-naph-
thoate (230). . . • • . • . . • . . . . . . . • . 275 
-
LXI. 4,5-Dihydro-7 ,8-dimethoxy-lH-benz[g]indazole (193). 276 
- - -
LXII. 4,5-Dihydro-l.!!_-benz[~]indazole-7,8-diol (194). . . . 
-
277 
LXIII. 4,5-Dihydro-7,8-dimethoxy-l-phenyl-lH-benz[g]indazole 
(195) • • . . . . . . . . . . . . -:-- . . . - . . . . . 278 
--LXIV. 4,5-Dihydro-l-phenyl-lH-benz[g]indazole-7,8-diol (196). 279 
- - -
LXV. 4,5-Dihydro-7,8-dimethoxy-l-(p-methoxyphenyl)lH-benz-
[g]indazole (197) . . • . . - . . . . . . . . -:-- . • • • 280 
- -
LXVI. 4,5-Dihydro-l-(p-hydroxyphenyl)-lH-benz[g]indazole-7,8-
diol (198) .. - •...•.... - .... : . . . . . . . 281 
-
LXVII. 4,5-Dihydro-7,8-dimethoxy-l-(p-tolylsulfonyl)-l.!!_-benz-
[g]indazole (199) . . . . . - . . . . . . . . . . . . . 282 
- -
LXVIII. 4,5-Dihydro-7-methoxy-l-phenyl-l.!!_-benz[~]indazole (203) 283 
-
LXIX. 4,5-Dihydro-l-phenyl-lH-benz[g]indazol-7-ol (204) 284 
- - -
LXX. 4,5-Dihydro-7,8-dimethoxynaphth[2,l-g]isoxazole (185) 285 
-
xiii 
Plate 
LXXI. 
LXXII. 
LXXIII. 
LXXIV. 
LXXV. 
LXXVI. 
LXXVII. 
LXXVIII. 
LXXIX. 
LXXX. 
LXXXI. 
LXXXII. 
LXXXIII. 
LXXXIV. 
LXXXV. 
LXXXVI. 
LXXXVII. 
LIST OF ILLUSTRATIONS (Continued) 
4,5-Dihydro-7,8-dimethoxynaphth[l,2-c]isoxazole (186). 
. - -
2,3a,4,5-Tetrahydro-7-methoxy-3!!_-benz[fii]indazol-3-one 
(3] 3) • • • • • • • • • • • . • • • . • . • • . . • . 
2,3a,4,5-Tetrahydro-7,8-dimethoxy-3H-benz[g]indazol-3-
one (207) .....•.•.... -:-- ... - ..... . 
-
2,3a,4,5-Tetrahydro-7,8-dimethoxy-2-phenyl-3H-benz[g]-
indazol-3-one (208) .....••..... - ... : . 
-
2-(E-Fluoroe~enyl)-2,3a,4,5-tetrahydro-1,8-dimethoxy-
3H-benz[gJ1ndazol-3-one (209) ......•..•. 
- - ---
2,3a,4,5-Tetrahydro-7,8-dimethoxy-3a-me~hyl-3H-benz­
[g]indazol-3-one (210) • . . • . . . • . . -:-- . . . . 
- -
2-Amino-4,5-dihydro-7,8-dimethoxynaphtho[l,2-d]thia-
zole (211) . . • . . • . ·. . · . . • . . . . : . . . . 
-2-Anilino~4,5-dihydro-7,8-dimethoxynaphtho[l,2-d]thia­
zole (212) . . . . . . . . . . . . . . ; . . : 
-
2-(Allylamino)-4,5-dihydro-7,8-dimethoxynaphtho-
[l,2-d]thiazole (213) ..•.......... 
- -
4,5-Dihydro-7,8-dimethoxy-2-methylnaphtho[l,2-d]thia-
zole ( 214) • . • . . . . . . . . . . . . . . - . . . . 
-
Methyl 3,4-Dihydro-6,7-dimethoxy-61 (2.!!),y_naphthalene-
crotonate (235) •.....•....•... 
.,,..._ 
6,7-Dimethoxy-l-naphthalenebutyric Acid (236) .• 
-
3,4-Dihydro-6,7-dimethoxy-1(2H)-phenanthrone (188) 
- -
3,4-Dihydro-2-(hydroxymethylene)-6,7-dimethoxy-1(2.!!)-
phenanthrone (237) . • . . . . . . . . . . . . . . . 
-
10,ll-Dihydro-7,8-dimethoxy-3H-phenanthro[l,2-c]pyra-
zole (215) ........ -:-- •....... - ..•• 
-
10,ll-Dihydro-3H-phenanthro[l,2-c]pyrazole-7,8-diol 
(216) ..•. -:-- ........ - .......... . 
-10,ll-Dihydro-7,8-dimethoxyphenanthro[2,l-d]isoxazole 
(190) ...•........•.•... - .. · .... 
--
xiv 
Page 
286 
287 
288 
289 
290 
291 
292 
293 
294 
295 
296 
297 
298 
299 
300 
301 
302 
LIST OF ILLUSTRATIONS (Continued) 
Plate Page 
LXXXVIII. 10,11-Dihydro-l-(£-fluorophenyl)-7,8-dimethoxy;..3.!!-
phenanthro[l, 2:...c]pyrazole (217). • . . • . • . . . . 303 
- -
LXXXIX. lO;ll-Dihydro-1-(p-fluorophenyl)-3H-phenanthro[l,2-c]-
pyrazole-7,8-diol (218) ••.•• - •..•.••• - 304 
-
XC. 2,3,4,5-Tetra-0-acetyl-a-D-glucosyl bromide (238). 305 
- = -
XCI. 1-8-:Q-Glucopyranosyl-4,5-dihydro-7-methoxy-lH-benz[g]-
indazole Tetraacetate (ester) (206) .... - ..• - 306 
-XCII. 1-8-D-Glucopyranosyl-4,5-dihydro-7,8-dimethoxy-lH-
be~z[g]indazole (201) ••..•......•. -. 307 
. - ~
XCIII. 1-8-2-Glucopyranosyl-4,5-dihydro-7,8-dimethoxy-l_!!-
benz [g]indazole (202). • • • • . . . . . • • • • . 308 
- -
XCIV. 3-8-D-Glucopyranosyl-10,ll-dihydro-7-methoxy-3H-phen-
anthro[l,2-c]pyrazole Tetraacetate (ester) (Z20) . 309 
- -
XCV. 3-8-0-Glucopyranosyl-10,ll-dihydro-7-methoxy-3H-phen-
anthro[l, 2-c]pyrazole (221). . • . • • • . . -. . . . 310 
- -
xv 
CHAPTER I 
HISTORICAL 
Pyrazoles 
It is surprising to note that only two naturally occurring pyra-
1 i i d 1244 d 2143,302,363 zo e-conta n ng compoun s,,,.... an .-.. are known, while synthet-
236 ic examples are innumerable. Knorr (in 1885) introdu.ced the name 
0 
I 
CH -CH-CO H 2 I 2 
NH2 
1 2 
- -
pyrazole for this class of compounds to denote that the nucleus was de-
rived from pyrrole by replacement of a carbon with nitrogen. N-Substi-
tuted alkyl- and arylpyrazoles continue to be a very important family 
in organic chemistry since Chemical Abstracts devotes an entire sub-
section to pyrazoles and derivatives. A survey of the literature re-
42 
vealed thirteen books, monographs, and review articles on pyrazoles ' 
197,211,219,243,254 d 1 d . . 130,227,310,385 ( d 
an pyrazo e erivatives concentrate 
in the years 1953-1967) besides the countless number of papers in the 
years 1885-1953. 
Seventeen different methods have foupd ~pplication in the labora-
1 
2 
tory as synthetic approaches to pyrazoles (excluding fused pyrazoles). 
A. Synthesis of Pyrazoles 
(1) From S-dicarbonyl compounds and their functional derivatives 
(ethers, enol ethers, acetals, enamines, etc.) with hydrazine and its 
derivatives: 
RC(O)CH2C(O)R' + R''-NHNH 2 
4 
-
... 
;:JR 
R' N 
I 
R" 
Sa 
-
+.pR' 
R,)(N) 
I 
R" 
Sb 
-
When the S-dicarbonyl compound is unsymmetrical (3, R ~ R'), two isomeric 
-
pyrazole derivatives (Sa and Sb) are usually formed if a substituted 
,,,...._. ..,,...._, 
hydrazine (4, R" ~ H) is used. Only a single compound is obtained from 
,....., 
hydrazine itself (4, R" = H) 20 ' 21 , 234 , 237 , 297 , 316 or by using symmet-
-
rical S-dicarbonyl compounds (3, R ~ .R.'). 
-
Many structural and experiment~! factors are involved in selective 
formation of one of the two isomeric compounds but at present the con-
trolling influence of such factors is not fully understood. In many 
experiments <the structure of the products has not been established, 4S, 
2Sl 31S . 
· ' or was assigned without definitive experimental evidence, or on 
. 10 19 23 the strength of simple analogies. ' ' Only in a few examples have 
structures been established on the basis of rather rigorous experimental 
i ~ 137,139,140,322 ev uence. 
Benzoylacetone (6) reacts with phenylhydra~ine to give a mono-
-
phenylhydrazone 7. As with other S-diketones, no bis-phenylhydrazone 
-
is obtained. On heating or by treatment with acids or with hydrogen 
chloride in pyridine, the phenylhydrazone is converted to a single 
30 product, 3-methyl-1,5-diphenylpyrazole (8) • 
..,,......, 
6 
_.,., 
7 
The reaction of hydrazines with S-keto aldehydes (a-hydroxymethyl-
ene ketones) appears to be more complex than the reaction with S-dike-
tones. For example, hydroxymethyleneacetone (9) and phenylhydrazine 
3 
yield, in acetic acid solution, the two possible isomeric pyrazoles (lOa) 
. .,,....._ 
and (lOb). 95 •96 Several attempts have been made to devise methods for 
.-
9 lOa lOb 
-- - -
the selective synthesis of one of the two possible isomeric pyrazoles 
through the use of specific functional derivatives of a S-dicarbonyl 
compound such as acetals of S-keto aldehydes, enol ethers, enol esters, 
enamines and 13-chlorovinyl ketones. 
The following examples represent only a small fraction of the many 
that can be found in the literat11re: 
4 
z R Reference 
Alkyl-0 (12) E-02NC6H4 
-
78 
Alkyl-0 (13) CH3 
-
78 
c6H5C(O)O (14) C6H5 
-
78 
c6H5-C(O)O (22) E-02NC6H4 78 
Cl (16) C6H5 
-
297 
3 
CH3C(O)CH2CH(OR') 2 + RNHNH2 
17 
O CH 
N/ (Ref. 138) 
-
I 
R 
18 
--- -~ 0 Hsc/Z N/'N 
I 
CH3C(O)CH=CHNHC H + C H -NHNH 
. 6 5 6 5 2 (Ref. 47) 
C6H5 
(2) From acetylenic carbonyl compounds with hydrazine and its 
derivatives: Hydrazine gives pyrazoles directly a-:.1d the open-chain com-
36 63 pounds 21, 22 have never been isolated, ' when R=H. When a substi-
,_ """ 
tuted hydrazine is employed, the two isomeric pyrazoles 21 and 22 may be 
~ ~ 
formed. However, methylhydrazine (~ R" = CH3) and phenylpropiolalde-
RC(O)c::c-R' 
19 
--
+ R"NHNH 2 
20 
~ 
..,. R-c-c::c-R' 
II 
N-NH-R" 
21 
R 
_ __..,. n R'"',{~N ;N 
R" 
23 
_, 
R' 
RC(O)CH=C-R' D R"-NH-~H --1·P I \ 
R N/ 
22 
--
I 
R" 24 
-
5 
hyde (~, R = tl, R' = C6H5) give a single pyrazole, l-methyl-5-phenylpyrazole 
(~ R=H, R' = c6H5, R" = CH3). 28 Apparently, formation of the methyl-
hydrazone (3,!, R = H, R' = c6H5 , R" = CH3) is favored over the addition 
of the hydrazine to the triple b·Jnd. Another unexpected result is the 
reaction of phenylhydi:'azine or semicarbazide with phenylpropiolaldehyde 
<J.2, R = H, R' = c6H5) which gives only the hydrazone derivative, JJ, 
30 
and not the corresponding pyrazole. This has been attributed to the 
formation of a "trans" form of the hydrazone, 21, which cannot cyclize. 
-
(3) By ring closure at the 4,5-positions: A few examples are 
known of this type of synthesis. One case includes the cyclization of 
some l-aroyl-1-phenylhydrazones of S-keto aldehydes 25 (benzoylacetalde-
-
hyde and e-toluylacetaldehyde) in the presence of alcoholic NaOH. 25 
25 
--
e 
OH 
26 
-
6 
More recently, 9 hydrazinoacetic esters 27 were allowed to react with a-
-
dicarbonyl compounds 28 and resulted in ring closure at the 4,5-posi-,._ 
tions. 
co2R + 
I 
CH _N -NH2 2 I 
R' 
27 
-
C(O)-R" 
I 
C(O)-R"' 
28 
-
R"'= CH3 
R" -C(O)- fi- R'" 
JCH2, N./ N 
---,· R02c ~' 
29 
-l 
R" 111 
R02Cl)R 
R 
30 
--(4) From 1,2,3-tricarbonyl compounds and their functional deriva-
tives with hydrazine and its derivative: Compounds containing three 
adjoining carbonyl groups 31 react with hydrazine to yield 4-hydroxy-
,,,.-..-
pyrazoles (33). 335 Further clarification is required to explain the 
~ 
NH 
RC(O)C(O)C(O)R' RC(O)CHOHC(O)R' 2 4~ 
HO R 
)3. --o~N 
R=R'=CH 3 
R', N/ 
' H 
33 
--
course of this type of reactions, since a reduction process is involved, 
and the role of hydrazine is not understood. Arylhy-
36 
-
R-C(O)C(O)C(O)-R' 
31 
,.__; 
R'r1N-N-c6H5 
l~"-N~ R' 
b6H5 ""------
R-C - C-N=N-C H 
II II R' 6 5 
N C,.... 
"-NH'OH 
I 
C6H5 
35 ,...__,, 
34 
--
298 drazines behave differently to form 4-(arylazo)pyrazoles, probably 
through formation of osazones 35 as intermediates • 
............ 
(5) From a-halo carbonyl compounds with mono- and di~thiocarbo-
hydrazide: The reaction of ~-alkyldithiocarbohydrazides 38 with a-halo-
_....._ 
336 
carbonyl compounds 37 results in 3-alkylmercaptopyrazoles 40. The 
-- '"'-
R-CH-Cl 
I 
R'-C=O 
37 
-
+ 
HS SR" 
'c ...... 
II 
N 
I 
NH-R''' 
38 
-
-----..lllJlo lR~~('r-R" 
'N,..... 
~"' 39 
s + 
mechanism of this reaction is still unknown. Formation of 1,3,4-
7 
thiadiazine .'.!2_ which later was desulfurized was proposed with no further 
evidence. 
(6) From aldehyde arylhydrazones with f3-keto esters: Arylhydra-
zones of aliphatic and aromatic aldehydes 42 condense with f3-keto esters 
~ 
0 41 in presence of anhydrous zinc chloride at 120-140 to yield esters 
_... 
287 
of pyrazole-4-carboxylic acids 43. 
--
reaction are not known. 
c2H502c-1H2 CH-R' ZnC12 
+ ~ C=O 
'NH R/ I 
Ar 
41 42 
--
The intermediate steps in this 
C2H502DR' 
.... R ,....N N 
I 
Ar 
43 
.,...._, 
8 
(7) From aliphatic diazo compounds: (a) With acetylene deriva-
tives: Acetylene derivatives react readily with aliphatic diazo com-
pounds to yield pyrazoles. With some asymmetrical acetylene derivatives 
the addition of the diazoalkene system to the triple bond usually takes 
1 i i . i 1 d 111,231 p ace g v ng rise to a s ng e pro uct. · With other substituents 
RCHNZ + R'-c=c-x Ill> 
):JR 
j!!., il 
x :tt1"/ 
46 H 
-two isomeric products are obtained. Thus, phenylacetylene and ethyl 
phenylpropiolate (':J) give isomers ~ and ~· 231 
C/ C6H5 
• C6H5 R 
C2H502DR J!j 
• f ~ + ~ ~ RCHN2 + Ill c 
C6H5 ~ /N C2H502C lj'l/ N ......... co2c2H5 
H H 
47 48a 48b 
- - -(b) With malonic esters: Some substituted malonic esters and 
diethyl malonate (50) yield 4-hydroxypyrazole derivatives by reaction 
.......... 
· with ethyl diazoacetate ~ in the presence of Naoc2H5 . 
49 
08 
I 
~-OC2H5 
CH-co2c2H5 + 
49 50 
-
--
(8) From hydrazonoyl halides: (a) With alkaline salts of com-
pounds containing activated methylene group: One of the more general 
syntheses of the pyrazole ring utilizes the reaction of hydrazonoyl 
the anion of activated methylene compounds as 54. The products are 
-
substituted pyrazoles (~ R' = H, aryl or alkyl group, X = an acti-
52. 
vating group, e.g., C02R, C{O)NH2 , CN, S02R, C(O)R, etc.) 
R-C-Hal 
" N-NH 
I 
Ar 
53 
_.., 
+ 
GNa@ 
CH-X 
I 
C(O)-R' 
54 
~ 55 
--
(b) With enamines: The importance of this relatively new proce-
dure is that it offers, generally in high yields, compounds (e.g., 4-
148 149 
alkylpyrazoles) that are not easily obtained by other methods. ' 
Open form (like 322 or cyclic form (like 57) intermediates have been 
__..., 
148 149 postulated: ' 
+ ... 
c6H5NH-T, 
c:) 
--0 C2H5C02- C 
co2c2H5 I 
w 
C6H5 c:i 
56 
,,.......,. 
57 
,,,.._, 
9 
10 
(c) With organomagnesium derivatives of acetylenic compounds: 161 
This is a novel method and only rarely found in the literature. 
R 
R-C-Hal BrMg-C CTR' Ill + MgBrHal " + R'-C ~ N, NH I 
I Ar 
Ar 59 
_. 
60 
-
B. The General Character of Pyrazoles 
(1) Tautomerism and isomerism: Three tautomeric forms can be 
written for unsubstituted pyrazoles{.§2:... E, and illand five forms(~ 2, 
66, 67, 68)for compounds in which the two carbon atoms adjacent to nit-
- - -
rogens carry different.substituents. QR 0 0 0 ~/ ~/ N/ 
H 62 63 H 64 o: - OR - CR -OR 61 - /"' N N N~ N 
65 66 67 68 
- -
- -
Evidence for only the common forms ~and ~has been obtained. 
However, forms 62 and 66 and forms 63, 67, and 68 can apparently exist 
.,,..__,. .......,; ,.._. ,,.._, ,,,,.._. 
1 . h d . . 42 ' 243 . h. h 11 f h d f th on y wit erivatives in w ic a our y rogen atoms o e nu-
. 12 200 201 
cleus are substituted. ' ' Such compounds often show a tendency to 
rearrange to yield "true" pyrazoles. 42 ' 243 Alkylation or arylation of an 
unsymmetrically substituted pyrazole .§.2 yields normally two isomeric prod-
ucts 71 and 12. 73 This establishes that the hydrogen atom can be bound to 
- -
either nitrogen atom in the parent molecule. Actually when alkylation is 
11 
e 
+OH 
RDR' 
69a 
--H 
.. ~~· 
.... 
.. 6911 R N 
e 
+OH 
-H@ DR' 
R N/ 70 
__. 
-H@ 
< > Ro: 70 
,..-
e 
+R"X !(JR' 
R ~/ 
R" 
R' +R"X 
RCN"R" 
71 72 
- -
carried out in presen~e of strong base, intermediate formation of a 
resonance-stabilized anion 70 has been postulated. It is impossible to 
____.. 
represent by a classical structure a pyrazole molecule in which a hydro-
gen atom is connected equally to two nitrogen atoms, but complete sym-
f h . 1 1 . .bl 243 metry o t e monomeric mo ecu e is possi e. The system may be 
described as one which includes an aromatic sextet of ~-electrons with 
R&R 
H 
the double and single C-C and C-iJ bonds of equal length, and possessing 
a hydrogen atom in some way connected to both nitrogen atoms simul-
252 taneously. 
(2) Spectroscopic properties: Nuclear magnetic resonance studies 
of pyrazole structures have established the relative amounts of the 
. . . 143 16 7 282 388 tautomers present under different conditions. ' ' ' It has 
57 141 been found ' that the hydrogen atoms in positions 3 and 5 of N-sub-
12 
stituted pyrazoles for some reason have the same chemical shifts, though 
The effects of several shift reagents on the PMR spectra of some 
pyrazole derivatives have been recorded. 97 The effects of substitution 
(on the pyrazole ring), lanthanide-shift reagents, solvent changes,and 
tautomerism were investigated by the 13c chemical shifts of some pyra-
132 
zoles. It was concluded that 13c chemical shifts are of limited 
value for ascertaining the positions of tautomeric equilibrium for 
rapidly interconverting azole tautomers. 132 The synthesis and NMR spec-
tra of some heterosteroids with a pyrazole D ring was reported by J: 
Lematre and J. Soulier (1967). 252 
NMR analysis indicated the phenyl group at position 15 of 78 exerts 
.......... 
a long-range shielding effect on the proton of position 7,which appears 
as a doublet centered at 7.05 ppm (J6 , 7 = 8.5 Hz). Similarly, NMR 
analysis showed 80 had the methyl group situated on N-16. 252 
~ 
A rather comprehensive analysis of the ultraviolet spectra of more 
than 50 pyrazoles was recorded86 in various solvents and conditions of 
pH. Alkylpyrazoles show maxima in the region 210-225 nm (log E = 
max. 
3.5-4.0). A small bathochromic effect of alkyl substituents as a rule 
does not exceed 2-3 nm. _The maxima for all arylpyrazoles lie between 
250-280 nm (log E = 3.4-4.2). The introduction of such chromophoric 
max. 
groups as -No2 , -C(O)R, -CHO, -co2c2H5 into alkylpyrazoles gives rise to 
a bathochromic shift of the order of 25-40 nm. 86 , 162 Ultraviolet spec-
78 tra of various pyrazoles are.available .from other sources too. 
Infrared analysis of pyrazoles in the crystalline form and in con-
centrated solution reveal an absorption band corresponding to the N-H 
74 
-
73 
--
i 
02C2H5 
75 
-
Figure 1. Synthesis 
76 
-
78 
-
+ 
J._9s_ 
co2c2H5 
.... 
-------..... 
77 ,,.._ 
252 
of Some Phenanthropyrazoles 
co2c2H5 
J..2b .. --. 
co2c2H5 
80 
.--
...... 
w 
14 
-1 group at 2.7-3.0µ (3500-3100 cm ), the breadth of the band suggesting 
. 275 hydrogen bonding. It was concluded that the association of pyrazoles 
may be either linear or in cyclic dimers or trimers. 14 
0---H i I H---o 
Infrared spectra of other pyrazole. derivatives are included in a 
number of papers.65,162,164,275 306 Orgel (1951) noted that the maximum 
electron density occurs at C(4), in agreement with the results of elec-
trophilic substitution experiments. The mass spectrum of pyrazole re-
67 
vealed an intense molecular ion. The ·!!}_l!i:_ 41 peak most probably re-
sulted from loss of HCN from the molecular ion whereas m/!i:._39 can be due 
+ to c3H3 • 
® -H· e: ~ -·~~+ ~ • N/ h H 
+ M, "!!!_/ !!:... 68 "!!!/!!:... 68 "!!!_/ !!:... 41 
-y l-N2 Jr 
+ 
~+ -H· ~: $1 --+ HC:::NH ~ "!!!_/ !!:... 28 
.....-c~.+ m/~ 39 "!!!_/ !!:... 40 H NH 
"!!!_/ !!:... 40 
15 
Th i b i "bil" · h 67 i f I 40 ree so ar c possi ities were s own to ex st or .!!!. ~ • The 
i I 28 i l "k 1 d +· +. on at.!!!_~ s most. i e y ue to CH2N rather than N2 . 
The mass spectrum of l-ethyl-3,5-dimethylpyrazole67 has an intense 
M+-CH3 ion, showing the importance of a-cleavage in B_-alkylpyrazoles. 
Ring expansion of the ion may be produced via rearrangements of C-C or 
+ N-C bonds. As expected, the M -cH3 species shows marked loss of CH3CN . 
~/~ 96 (100%) .!!!_/~ 109 (84%) 
A 
(C-C 
CH3wj CH3 CH3~CH3 
~ + N H-~z.oJ 
rearrangement) ~/ .._. 
H 
(N-C rearrangement) 
(3) Biochemical and medicinal applications of pyrazoles: The use 
of pyrazole derivatives in medicine is undoubtedly the principal one. 
Certain alkylpyrazoles have shown quite significant bacteriostatic, 
b . id 1 d f i id 1 . 127,163,176,268,324 acterioc a , an ung c a actions. In this re-
spect sulfonamides based on pyrazole ("sulfapyrazoles") are of particu-
lar interest, e.g., Orisul (81), which has a prolonged bacteriostatic 
i . . 7,165,320 act on in vivo. 
..-...... 
16 
81 
-
Alkyl- and arylpyrazoles have a sharply pronounced sedative action 
on the centrai nervous system. 311 •375 Steroidal compounds whose struc-
tures includ'e pyrazole rings are of interest as possible psychopharma-
cological agents.lOO,l02 Pyrimidinopyrazoles are being studied in the 
151 fight against cancer. I . f 1 h . d395 f n a series o pyrazo es synt es1ze or 
the most part by the reaction between S-diketones and hydrazines or 
semicarbazides, 2-benzoyl-3, 5-dimethylpyrazole appeared to be more active 
than 3,5-dimethylpyrazole in preliminary screening. 
C. Pyrazolosteroids 
The first pyrazolosteroid was 5 1 -:carboxycholest-4-eno[3,2-.s:_]pyra-
zole (82) 334 obtained by condensation of 2-oxalylcholestenone with 
- C8Hl7 
82 ,.._ 
hydrazine. Additional transformations were performed on 2-oxalyl-17a-
methyldihydrotestosterone, which 
OH 
was obtained from ethyl oxalate, sodium 
...-cH3 
H 8} 83 
- 84 ,..._. 
h ·d d h d. 3 k ·d 332 met ox1 e, an t e correspon 1ng - etostero1 . 
It has been mentioned previously that steroido[3,2-c]pyrazoles 
form a new class of steroid hormones with interesting physiological ac-
tivity. lOO The main method of synthesis of the compounds of this class 
17 
is the condensation of ~-hydroxymethylen+3-ketosteroids with an excess 
of hydrazine. The requisite hydroxymethylene ketones are obtained by 
HO:x} 
formylation of the corresponding ketones with ethyl formate in the 
presence of NaH or Naoc2H5 (in c6H6 or dioxane) with either saturated 
or unsaturated ketones. 326 
It would be expected that the condensation of ~-hydroxymethylene)-
3-ketosteroids with substituted hydrazines should give, depending on 
the reaction conditions, mixtures of l'- and 2'-substituted pyrazoles 
85a and ..§.2!>. 
R-Nxt 
'N-- } \xt] 
k 
85a 85b 
- -
However, it was shown 102 that for an alkylhydrazine (in which the 
substituted nitrogen has more nucleophilic character) only the isomer 
~ was obtained. For phenylhydrazine, the S-nitrogen atom was more 
nucleophilic and isomer 85b was obtained. 
- 181 182 Extensive studies of the steroidopyrazoles have been reported ' 
in which certain 8a-pregn-4-eno[3,2£]pyrazole derivatives 86 (based on 
-
cortisol and its 16 a-methyl and dihydro derivatives) were prepared 
through hydroxymethylene precursors. 
- - -OH 
-- - CH 3 
86a-c 
, ...,-
18 
where in (a), R = H; R' = H; in (b), R = CH3Co; R' = c6H5 ; X H,F 
in (c), R = H; R' = :e-F-C6H4; X = H,F. 
Treating the acetate 87 in two steps 
-
formed the corresponding 
Sa-pyrazole 89. 
-
87 
-
OCOCH3 
A series of 5'-amino-substituted steroidopyrazoles were obtained 
by condensation of 2a-cyano-3-ketosteroids with hydrazine. 
R=H, CH3 
The 168, 20a-isopropylidenedioxysteroids of type 90 are also of 
..-.... 
interest for the synthesis of steroidopyrazoles. They are readily con-
verted into 16,20-diones, which with hydrazine in ethanol form 
pyrazole derivatives 91 in which the heterocyclic ring is condensed 
__, 
with a steroid component in positions 16 and 17. 121 Other analogs were 
• 
90 
-
,1'r> 
----•P 
91 
-
19 
also obtained from 5cx-pregnan-3S, 16S,20o:-triol. 225 
Synthesis of [17,16-.£.]pyrazoles of the androstane and estraneseries 
. . 331 is conveniently effected by treatment of 17-ketosteroids with ethyl 
formate or diethyl oxalate in the presence of sodium hydride or methoxide 
with subsequent cyclization with hydrazines of the 16-formyl derivatives 
obtained. 
0 
N-N-R" 
0 
+iYc(O)R' 
.. ,)-1 
~R' 
---111t•)-J 
RO 
On heating in a bomb with methyl iodide, l'-methylsteroido[3,2-_£]-
pyrazoles are converted into l',2'-dimethylpyrazolium salts, which are 
stable, high-melting compounds, but of relatively low solubility in 
102 
water. 
All the androstrano[3,2-_£]pyrazoles have a characteristic absorp-
tion maxima. in the UV spectrum at 223 nm (E ~ 5000); this band is dis-
placed in 0.01 ! alcoholic HCl solution to 229 nm (E ~ 6200). When a 
conjugated double bond is present, th~ steroidopyrazoles have absorption 
maxima in the 261 nm region (E ~ 10,000). The bathochromic shift of 
the maxima ~n the acid solution is explained by the protonation of the 
pyrazole ring, since such a phenomenon is not observed in alcoholic 
alkali solution. 102 
The fusion of a coplanar pyrazole ring to the steroid nucleus leads 
to substitution of the C(3) oxygen atom by nitrogen, which changes the 
nucleophilic environment in this region. In this instance there is a 
change in the distance between the active centers of the steroid mole-
20 
0 
cule at C(3) and C(l7), since the length of the C=N bond is ca. 1.4 A, 
0 
and the length of the C=O bond in the original ketone is 1.2 A. This 
shows some influence of the strength of the bond of the steroid molecule 
with the chelate receptors and can lead to selectivity in the reaction 
102 between the steroid and the receptor. 
A significant fall in the estrogenic activity of certain [3,2_~_]­
pyrazolosteroids' has been observed. 102 , 308 Such physiological activ-
ities were absent for compounds with the pyrazole ring attached to posi-
tions 16 and 17. 331 
The [3,2-_£]-2'-phenylpyrazole of 9a-fluoro-6,16a-dimethyl-~6-hydro-
cortisone (86c) has been claimed to be the most potent anti-inflammatory ,...., 
steroid yet known, being some 2000 times as potent as hydrocortisone in 
357 the rat systemic granuloma assay. Other compounds of the series in-
elude the .[3,2-E_]pyrazole of 16a-methylcortisone1which has four times 
the activity of the parent steroidl57 and the [3,2-_£]pyrazole of 9a-
fluoro-16a-methylhydrocortisone ~aJwhich has 10 to 20 times the activ-
181 ity of hydrocortisone. . · 
Certain steroidal [3 ~ 2-_£]pyra.zoles102 'lOO are already known to 
posess very favorable anabolic-to-androgenic ratios. One representative 
of these compounds1 17a-hydroxy-17a-methylandrostano[3,2-_£]pyrazole ~), 
has shown to be active by the oral route on a preliminary clinical 
trial. 102 
Dimethyl carbamates and dialkyl phosphates of 5-hydroxypyrazoles 
h b d h 1 . . i h"b" 136,170,383 ave een use as c o 1nesterase n 1 1tors. There is some 
100 
evidence that 3,5~dimethylpyrazole has a stimulant action on plants. ' 
102 Besides the traditional interest in pyrazole derivatives, which has 
been the basis of numerous dyes and drugs, a number of pyrazole anesthe-
21 
300 373 tics have appeared. ' 
The hypocholesterolemic and antiatherosclerotic effects of 17a-
methyltestosterone (93) and a new protein-anabolic steroid, 7a-ethylthio-
.r.J 
17S-hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole (~),have been com-
H - OH 
---CH 
3 
0 
92 93 
---
_, 
pared in male rabbits fed a diet supplemented with cholesterol and co-
·1 291 conut 01 • Methyltestosterone (93)does not lower serum sterol levels 
-
significantly when administered subcutaneously at 0.3, 1.0, or 3 mg/kg 
(body wt.) at 48-hr. intervals. Under the same conditions, 92 is an 
,,,......,. 
effective hypocholesterolemic agent; a 20% lowering was reported at 
doses of 3 mg/kg. 77 It also brought about an increase in the oxidation 
14 bile of cholesterol-4- C to acids of male rats with bile fistula, and 
the fecal excretion of 14c-bile acids from ingested tagged cholesterol 
was increased. In rabbits the frequency and severity of artificially 
induced atheroma was noticeably decreased by pyrazole 92. 291 
,.,........ 
D. Tetrahydroindazoles 
(1) Synthesis ancl biological application: Cyclotetramethylene-
C» 94 
-I R 
pyrazoles (94) [or cyclohexenopyrazoles: or 4,5,6,7-tetrahydroindazoles, 
-
R = H] are usually prepared by the reaction of(z-hydroxymethylen~yclo-
5 hexanone with hydrazine hydrate. Presumably the intermediate is a 
hydrazone, which should lead to a 2-substituted derivative 94a when a ,,,._ 
22 
substituted hydrazine is employed. However, the 1-derivatives appear 
---·- CCOH----1•• COR 
I 
NHR 94a 
..--
in many cases to be the more stable, and the product may consist en-
22 
tirely of the 1-substituted compound. The enol acetate or benzoate 
may provide a more convenient starting material than the hydroxymethyl-
42 
ene compound. 
Ring closure of 2-chlorocyclohexanone phenylhydrazone is a report-
ed preparation of tetrahydroindazole. 248 2-Cyclohexanecarbaldehyde 
338 behaved similarly with hydrazine hydrate. Diazomethane and cyclo-
hexene gave tetrahydroindazole in poor yield. 286 Tetrahydroindazoles 
have also been obtained by the hydrogenation of certain indazoles using 
Pt in acetl.·c aci"d. 147 Th · · f t t h d · d 1 d e imino group o e ra y rain azo e un ergoes 
dialkylation readily. 29 Fractional crystallization of the picrates or 
perchlorates of 1- and 2-substituted alkylated products was commonly 
used to separate the isomers. 8 
67 . 
Bredereck and co-workers were able to 
obtain 4,5,6,7-tetrahydroindazole [(94), R = H] (24%) by condensing 
-
2-(dimethylaminomethylene)cyclohexanone with hydrazine. 
347 Scuri and co-workers have recently shown that substituted 
tetrahydroindazoles like 95 exhibited analgesic action superior to that 
_,_,, 
95 
,,,....,, 
of phenylbutazone, acetylsalicylic acid, aminopyrine, and benzidamine. 
The anti-inflammatory activity of 95 was found to be equal to that of ,...., 
23 
phenylbutazone. The authors labeled the compound "tetridamine" and sur-
veyed it pharmacologically in mic~rats, guinea pigs, and cats. Tetrida-
mine showed antitussiv~>local anesthestic,choleretic, and spasmolytic 
activities. Unlike many other antiinflammatory drugs, this compound 
was not ulcerogenic .and was able to prevent the formation of experimental 
ulcers. N-Substituted tetrahydroindazoles ·1 303 ike 96 were demonstrated 
,..,, 
to have some herbicide activities. It was also used as a plant growth 
regulator. 
(2) Spectral properties of tetrahydroindazoles: (a) NMR and UV 
studies of N-substituted isomers: Albright and Goldman8 and later 
Butler8 used NMR to differentiate between isomeric tetrahydroindazoles 
98 and 99. Reaction of 2-(hydroxyrnethylene)cyclohexanone (97) with 
- - -
97 98 99 
- - -l Pd/C,O 
00-CHJ 
100 
.--
methylhydrazine in methanol at 0° gave a mixture of 2.§,29 (14%) and 2j22 
(86%) as shown by NMR: analysis, while reaction of methylhydrazine sul-
24 
fate gave a mixture of 1:2 98 (33%) and 99 (67%). Reaction of the mix-
-- -
ture with picric acid, followed by repeated recrystallizations of the 
mixture, gave pure picrate of ,22· The picrate was converted to _22. 1 
which when dehydrogenated with 10% Pd-C in boiling decalin6 ' 242 pro-
duced 2-methylindazole (100). 24 The characteristic UV spectrum of 100, 
- ..,....,. 
which differs significantly from that of 1-methylindazole (98) 45 , 33o, 
allowed the unequivocal assignment of structure 99. 
-
-
The mixture of 98 and 99 showed signals in the PMR spectrum at 
- ;-V. 
o 3.70, o 3.80, o 7.03 and o 7.25, while in pure 99 the signal of the 
---
methyl group was observed at o 3.80 and the pyrazole proton at o 7.03. 
Therefore, the signals at o 3.70 and o 7.25 in the spectrum of the mix-
ture were attributable to 98. 
_..,, 
From these spectra it is apparent that when the methyl group is on 
the pyrazole nitrogen which is bonded to the carbocyclic ring, the ab-
sorption appears at higher field* and in the pyrazole proton signal at 
lower field (structure 98) than in the isomer (structure 99). The dif-
__, . .-... 
ference, therefore, between the chemical shift of the methyl proton 
signal and the signal for the proton on the pyrazole nucleus is charac-
teristic for each isomer and may be used to assign structures to isomeric 
pyrazoles. Additional examples are summarized in Table I. 
* Similar variations in the chemical shifts of C(l8) and C(l9) 
methyl groups in steroids have been discussed by N. S. Bhacca and D. H. 
Williams ("Application of NMR Spectroscopy in Organic Chemistry", Holden-
Day, Inc., San Francisco, Calif., 1964, p. 16), who pointed out that 
"as a given angular methyl group is able to 'see' less of the remaining 
skeleton, it will appear at lower field". 
TABLE I 
NMR SPECTRA OF ISOMERIC !!-METHYL-3(5)!!_-PYRAZOLES8 
Compound 
l-Methyl-4,5,6,7-tetrahydroindazole (98) 
""""'-' 
2-Methyl-4,5,6,7-tetrahydroindazole (99) 
""' 
17-(l-Methyl-5-pyrazolyl)-5-androsten-3S-ol acetate (101) 
~ 
17-(l-methyl-3-pyrazolyl)-5-androstan-3S-ol acetate (102) 
. -"'-
17S-Hydroxy-17a-methylandrostano[3,2-c]2'-methylpyrazole 
(103) -
-~ 
Chemical Shift (o) 
Pyrazole Proton 
7.25 
7.03 
7.42 
7.27 
7.79 
N-CH 3 
3. 70 
3.80 
3.83 
3.87 
4.25 
oH-oN-CH3 
3.55 
3.25 
3.59 
3.40 
3.54 
N 
\JI 
AcO AcO 
101 102 
-
-
103 
-
Albright and Goldman8 examined the PMR spectra of pyrazoles 104-
. 394 107, whose structures were known from their UV spectra. 
·--
(02.30) H3c......._. _ __,H (06.08) (02.17) H3C ..,._.____,. 
I 
(82.27) 
N 
'N 
I 
CH3 
(03.80) 
106 
--
N ~ 
H C/ '-N 
3 
(83.65) 
105 
-
107 
__, 
(06.23) 
26 
27 
The !'!-methyl proton signals of pyrazoles ~ and ~are found at 
lower field than in the corresponding isomers 105 and 107. This shift 
- -
to lower field may be attributed to deshielding by the aromatic groups 
which are in close proximity to the methyl groups in structures 104 and 
-
106. 
_-.,... 
The UV spectra of !Qi and ~provided evidence for such interac-
tion, for inhibition of resonance of the aromatic group with the pyra-
394 . . 37 
zole nucleus had been noted. Jacquier and co-workers (1967) con-
firmed these results by preparing some substituted !'!-nitrophenyltetra-
hydroindazoles and comparing their NMR and UV data simultaneously. 
(b) Mass spectral data: The mass spectrum of 4,5,6,7-tetrahydro-
indazole (94) was studied by Audier and co-workers18 in 1971. ,,,..._ 
av 
H 
~/~ 121 
~/~ 94 
~/~ 94 
---.-. -~ Ccv 
H 
~/~ 121 
28 
The mechanistic fragmentation pathways were reported by those 
authors. 125 For the 7-methyl analog, the following scheme was suggested. 
J!!./~ 108 
+· 
m* ~ ~N):S 
. 
H 
+ M , J!!./~ 136 l 
!!!_/~ 94 
Considerable effort on a variety of pyrazoles is needed in this 
field before fragmentation patterns can be rapidly used as a diagnostic 
tool to identify unknown pyrazoles. 
386 Pyrazolones 
One of the first synthetic organic drugs to be marketed and used 
before the correct structure had been assigned was 3-methyl-l-phenyl-2-
pyrazolin-5-one (108). It was prepared by the reaction of ethyl aceto-
~ 
29 
acetate with phenylhydrazine by Knorr in 1883. 235 
108 
---
Pyrazolipones and pyrazolidinones are oxo derivatives of pyrazolines 
and pyrazolidines, respectively, and are so named in Chemical Abstracts 
at present. However, the usual method of naming in the earlier litera-
ture is the pyrazolone-pyrazolidone system. Although a large number of 
tautomeric structures are possible for pyrazolinones, the usual assign-
ment is as shown in 109a, 109b and 109c. 
---- ,....._.. -
Oo R),N::lo 
,....o 
CT I I I H H H 
109a !Q9JJ. 109c 
--
-
(1) Synthesis of 2-pyrazolin-5-ones: By far the most widely used 
synthesis for 2-pyrazoline-5-ones is the condensation of a S-keto ester 
with a hydrazine. 4 
0 :K' 0 
II i ti 
R '-C-C-COR + R"' NHNH2 I 
R 
______ .,. RU" I R 
'N 
I 
R'" 
274 This procedure was modified by using S-thiono esters, a-oximino 
329 d 0 k .d 346 esters, an µ- eto am1 es. 
A useful synthesis for 3-pyrazolin-5-ones is the condensation of a 
S-keto ester with acetylphenylhydrazine. The acetyl group is lost and 
30 
the phenyl group appears at N(2). 271 If a symmetrically substituted hy-
0 
R'C(O)CH2C02R" + C6HSNllNHC(O)CH3 .. ROH 
I 
C6H5 27 
drazine is used 1,2-disubstituted-3-pyrazolin-5-one is produced. 
A modified method of synthesis is the use of acid hydrazides. 4 ' 55 
i-fo 
• H C~N _....N-..... 3 H 
In addition to S-keto esters, the corresponding amides and anilides 
68 346 have been employed in a number of cases ' under very mild conditions. 
(2) Spectral properties: Ultraviolet and infrared analysis have 
established that pyrazolin-5-ones 109a, 109b, and 109d were chief tauto-
- - -
a 1),NJ.o 0 0 
I I I H H H 
109a !.Q9b_. 109c ,...._ 
-
109d 
-
56 
meric contributors. It has also been found156 that l-arylpyrazolin-5-
ones with no N(2) substitutents are usually of type 109a since no imino 
-
or hydroxyl absorption occurs in the infrared spectra of 1,4-diaryl-2-
pyrazolin-5-ones. The presence of an absorption peak at 2400-2700 cm-l 
for some pyrazol-5-ones was attributed to the presence of zwitterionic 
359 forms such as shown. 
H 
3a,4,5,6-Tetrahydrobenzo-6,7-cyclohepta[l,2-c]pyrazol-3(2H)-one (110) 
- ,.._ 
enolizes readily and can be titrated with sodium hydroxide solution 
(PKa 9.69). 1.16 h ( ) T e NMR spectrum in DMSO shows a broad two-proton 
peak at ca. 10.65 ppm (NH and OH) indicating a structure as llOa. 
110 (C=O form) 
--
110a (OH form) 
-
The complex tautomerism of N-substituted pyrazolin-3(5)-ones was 
studied by A. R. Katritzky224 using UV spectroscopy and basicity meas-
31 
urements. In aqueous solution (polar medium) the stability of the form 
was lllb> llld> lllc> llla whereas for cyclohexane solution (nonpolar 
- - - ,,,,,_-
medium) the order was llld> llla> lllb, lllc. 
- ----
DCH3 DCH3 ...-CH UCHj I I 3 -
N 0 N/ 'H H~ HO "'-ii ,.-11..,_H 
t I H 
H H 
1lla 11lb lllc llld 
- - - -
The tautomerism of l-aryl-2-pyrazolin-5-ones not bearing a 3-sub-
135a 
stituent has been studied by P. Pauwels using NMR and IR spectro-
32 
scopy. In CC14 and HCC13 compounds without a substituent at C(4) exist 
essentially in the CH form (llla). However, with a 4-ethoxycarbonyl 
-
substituent the NH form (lllb) is favored. 
-
In addition to NMR data which supported fonm llla, IR spectroscopy 
.....--
was used to distinguish between the OH form lllc and the NH form lllb. 
- -13 Recent CMR analysis suggests that pyrazolin-5-one exists mainly in the 
OH form. 309 
The pyrazol--3- and 5-ones can exist in a number of forms, namely 
112a, 112b and 112c. PMR spectra of a number of these compounds have 
-- - ~ 
"D H I J:N',~ JCJ 0 N_.....N HO . / I I I 
R R R 
112a 112b 112c 
-- -- -
2 (f:l -5-one form) . 3 (l:l -5-one form) (3-0H form) 
been used, in conjunction with other spectroscopic techniques, to de-
i h f h d . . 1 i 213 d term ne t e structure o t e pre ominant tautomers in so ut on an 
2 . 
to identify definitively the l:l -5-one structures. Thus, in cc14 or 
DCC13 solutions, compounds without a 4-substituen't have been shown to 
• . 2 299 
exist essentially in the l:l -5-one form. However, in the presence of 
a 4-ethoxycarbonyl substituent, the l:l2-5-one form predominates. 
15 . 255 Labeling ( N) studies and NMR analysis were reported on 
3-anilino(15~)-l-phenyl-2-pyrazolin-5-one (113). The only species 
--
33 
present in DCC13 , pyridine, or DMSO was the ~-oxo amino isomer as shown 
15 by absorption by the· 4-methylene group and. the presence of N-H coupl-
ing in the 15N-anilino derivative. 
(3) Medicinal applications: Since the synthesis of antipyrine 
(2,3-dimethyl-l-phenyl-3-pyrazolin-5-one) by Knorr in 1883, pyrazolin-
ones have been widely used in medicine as analgesics238 and anti-
238 pyretics. The discovery of this drug led to a widespread search for 
other effective pyrazolinones and led to the discovery of aminopyrine 
(4-dimethylamino analog of antipyrine) and phenylbutazone (4-butyl-l, 
2-diphenyl-3,5-pyrazolidinedione) and their application in medicine. At 
the present, antipyrine enjoys little use today in the U.S.A. (owing to 
replacement by the more effective salicylates) although it is used main-
ly in Europe, South America, and the Mid-East. 
157 Antipyrine is absorbed rapidly from the gastrointestinal tract. 
Metabolism is rather rapid as water solubility is high and distribution 
157 in the tissues is in proportion to their water content. About 30-40% 
of ingested antipyrine is converted to 4-hydroxyantipyrine and excreted 
1 . "dl57 in the urine conjugated with g ucuronic aci · • 
The mechanism of action of aminopyrine is not known. · The action of 
aminopyrine in rheumatic fever is equal to that of the salicylates, 157 
and it is effective in reduction of inflammation due to edema and 
necrosis. 387 The chief toxic manifestation of aminopyrine is agranu-
locytosis. In some individuals there seems to be a hypersensitivity to 
this drug. Other toxic effects are central nervous system involve-
34 
ments, rash, and hemoglobin alterations. 
Phenylbutazone (114) (synthesized by H. Stenz! in 1946) is clinical-
ly the most useful of the pyrazolinone and pyrazolidinone series. 
Hemming and Kuze11178 (1953) have µublished an extensive review on the 
O~C4H9 (.!!_) 
CH ./ 'N 114 
6 s I . -
C6H5 
biological properties and medical uses of phenylbutazone. The principal 
action of phenylbutazone is inhibition of inflammatory action, although 
it is also a mild analgesic and antipyretic. It has a very striking 
clinical effect in many arthritic cases, giving rapid and complete re-
lief from pain. Its field of usefulness is very similar to that of the 
corticosteroids, and as a consequence, it has,been suggested that it 
b . 1 f h . i d 1 240 p l' may e a stimu ant o t e pitu tary-a rena system. yrazo inanes, 
either alone or as mixtures with other materials, have been claimed to 
. 'd 15 85 be effective as germici es, for treatment of influenza, as anti-
155 . 198 319 
microbial agents, as fungicides, as antiactinics, and as anti-
diuretics.187 
Pyrazolinones and pyrazolidinones are also used in photography as 
color couplers, sensitizers, developers, and antihalation agents. 402 
However, the most important commercial use for pyrazolinones is as 
401 dyes. They have been extensively employed for this purpose since 
~a was synthesized by Zieyler and Locher in 1887; 401 this dye 
is still widely used as an approved food color. 
114a 
-
Ar' 
R 
Ar" = 4-Nao1sc6H4 
co2Na 
The presence or absence of biological action in some compounds is 
ascribed, in some cases, to their capacity for forming or not forming 
34 hydrogen bonds. This capacity has substantial influence on their 
35 
physiochemical properties and therefore on their pharrnacodynamic activ-
ity. Thus, whereas 2,3-dimethyl-l-phenyl-3-pyrazolin-5-one (antipyrine) 
(!ld), which is soluble in water and moderately soluble in ethe~ has 
analgetic properties, its demethylated analog, the l-phenyl-3-methyl-5-
pyrazolone, being insoluble in water and only slightly soluble in ether, 
has no analgetic activity. This discrepancy may derive from the fact 
that the former compound does not form intermolecular hydrogen bonds, 
115 
whereas the latter compound ~ does, although this is speculative. 
115 
-
-(4) Pyrazolonosteroids: Although the following steroidopyrazolones 
have been recently synthesized, their biological activities have not 
been investigated or apparently reported. 
116 117 
-[Ref. 214] 0 -[Ref. 340] 
118 [Ref. 144] 
-
(5) Tetrahydroindazolones: Properties 
0 WH 
of tetrahydroindazolones: 
119 ,,...._ 
(a) Pharmacological: Tetrahydroindazolones have been found to 
36 
h 1 i d i . . 263 ave ana ges c an . ant pyret1c properties. They are usually prepared 
by reaction of an alkyl 2-oxocyclohexanecarboxylate with hydrazine and 
42 
alkylation of the product. 
(b) Spectral: Some indazolones yield molecular complexes with 
substituted barbituric acids. 333 Spectral studies of indazolones indi-
cate that they are resonance hybrids to which ionic structures are 
359 
strong contributors. 
121 
-
' H 
H3C'Y' . r,...cH3 
hN......_ 
C6H5 
()Q 
120b 
-
119 
--It was suggested that the structure of 4,5,6,7-tetrahydro-3-indazo-
lone (119) more closely approximates 121. To support this conclusion 
·--- . . -
the IR spectrum of 119 contain a doublet at 1600-1620 cm-l 
-
The authors 
+ claimed that although it is known that C=NH group absorption appears 
at 1660 to 1680 Cm-l, the resulting h"f h 1 1 h · s 1 t to t e onger wave engt is 
only explicable by the existence of the zwitterion 121. The carbonyl 
--group, whose double bond character was reduced by the dipolar structure, 
absorbed at 1600-1620 cm -l (thus accounting for the broadness of the 
absorption band in this are~ 1613(s), 1588(vs), 1545(ms) -1 cm A band 
. . -1 + 
at 2700-2200(s) with a peak at 2640 cm was assigned to C-N and 3064 
cm ...,l to N-H. 
37 
Th 1 301 (. . ) e mass spectrum of -phenyl-3-methyl-5-pyrazolone 108a indi-
. --
. cates that the main fragmentation is ring fission with formation of the 
-
Loss of CO and CHO from M+ are unimportant benzenediazonium cation 122. 
processes. 301 A tentative rationale for the spectrum was shown. 
·.~H~~ ~1+· 
ROAN .... ~ . .... O~N/M 
I . I ~a 
C H C6H5 6 5 
M+, m/~ 174 
-H' 
+ 
-CH2co 
C6H5N:N DCH3 
122, !!!_!~ 105 (30%) H3C71+· -- l /+ C6H5 . !!!_/~ 145 (6%) +· 
C6H5 C6H5 
!!!_!~ 77 (100%) !!!.1~ 132 (8%) 
119 It has been shown that the parent indazolone 123 exists in the 
.,,...._, 
enol form in the ground state. The fragmentation is thus easily explain-
ed with this formulation for the radical cation. Loss of 29 mass units 
. 
in the initial fragmentation is probably due to elisions of N2H (90%) 
and CHO (10%). The rationale for these decompositions is shown. 
+· 
O:f" > 
I 
H 
.1E• M+, E!I~ 134 / 
--~~~~~o f I 
38 
H 
+ a c=o I 
1-Methylindazolone shows a fragmentation pattern basically similar 
to that of the parent compound. ~-Methylindazolones undergo ring ex-
pansion, and S-fission (loss of CH3) leads to the hase peak. 
~~OH _-H· ... 
~N"" 
I~ 
CH-H 
2 
HO 
00 or 
I 
H 
I 1 39,245,317 soxazo es 
OH (XAN ;) 
I 
H 
The chemistry of isoxazole is associated with the name of Ludwig 
Claisen,who recognized in 1888 the cyclic structure of the product 
(3-methyl-5-phenylisoxazole) that Cereso189 had obtained in 1884 from 
the action of hydroxylamine on benzoylacetone. Claisen suggested for 
171 it the name monoazole, which was modified by Hantzsch to isoxazole, 
which is used by Chemical Abstracts. 
39 
Until recently no natural product containing the isoxazole ring was 
known, with the possible exception of the glycoside hiptazin (~) iso-
lated in 1920 by Gtlrter158 and described on the basis of rather doubtful 
chemical evidence as a derivative of (4-hydroxyisoxazol-5-yl)formohy-
droxamic acid (124a) • 
-- OC6Hllo5 
fl C-OH f(o)-11 
N 
'oH 124 
-
124a 
-(1) Synthesis: (a) Synthesis from 1,3-dicarbonyl compounds and 
hydroxylamine: The reaction of 1,3-dicarbonyl compounds with hydroxyla-
mine is the most widely used for the synthesis of isoxazoles. Formation 
of stable, stereoisomeric monoxime intermediates has been frequently 
observed with 1,3-diketones in which one of the hydrogen atoms of the 
-C(O)-CH2-C(O)- group has been replaced by a substituent. 75 In a few 
RC(O)CH2C(O)R _H...;2;;...N_o_H_-1_. •  R-c -CH ,!G 
-H 0 II I 2 -,....- R 
2 . ~ C = 0 :ti._ O OH 
o I 
H R Rho ___ ...... 
i-( 0~ -H2o 
instances the formation of dioximes in the reaction of hydroxylamine 
75 105 
with 1,3-diketones has also been reported. ' The dioximes yield 
26 isoxazoles on heating, or by the action of oxidizing agents, or when 
40 
treated with acid or alkali. 
In the case of unsymmetrical diketones containing two different 
groups, Rand R', the two isomeric isoxazoles corresponding to two enolic 
94 forms of the dicarbonyl compounds could result. 
R' 
H2NOH G 
RC(O)CH2C(O)R' --H-0--.. I ~ 
2 'o R 
Although several isoxazole syntheses reportedly give only one iso-
mer, critical analysis of the reaction mixture and the product's struc-
350 ture is lacking. A single isomer of unequivocal structure can be 
prepared by the action of hydroxylamine under appropriate experimental 
d . . i h h f h 1 f f . 1 d . k 284 con 1t1ons w t et ers o t e eno ic arms o unsymmetrica 1 etones. 
CH3C(O)CH= ~-c6H5 
oc2H5 
1,1,3,3-Tetraethoxypropane can be condensed with hydroxylamine to 
. b . d . 1 . lf 318 give unsu stitute 1soxazo e 1tse . Von Anwers (1934) investi-
0 
gated the behavior of a.,8-unsaturated ketones toward hydroxylamine. 31 
Keto aldehydes are postulated to react in a hydroxymethylene form ~ 
to give intermediate 126 which condenses with two extra moles of 
__,, 
hydroxylamine yielding the sesquiox:imel27. Acid treatment of the ses-
,,,...._,. 
quioxime gives either the 3- or the 5-substituted isoxazole depending 
RC(O)CH =CHOR 
125 
,.-...,, 
RCCH2CHO II 
N 
\OH 
on the concentration of the acid used. 
RC(O)CH 
II 
CH 
CHC(O)R 
II 
-f.N - CH 
I 
OH 
·1· 2H2NOH 2H20 
R R 
°'-NJ:> I 
OH 
126 
--
127 
-
215 Johnson and Shelberg utilized the difference in behavior of a-
hydroxymethylene derivatives of cyclanones to distinguish between ring 
sizes, as is shown in the following scheme: 
0 0 
(a) ©O H2NOH .. 
(b) 
41 
42 
This different behavior is probably best ascribed to strain effects. 
lsoxazole ring closure occurs easily in cyclohexanone derivatives. Very 
little chemical evidence for the structures was given in the examples 
shown. 
Only a few 4-monosubstituted isoxazoles have been prepared by the 
reaction of hydroxylamine with 8-dialdehydes. 4-Phenylisoxazole, for 
i 
example, has been prepared from phenylmalonaldehyde and isoxazole-4-
carboxylic acid from carbomethoxymalonaldehyde. 307 
(b) 
amines: 
Synthesis from a-acetylenic ketones or aldehydes with hydroxyl-
285 This method was once widely used; it has been recently ap-
+ 
R 
'c-c 
U IJI 
'\ 'R OH 
plied to determine the configuration of oximes. 217 The process was 
later modified by the use of acetals of a,8-acetylenic aldehydes for 
31 216 preparation of 5-substituted isoxazoles. ' 
HNOH 0 
R-c=c-CH(OR') 2 .. ,J.!..,.,.Y 2 R Q./ 
(c) Synthesis from nitrile oxides: Nitrile oxides condense with 
R-C 
m4() + 
R' 
I 
c 
Ill 
c 
I 
R' 
R")-('R' 
l'(o~' 
acetylenes to yield isoxazoles in good yields. The substituent R may 
159 160 35 be aromatic, heterocyclicJ or alicyclic. If allene is used with 
b i il id . bi . 1· i. b . d 356 enzon tr e ox e a spiro sisoxazo ine s o taine . 
A general mechanism for changing nitrile oxides to isoxazoles was 
suggested?9,245,317 
Ar-C . r.cHC02R 
11 I . 
N . A":°' C- CH3 
'rrl'" II 0-;) 
R~>r--fO 
R"~/O 
c2H5,cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl; R" = H, CH3, 
c2H5 , (CH3) 2CH, cyclopentyl, or c6H5 ; (R'R" = (CH2) 4 or (CH2) 5 ] with 
H2NOH gives mixtures of 3- and 5-isoxazolinones. A mechanism was pro-
. 208 
posed by Jacquier and co-workers in 1970. 
R' 0 
r R(O)~H-~NHOH 
43 
R' 
I 
R-C(O)CH-C02C2H5 
ArCH-CH CO R II 2 2 
N~OH 
oxidation 
cyclization ......._ __ ., 
CH3C(O)CH(GH3)co2c2H5 
1. HONH2 2. H2o 
44 
'Y YH3 
CH3C(O)~HNHOCH3 
CH3 
~H3 
CH3-~- CHC02c2H5 
NOCH3 
cn3y1-CHC02Na 
NOCH3 
J • 
(3) Spectral properties of isoxazoles and isoxazolones: The 
IR spectra of isoxazole derivatives have been extensively investi-
gated. 61•62•82•223•224 IR and UV data have been used to elucidate the 
. f . 1 5 62,353 tautomer1sm o 1soxazo - -ones. 
C-H form 
R'hR 
HO.J( o .. ).J 
0-H form 
45 
N-H form 
The 3-methyl-4-benzoyl derivative exists in the OH form both in the 
solid state or in solution; however, crystalline 4-substituted 3-phenyl-
isoxazolones are to be found in the NH form. In solutions the latter 
compounds can be in the NH form or in the CH forms or in a mixture of 
62 these with the NH isomer predominant. The hydroxy structure has been 
proved for 3-hydroxy-5-phenyiisoxazole. 314· 
Aminoxazoles exist only in the amino form, independently of the 
. . f h . . h . 62 position o t e amino group in t e ring. 
44 possess an amino and a carbonyl group. 
3(5)-Amino isoxazolones 
J . . d k 208 bl . h f acquier an co-wor ers were a e to estimate t e amount o 
amino tautomer (N-H) in solutions of 3-monoalkyl and 3,4-dialkylisoxazol-
in-5-ones, from their NMR, IR and UV spectra. The authors also investi-
gated the tautomerism of 2-methyl-3,4-dialkyl-3-isoxazolin-5-ones 128 
_.,, 
and 5-methoxy-3,4-dialkylisoxazoles (129). 
-
00 ~/H HOD R' Ji' 
H R R' R R' R 
C-H form N-H form 0-H form 
128a 128b 128c 
- -
-
;p O~,.CH3 CH3o>J,. h .. 128a -R' 
R R R' R 129 
-
46 
(4) Naphtho[2,1-~]isoxazole: The 4,5,6,7-tetrahydronaphtho[2,l-~]-
R(D 
R' 
R = R' ;!.. H 
R = R' = benzo 
isoxazoles have not been found frequently in.the literature contrary to 
their simple analogs. Bianchi-Frati (1966) 54 obtained 3-arylnaphtho-
[2,l-~]isoxazoles in fairly good yields according to the following 
scheme: 
. 0 
00 
Ar-C-OH 
II 
NOH 
Q 
• ©6 
Ar 
Ar 
i 
c 
+ 111 i 
0 (C2H5)20 
/:, 
x 
More recently (1970) Jacquier and co-workers209 studied the forrna-
tion of cyclotetramethyleneisoxazoles 130a and 130b in detail. The 
_..,, ..-.-
OJ 
R 130a 
-
R 130b 
-
authors proposed the following mechanisms for the formation of 130a and 
·-
130b: 
,,,-.-
47 
~ ?H o;OH w-:NH2 
... 0 
0 R 
---1•• 130a 
--
OH ~?H ~:k2 .... N 
c; 0 R 
----t•• l 30b 
-
The comparison of the NMR, IR and MS data and gas chromatograms 
of ~10a (R = CH3) and ~b (R = CH3) with the products from the H2NOH 
treatment of 131 (n 2,3,4, and 5) and 132 (~ = 4 and 5) showed that 
- - ---
131 132 
-- -
~1 (n = 2,4, and 5) gave ~ (R = cyclopropyl, cyclopentyl, and 
cyclohexyl) and 132 (n = 4 and 5) gave 130a (R = cyclopentyl and 
_._ - -
cyclohexyl). However, 131 (n = 3) gave both 130a (R = cyclobutyl) and 
- - __,, 
130b (R = cyclobutyl). 
-
The following reaction was studied in detai1 209 by Jacquier and 
co-workers in 1970. 
1 OH a~:kt2 CH 
I 
R 
R = -0-CH(CH3) 2 
= -0-CO-CH 
3 
48 
According to reference 209 the following results were obtained: 
R R ~R H2NOH Q) .. + ()j I 
R 130a 130b 
-- -
R % Yield 
130a 130b 
- --
C6H5 0% 100% 
-N(CH3) 2 10% 90% 
H 80% 20% 
/CH3 . 
-CH 35% 65% 
'CH 3 
OC0CH3 45% 55% 
CH3 75% 25% 
The products were analyzed by NMR, IR, UV, and GC analysis and 
thus were compared with authentic samples. The yields were quite varia-
ble and substituent-dependent. 
(5) Isoxazole derivatives of pharmacological significance: Al-
though the close chemical similarity between pyrazoles and isoxazoles 
made it likely that isoxazole derivatives would find application in the 
pharmaceutical field, systematic investigations of their pharmacologi-
cal behavior have been ~arried out only relatively recently. New inter-
est in this field was aroused in 1955 by the discovery that the anti-
biotic cycloserine (or oxamycin) is a simple derivative of 3-isoxazolid-
one. 
49 
Analeptics containing the isoxazole ring were developed in 1935. 184 
Among these substances the most practical appears to b,e B_,.!'.!_-diethyl-3, 5-
dimethylisoxazole-4-carboxamide (cycliton) (133), on which an extensive 
,_.._ 
pharmacological and clinical literature is available. 183 
Sulfa drugs containing an isoxazole ring are characterized as having 
low toxicity and strong activity in vivo against gram-positive and gram-
negative bacteria. In comparison with other sulfa drugs they are not 
skin irritants and do not accumulate in the kidneys. The most important 
of these substances is 3,4-dimethyl-5-sulfanilamidoisoxazole or Gantri-
, 344 
sin. 
3 5 D. h l' . 1 h b h . h'b' 367 , - imet y isoxazo e was s own to e a growt in i itor. 
Quinoline and isoquinoline derivatives containing an isoxazole ring have 
b d h . 1 . 1 . . 367 een reporte to ave no antima aria activity. 
265 Clinton and co-workers reported the synthesis of novel steroidal 
isoxazole derivatives. The [2,3-d]isoxazole 134 possessed more endocrine 
- _........, 
activities than did its 
= 
[3,2-~]analog 
OH 
- -CH 3 
135. It has been found 265 that 
_, 
135. [3. 2-~J 
-
[2,3-d]isoxazole 134 exhibits 9.7 times more anabolic activity than 
- .,..-
methyltestosterone, its precursor, while the androgenic activity was 
only 0.24 times but as twice as active for miotropic activity. Unlike 
50 
to the corresponding pyrazoles, these compounds are completely devoid of 
101 [ oestrogenic activity. The 3,2-~]isoxazole W was shown to be a 
strong anabolic agent. Two isoxazolosteroids 
88 to be effective antitumor agents. 
OCOCH3 
136 
1J6 and 137 were proven 
_....._,,, ~
-- -
Although the following isoxazolosteroids have been synthesized 
266 
recently , their biological activities have not been yet investigated 
or reported. 
0 0 
+H3C~ 
oV 
0 
80% 
a 
75% 
a{l. HC02c2H5 , CH30Na 
2. H2NOH, CH30H 
1. Hco2c2H5 , CH30Na 
b{2. H2NOH, pyridine 
51 
Since pyrazolo[4,3-~]pyrimidines which occur in the formycin anti-
biotics proved to have antitumor activity, 205 isoxazolo[4,5-~]pyrazine 
2 (~) systems have been synthesized to evaluate their potential anti-
tumor activity. Rrn 
R N CH3 
138 
---
R = H and OH 
It was shown that the rate of formation of 
cct ] and <XX J 
is. greatly dependent on the pH of the medium, the solvent, and the tern-
52 
259 perature. This fact is of great importance for the development of a 
process for the synthesis of [2,3-~]isoxazolosteroids, which are of 
greater biological interest as regards their biological activity than 
their [3,2-~] analogs. In a weakly alkaline medium a mixture of isoxa-
265 
zoles is usually formed. The reaction in glacial acetic yields one 
. f . 11 265 isomer pre erent1a y. ()_ ] 
Dulin, Gerritsen, and co-workers124 studied 3,5-dimethylisoxazole 
(139), which had unusual potency as an inhibitor of free fatty acid re-
__, 
139 140 
- -
lease and as a hypoglycemic agent in intact rats, and 3-methylisoxazole-
5-carboxylic acid (Y!:,9), which was presumed to be a metabolite of !2J· 
Cortisone can be converted into 2-(hydroxyrnethylene)cortisone, which 
on treatment with hydroxylamine forms 17a,21-dihydroxypregn-4-en-ll,20-
diono[2,3-~]isoxazole. 399 The acetate of 2-formyl-3-methoxyandrost-2-
en-178-ol (141), obtained by the formylation of the acetate of 3-methyoxy-
--
androst-3-en-178-ol (142) by the Vilsmeier reagent, was used for the ,...._ 
76 preparation of [2,3-~]isoxazoles. 
141 
-
142 
.....-... 
53 
(6) Other types of steroidoisoxazoles: In general, [2,3-~]isoxa-
H3c 
[Ref. 233] 
RO 
[Ref. 87] 
zoles absorb in the UV region at greater wavelength than the [3,2-~]-
l h . 227 + 2 d 222 + 1 . 1 43 ana ogs, t at is, at _ an _ nm, respective y. 
(7) Mass spectra of isoxazoles: 3,5-Diphenylisoxazole (143) was 
---
examined292 and the spectrum is similar to that of the azirine 144, 
.,..,.__,. 
143 144 ~I~ 105 (100%) 
- -
~/~ 221 
which is formed from the isoxazole photochemically273 The spectrum of 
the azirine contains relatively intense ions at m/e 165 and 166 which 
are absent from the spectrum of the isoxazole 143. This has been ex-
.--
54 
plained by assuming conversion of the azirine to 2,5-diphenyloxazole) 
which produces strong hydrocarbon ions at ~/~ 165 and 166 (not shown 
h ) 292,293 ere . 
Thiazoles 
Thiazoles have always been important in pharmaceutical and bio-
chemical fields. Commercially valuable compounds that contain a thiazole 
ring are the mercaptothiazoles (which are valuable rubber accelerators), 
various "sulfa" and antitubercular drugs, the penicillins, and thiamin. 
Certain thiazole derivatives are used as intermediates in the synthesis 
of amino acids, peptides, and purines. This application has been dis-
cussed by Heilbron. 77 As a consequence of the varied interest in the 
thiazoles, an extensive body of literature dealing with their syntheses 
d . i ·1 bl 1,17,41,52,70,107,212,288,303,315,355,365, an properties s avai a e. 
384,400 
(1) Synthesis: (a) The reaction of a-halo carbonyl compounds 
and thioamides: Thioformamide produces thiazoles unsubstituted in the 
R-CH-X 
I + 
R'-C=O 
s 
II 
C -R" 
j 
NH2 
R Alkyl, aryl, aralkyl, etc. 
X Br, Cl. 
R' = H, CH 3 , aralkyl, NHAr, etc. 
R' 
"-. N 
R£)_R" 
2 position. Thus, chloroacetaldehyde and thioformamide yield thiazole 
. lf 195 itse • 
If an N-substituted thioamide is caused to react with an a-halo 
carbonyl compound, quaternary thiazolium salts result, sometimes in 
i i . ld 368 quant tat ve yie s. Excellent yields (90-95%) of 2-aminothiazole 
R-CH-X 
I 
R'-C=O 
§ 
+ C - R" 
I 
NH 
11•/ 
R 
R = R' = R" = CH3 
X = Cl 
11 b . d f h' 313,199 are usua y o taine rom t iourea. 
Yield 100% 
(b) The reaction of ammonium dithiocarbamate and a-halo com-
55 
d 74,154 poun s. Use of various halogenated ketones gives 2-mercaptothia-
zoles: 
R-CH-X 
I + 
R'- C = 0 
H N-C-SNH 
2 11 4 
s 
-NH X ~ 
4 
The value of the dithiocarbamate reaction as a synthetic tool is 
the greater becau_se hydrogen can be substituted for the thiol 
group via reaction of hydrogen peroxide in the presence of strong acids 
222 
on the heterocycle. 
HOCH2CtH r N 
H C S)\.SH 
3 
HOCHz~CHz N 
-~ 
+ H C s"Cl 
3 
56 
(c) The reaction of a-acylamino carbonyl compounds and phosphorus 
t lfid 33,222,227 pen asu e. The reaction of 1,4-dicarbonyl compounds with 
P2s5 to produce thiophene derivative is well known. 
+ 
-----• n R~s,/--R' 
If one of the methylene groups between the carbonyl functions is 
replaced by an imino function, as in the acylamino carbonyl compounds, 
thiazoles result. 
RC(O)CH2NHC(O)R' + 
(2) 4,5,6,7-Tetrahydrobenzothiazoles (145) and 4,5-Dihydronaphtho-
,,,......_, . 
[1,2-~]thiazoles (~): (a) Synthesis: The syntheses of 2-amino-4,5,-
(1)-Y 
145 
--
Y H, CH3 , NH2 , NHAr, 
6,7-tetrahydrobenzothiazole (-!:i,6), Y = NHt have been of great interest 
53,294 in recent years. The general method of preparation of these com-
pounds is: 
0 
HN~Y 
2 
x Br 
Cl 
0)-Y 
145 
-
295 The yields vary from fair to high, depending on the group Y. More 
343 
recentlya German patent (1971) reported a yield of 76% of thiazole 
~· Y = NH2 . The base obtained was useful as an insecticide and a source 
for novel sulfonamides. 
HCC1 3 • 
0.5 hr. 
dil HCl • 
extraction 
145 
-
2-Arnino-4,5-dihydronaphtho[l,2-~]thiazole (~) was prepared in 
270 1970 and claimed by Japanese workers to be an e~fective anesthetic 
for aquatic animals. The mechanism of resistance of aminothiazole in 
d . d 270 microorganisms was also iscusse • The recent interesting work of 
57 
Fravolini and co-workers144 deals with new heterocyclic ring systems of 
which 4,5,6,7-tetrahydrobenzothiazole is a part of this system. 
X NHR, OCOCH3 
The thiazole ring system has attracted the interest of chemists 
and pharmacologists from the discovery of penicillin to the present 
d t 43,71 h a e. Fusing t iazole rings to ring A of a steroid system has 
produced compounds showing some activity. The anabolic-to-androgenic 
ratio of thiazolosteroid 149 was higher than that of the parent carbo-
..-
. 123 246 
cyclic steroid. ' 
s ......... R-~ I N..,...... 
... 149 .... 
R' = C8Hl7; R" = H 
R' = OH; R'' = CH3 
R H, CH3 ~ NH2, c6H5NH, CH2=CHCH2NH 
58 
(b) Mass spectra of thiazoles and related compounds: The molecular 
ion·of thiazole (150) is the base peak of the spectrum and the only im-
~ 
portant fragmentation is loss of HCN to give the thiirene radical cation 
' 98 + (m/~ 58). In the mass spectrum of thiazole-~-~ ~) the M-HCN peak 
is replaced almost entirely by an M+-DCN peak which confirms the ihvolve-
ment of C(2) in this process. 109 
(a) 
i +· (cl_ 6 N - r1t - -HCN ciD -~;'-;~if ... ~ 
" +· ' +· , ' 
ch'> '!!!._/ !E. 58 151 
150 -
-M+ 
' 
m/!E_ 85 
(b)I -c2H2N 
... H-c=s + '!!!._/ !E. 45 
4-Methylthiazole ion (~) does not lose CH3CN but only HCN, where-
as that of 2,4-dimethylthiazole (~) shows an intense M+-cH3CN peak. 
59 
These basic fragmentations are displayed by a range of simple thiazoles; 
the full paper should be consulted for further details. 98 
-HCN 
152 
-
+· 
s ~ /u\ 
HC~--.. 
3 
153 
-
m/e 72 (97%) 
r-H" 
+ M , '!!!_/~ 113 (100%) 
Fs~ ---i~·bd ( 
Ethyl 4-methylthiazole-2-carboxylate (154) shows an interesting 
~ 
fragmentation involving lossof the elements of acetaldehyde from the 
98 
molecular ion. The process can be formulated as involving a six-
center intermediate including a hydrogen transfer. This is closely re-
lated to the McLafferty rearrangement, and the driving force is pre-
sumably the ability of the electron-deficient nitrogen atom in the 
H 
+· H" I ,.....CH H3Cri-S-~ A Hfn--N , C 3 ~c~ -...... -- ls~/• ~ -CH3CHO 
c~+ 
""!o o 
+ 154.. 
M , '!!!_/~ 171 (31%) 
m/e 127 
(25%) 
molecular ion 154 to act as hydrogen acceptor. 
-
2-Methylbenzothiazole (~) shows the expected loss of CH3CN (~/!E,. 
60 
108) together with a considerable loss of CH2CN (~/!E,. 109). Loss of HCN 
also occurs; its formation must necessarily involve much skeletal re-
272 
arrangement. 
~l!E_ 108 
(12%) 
~l!E_ 122 
(2%) 
0:. ~· -H· I 
.JlCH 
3 
155 
-+ M , ~/!E_ 149 
~l!E_ 109 
(6%) 
m/e 155a 
-- -
(10%) 
+ 
~N ~S·~CH 3 
The origin of the hydrogen atom last in the formation of the M+-1 
species has not been determined by deuterium labeling, and,in fact, the 
resultant ion was formulated as 155a. The mass spectra of thiazolines 
--72,232,378 . . 
and penicillins have also been studied in detail. 
Polymethoxy Cyclic Ketones and 
Polymethoxy Steroids 
Polymethoxytetralones and polymethoxyphenanthrones have been of 
interest to many organic and medicinal chemists for years. 38 The pas-
sible significance of the methoxyl functionalities in biological activ-
61 
ity is clearly illustrated via their incorporation in such compounds as 
mescaline, apomorphine and many other narcotics and naturally occurring 
alkaloids. 221 Campbell (1950) 83 first suggested that the methoxyl 
groups on the A ring of colchicine (156), among other things, were in-
...--
directly responsible for that alkaloid to act as a tumor-growth inhibi-
tor. In order to lower the toxicity of this type of compound and main-
tain the antitumor activity, Campbell synthesized a series of 2-(alkoxy-
OCH3 
0 
156 
CH3o -
methylene)-1-tetralones 157, but found all examples to be less active 
""""' 
0 
HOR 
157 
--
than colchicine. 3-(Hydroxymethylene)-l,2,3,4-telrahydrophenanthrene-4-
83 
one (158) was later prepared by Campbell and co-workers and found to 
~ 
have some antitumor activity when R = H but not when R = CH3. The test 
CHOR 
R H, CHJ 
was run against mouse sarcoma 37 (NIH). Campbell believed without 
further experimental evidence that the high toxicity of 156 was due to 
the highly unsaturated nature of ring C. 
339 Schlager emphasized the importance of vicinal methoxyl groups 
f b. · 1 i 1 · i Ra d k 38c h · d (+) 2 3 4 or 10 og ca act1v ty. o an co-wor ers synt es1ze - , , -
trimethoxyestra-l,3-5(10)-trien-17S-ol from 3,4-dihydro-5,6,7-tri-
methoxynaphthalen-1(2H)-one (159) and found it to possess analgesic 
---
activity. 
-
CH30 
---·-· CH3o 
OH 
203 S. Imai (1969-71) published , in some detail, different routes 
for th~ synthesis of some polymethoxyphenanthrones but the methods are 
of little preparative value. 
R' 
R = R"' OCH3, R' = R" = H 
R = R" = H, R' R'" = OCH3 
R. = ·R'" H, R' R" = OCH3 
0 
62 
Many publications have appeared in the last few years dealing with 
the synthesis and/or biological activity of dimethoxy-substituted 
heterosteroids and alkaloids. Some examples are illustrated here: 
0 H 
[Ref. 206] 
R = R' = H, CH3 ; 
R' = Ac, CH3 
,,.,R" 
[Ref. 289] 
R = R' =.H, 
R' = Ac, CH3 
h 1 . 720,309,358,374,398 Other examples are found in t e 1terature. 
63 
Nucleoside Analogs and Related Compounds 
. 256 
It was originally proposed that the term nucleoside be used only 
for carbohydrate derivatives of purines and pyriciidines isolated from 
the alkaline hydrolyzate of yeast nucleic acid. This was found too 
limiting since the major carbohydrate constituents of yeast nucleic acid 
are either D-ribose or 2-deoxy-P.-erythropentose (2-deoxy-~-ribose). It 
= - -
281 has now been generally accepted that the term purine nucleoside re-
fers to all glycosyl derivatives of purines, both synthetic and natural, 
370 
and it has been proposed that this terminology should apply to the 
entire field of heterocyclic glycosides. 
(1) Syntheses: Chemical synthesis of various heterocyclic N-
glycosides: The chemical preparation of heterocyclic glycosides is a 
relatively new area in comparison to the related areas of purine and 
pyrimidine nucleotide chemistry. An early interest in the area of imid-
azole nucleosides and nucleotides developed rapidly, 370 because purine 
nucleosides found in nucleic acids depend on imidazole nucleotides as 
precursors. 
(a) Condensation of silver salts of the heterocycle with polyacyl-
glycosyl halides: A general method for the preparation of benzimidazole 
~ R~N @:) 0 ~Ag(±) + Xylene .... ('.. R R Br R~ 160 R ·O - R 
162, R OAc R ill' R = CH3 R 
-
161, R = N02 163, R OH 
_,.._ 
-
64 
glycosides has been devised379 by reaction of sil,ver salts of the ap-
propriate benzimidazole with an acylated glycosyl halide followed by the 
deacylation of the condensation product. Metathesis of the silver salt 
of benzimidazole (160) with 2,3,4,5-tetra-0-acetyl-a-D-glucopyranosyl 
,,....._,_, - -;::. 
bromide in boiling xylene gave crystalline 1-(tetra-Q-acetyl-B-Q.-gluco-
pyranosyl)berizimidazole (162) in good yield. Deacetylation of 162 with 
- _. 
sodium methoxide in absolute ethanol or with dilute hydrochloric acid 
afforded 1-(B-g_-glucopyranosyl)benzimidazole ~· The latter compound 
was identical with the nucleoside synthesized by Mamalis and co-workers 
(1950) b . 1 h d 261 y a ring-c osure met o • In a like manner, the condensations 
f h ·1 1 f h b . d b . 'cl 1. 185,261,379 . h o t e si versa ts o ot er su stitute enzimi.azo es wit 
diff b 'b. 376,380,381 1 380 b" 185 erent romo sugars, e.g., ri ose, xy ose, ara inose, 
99 99 371 glucose, and galactose, have been reported. 
392 The first chemical synthesis of a benzotriazole nucleoside was 
accomplished by a condensation of the silver salt of 5,6-dichlorobenzo-
·1 
385 . i 
triazole (169) with 3,5-di-O-benzoyl-D-ribofuranosyl chloride (168) 
_,_.__. - = _...._... 
in boiling xylene, which produced four crystalline isomeric and ano-
meric nucleosides 164, 165, 166 and 167. These were separated by 
,...._,,. ,..,...,. ,_.._.,, ,......_,... 
fractional crystallization. Debenzoylation of the nucleosides with 
methanolic ammonia afforded the corresponding nucleosides 170, 171, 172, 
--- - -
d 3 h k 256,281,370,385,392 an 17 . Ot er benzotriazole N-nucleosides are nown. 
(b) Condensation of halomercury salts of heterocycles with poly-
acylglycosyl halides: 117 It has been found that the chloromercuri deri-
vatives of benzimidazoles 174 are much superior to silver salts for 
- 118 
reaction with poly-0-acylglycosyl halides. The 5'-phosphate and 5'-
triphosphate of 1-(B-Q.-ribofuranosyl)benzimidazole have been pre-
d202,393 d d A 1 k . h hl pare an reporte to possess TP- i e activity. T e c oro-
Cl~N Cl/0W + Ag 
Clr§r) BzO~ 
Cl N 
BzO HO 
OBz ClX§rN' 
Cl...- 0 N, 
OH 
164 165 
- --
HO HO 
OH 
Cl0cNft Cl~· NI' 
HO OH 
170 171 
-
+ BzO~Cl 
BzO OH 
ClDN' BzO 
Cl ~ -NIN 
BzO Cl(X~ 
Cl ::-..... "N 1 
BzO OH 
166 167 
- -
HO 
172 
-
173 
-
65 
66 
@=ck@ 
Ac0CH2 
+~Cl 
Hg Cl 
AcO OAc Xylene, /':i. 
174 
-
@X) AcO\::? 
AcO OAc 
mercurio method was successfully applied to prepare many other nucleoside 
d . . 106,142,278,279 1 f 5 d 6 h erivatives. For examp e, a mixture o - an -met oxy-
1-(a and 8-D-ribofuranosyl)benzimidazole 
146 by chromatography: 
+ 
HO OH 
146 
was prepared and separated 
(c) Direct alkylation of the heterocycle with a polyacylglycosyl 
halide: In thismethod the metal-free heterocyclic base is caused to re-
act with a poly-Q-acylglycosyl halide in boiling dry dioxane. This re-
67 
action is similar to the Hilbert-Johnson method used for the synthesis 
of pyrimidine nucleosides. 139 , 226 
11 397 A more recent method ' involves the condensation of the hetero-
cyclic compound with acetobromoglucose in dry nitromethane containing 
mercuric cyanide. In this process a mixture of anomers is usually ob-
360 tained,more of the a-anomer usually being formed than of the a-anomer. 
The two anomers are commonly separated by chromatography or fractional 
. 11 360 
crystallization. ' 
(d) N-Glycosidation in acid: This technique was first employed in 
337 the area of nucleoside synthesis to produce !-glycosylpurines and 
370 later applied to various other heterocyclic systems. Thus, benzimi-
0 dazole 175 was fused at 160 in the presence of chloroacetic acid as a 
.--
caualyst with the triacetate 176. Subsequent deblocking of the carbo-,,__. 
hydrate moiety and separation of .the a- and a-anomers by fractional 
crystallization and chromatography(alumina)gave a fair yield of ~a 
382 
and 1778 anomers. There was proposed a reaction mechanism involving 
,,....., 
alkylation of the benzimidazole nitrogen (tertiary nitrogen) by a 3,5-
di-Q-acetyl-2-deoxy-Q-ribofuranosyl-l-carbonium ion intermediate. This 
AcOCH2 ~ AcO~~ ~OAc • o-Acl I (±) 
AcO H AcO H 
176 
-
HG AcOCH G)~ 2 + N:@ @:'~ ... ~ + (N"' () 
AcO~ AcO H H 175 
·-
-H@ AcO IH 1. anomers 177 Hydro~ysis a and a -2. 
68 
mechanism predicts that a more basic benzimidazole should be glycosylat-
ed much more rapidly than an acidic benzimidazole. However, Townsend 
371 
and co-workers have found that this acid-fusion procedure is inappli-
cable to many other ribofuranoside systems. 
(e) Trimethylsilyl method: This method, developed by Iwai and co-
207 
workers (1964), constitutes a modification of the Hilbert-Johnson 
180 
synthesis of nucleosides. A principal advantage of the approach is 
that the silylated derivatives may be prepared in excellent yields 
directly from the heterocyclic base. Silylation is readily accomplish-
ed with either chlorotrimethylsilane, hexamethyldisilazane, or tri-
methylsilyl-N ,_!i-bis ( trimethylsilyl) acetamide f 1bis-( trimethylsilyl)-ace-
tamide"]; the latter was proved to be an exceptionally powerful silylat-
403 ing agent. The trimethylsilyl derivative procedure frequently af-
fords a mixture of anomeric nucleosides in which substantial proportions 
of the a-anomer may be present. 
The literature of the trimethylsilyl method has been increasing 
drastically over the last ten to fifteen years so that only a represen-
tative is shown here. 64 Other examples are available in the litera-
t 160,290,323,348,349,362,391,403,404 ure. 
(2) 59 364 Biological importance of nucleoside analogs: ' The broad-
spectrum antiviral activity348 of l-B-Q-ribofuranosyl-1,2,4-triazole-3-
carboxamide (Virazole) (178) 390 has prompted many investigators to ex-
..--. 
. 11 389 plore the biological activity of other !!-glycosyl heterocyclics. ' 
3-Deazauridine (179) increased the survival time of mice bearing 1-1210 
-
leukemia by 55-65%. 60 
O N\ ~+ 
N Si(CH ) 3 3 ~r 
R 
110-130° 
vacuum • ~N~ ~N 
CH30H polyol <1111!----';;.._ _ _. 
Ba(OH) 2 
39% 
. -7 60 3-Deazacytidine 180 inhibits E. coli at 10 M. 3-Deazauridine 
-- - --
(179) has recently been shown to be more effective against Ara C re-
---. 
sistant 1~1210 leukemia than the parent sensitive strain. 69 
Virazole (178) was found to be effective against L-1210 leukemia 
----
. i 1 . 228 in exper menta mice. This was the first instance of a nucleoside 
to exhibit broad spectrum antiviral activity against both RNA and DNA 
viruses in animals. A 90% increase in life span was obtained when 
uridine ~was administered to mice bearing L-1210 leukemia. 229 Com-
69 
pound 181 was equally effective against 6 MP resistant or Ara C resist-
...._ 
ant L-1210 and P-388 mouse leukemia. 
179 178 180 181 
- - -
CHAPTER II 
RESULTS AND DISCUSSION 
A major objective of this research has been to synthesize hetero-
steroids and related model compounds with two methoxyl groups in ring A 
and special physical properties. As a working hypothesis, it was con-
tended that strategically positioned hetero atoms in the steroid struc-
ture (or in the model systems) could greatly increase aqueous solubility, 
permit electron-pair donation for possible charge transfer complexa-
tion to occur with selected anticancer agents, and to provide a '~ydro-
1 h d" f 1 b b 11 . 126 w po ar ea to aci itate mem rane or mem rane-wa penetration. e
have developed a new synthesis for the key precursor 6,7-dimethoxy-3,4-
dihydro-1[2!!_]-naphthalenone (182) 352 and 6,7-dimethoxy-3,4-dihydro-l-
,,,,._ 
[2!!_]-phenanthrone (188). 
CH30 
OCH3 
182 
-
--
RO 
OR 
183 
-
OCH3 
186 
-
R H, CH3 
R'= H, Ar 
70 
OCH3 
184 
,..-
R 
R' 
OCH3 
187 
-
-R' 
H, 
H, 
0 
CH30 
OCH3 
CH3 185 
-Ar 
NH2 , NHC6H5 , 
CH3, NHCH2 CH= CH2 
CH30 
0 RO 
CH30 RO 
R = H, CH3 
188 189 
- -
R'= H, Ar 
190 
-
Consequently, a novel series of substituted pyrazoles (Table II), 
pyrazolones (Table IV), isoxazoles (Table V), thiazoles (Table VI) and 
I 
N-glucosides (and derivatives) 191 of some of the pyrazoles have also 
- -
been prepared. The families are represented by 183, 184, 185, 186, and 
,,,,....._,. ,,,..._,, .,,,..,._,, ,__,,,, 
71 
187 starting from 182. Likewise, families 189 and 190 were derived from 
,,,_, .,,..._ ,,,.....,. /4-' 
188. 
~ I ~20R 
CH3o R C(O) CH3 
CH30 OR R H = RO 
191 
Preliminary studies of the action of actinomycin Don the growth of 
Pseudomonas fluorescens in the presence of 10,11-dihydro-3.!!_-naphth-
[l,2-g]indazol-7-ol (192) revealed a potentiation factor of 8 for the 
- -
latter. 125 However, in mice the factor was only 1.04. Careful PMR 
studies in D20 demonstrated that a molecular complex formed between 
actinomycin D and 10,ll-dihydro-3H-naphth[l,2-g]indazol-7-ol (192~2 • 126 
- - ,......_,. 
An upfield shift of 20 Hz for the methylene protons in 192 in the com-,_ 
plex suggested a structure for the complex as shown. 
HO 
192 
Actinomycin D Jr 
,._.. 
0 
/ 
I 
I 
0 
\ H 
\I 
h 
====-c I 
HN 
I CcH 
c~o 
I 
NH 
I 
HC~ 
I 
I 
72 
H-bonding 
1 Charge transfer 
I 
TI-TI Overlap 
UV-fluorescence spectral.analysis also supported the formation of 
the molecular complex. An excitation maximum occurred at 320 nm in 
10,ll-dihydro-3H-naphth[l,2-g]indazol-7-ol (192) and an. emission maximum 
- - ---
was observed at 382 nin. When actinomycin D was added to indazole 192 
--
(1:1 molar ratio), it quenched the 382 nm emission peak by 35-40%. DMSO 
(2M) added prior to complex formation produced only a 5% quenching ef-
feet. Thus, the complex must possess much H-bonding which is disrupted 
by DMSO. DMF also destroyed the complex. Consequently, a structural 
design for a potentiation agent might include H-bonding atoms as well as 
73 
atoms capable of charge transfer if actinomycin D were to be the anti 
cancer agent examined for complexation. Actinomycin D is a clinically-
d ·1 k i 260 use anti eu em c agent. 
13 1 f · h b a· a260 C Nuc ear magnetic resonance o actinomycin D as een stu ie 
260 
and the most probable structure was proposed with the carbon atoms 
positioned approximately as shown. 
TABLE II 
7,8-DIMETHOXY-(AND 7,8-DIHYDROXY)-4,5-DIHYDRO-l!!_-BENZ[~]INDAZOLES AND DERIVATIVES 
TABLE II (Continued) 
Compound Name Cpd. R 
4,5-Dihydro-1-(p-hydroxyphenyl)-lH-
benz[~]indazoie-7,8-diol - 198 OH 
--
4,5-Dihydro-7,8-dimethoxy-1-(p-tolyl-
sulfonyl)-1~-benz[~]indazole 199 OCH3 
-
1-(Chloromercurio)-4,5-dihydro-7,8-
dimethoxy-1~-benz[~]indazole 200 OCH3 
---
l-B-D-Glucopyranosyl-4,, 5-dihydro-7, 8-
dimethoxy-lH-benz[g]indazole tetra-
acetate (ester) - 201 OCH3 
-
1-B-D-Glucopyranosyl-4,5~dihydro-7,8-
dimethoxy-1~-benz[~]indazole 202 OCH3 ___,; 
R' 
p-C H -OH 
- 6 4 
E-so2-c6H4-cH3 
HgCl 
~20Ac 
OAc 
AcO 
~20H 
0 
OH 
HO 
0 
m. p. , C 
295 
185-7 
>300 
170-1 
167-8 
Yield, % 
74 
30 
100 
66 
42 
....... 
Vl 
TABLE III 
1-_!!-SUBSTITUTED-7-METHOXY-(AND 7-HYDROXY)-4,5-DIHYDRO-l.!!_-BENZ[~]INDAZOLES 
R 
Compound Name Cpd. R R' 0 m.p., C 
4,5-Dihydro-7-methoxy-1-phenyl-1~-benz[~J 
indazole 203 OCH3 C6H5 105-6 
-
4,5-Dihydro-1-phenyl-lH-benz[g]indazol-
7-ol - - 204 
---
OH C6H5 238-240 
1-(Chloromercurio)-4,5-dihydro-7-methoxy-
1g-benz[~]indazole 205 OCH3 Hg Cl >Joo __, 
~20Ac 
l-S-D-Glucopyranosyl-4,5-dihydro-7- c 
methoxy-lH-benz[g]indazole tetra-
acetate (ester) - 206 OCH3 OAc 155-6 
.--- AcO 
Yield, % 
89 
72 
94 
25,42 
-..J 
O'I 
TABLE IV 
2,3a,4,5-TETRAHYDR0-7,8-DIMETHOXY-3_!!-BENZ[~]INDAZOL-3-0NES AND THE 2-ARYL ANALOGS 
R 0 
2,3a,4,5-Tetrahydro-7,8-dimethoxy-2-
phenyl-3!!-benz[~]indazol-3-one 
2-(p-Fluorophenyl)-2,3a,4,5-tetrahydro-
7~8-dimethoxy-3!!-benz[~]indazol-3-
one 
2,3a,4,5-Tetrahydro-7,8-dimethoxy-3a-
methyl-3!!-benz[~]indazol-3-one 
208 
--
209 
____. 
210 
--
-R" 
OCH3 
OCH3 
OCH3 
H C6H5 200-2 
H £-C6H4F 243-4 
CH3 H 219-221 
92 
65 
82 
-..J 
-..J 
TABLE V 
4,5-DIHYDR0-7,8-DIMETHOXYNAPHTH[2,l-d]-AND [1,2-~]ISOXAZOLES 
AND 4,5-DIHYDR0-7,8-DIMETHOXYPHENANTHR0[2,l-~]ISOXAZOLE 
Compound Name 
4,5-Dihydro-7,8-dimethoxynaphth[2,l-d]-
isoxazole -
4,5-Dihydro-7,8-dimethoxynaphth[l,2-c]-
isoxazole -
10,11-Dihydro-7,8-dimethoxy-phenanthro-
[2,l-~]isoxazole 
R~ 
\.__ R" X 
Cpd. x 
185 0 
~ 
186 N 
,-...... 
190 0 
y R + R" 
N CH}9J 
OCH3 
0 CH30~ 
OCH3 
N 
CH3om 
CH30 
0 
m. p. , C 
189-190 
178-179 
194-195 
Yield % 
84 
38 
85 
-...J 
00 
TABLE VI 
2-SUBSTITUTED-4,5-DIHYDR0-7,8-DIMETHOXYNAPHTHO(l,2-~]THIAZOLES 
CH3 
Compound Name 
2-Amino-4,5-dihydro-7,8-dimethoxynaphtho-
[1,2-~]thiazole 
2-Anilino-4,5-dihydro-7,8-dimethoxynaphtho-
[1~2-~]thiazole 
2-(Allylamino)-4,5-dihydro-7,8-dimethoxy-
naphtho[l,2-~]thiazole 
4,5-Dihydro-7,8-dimethoxy-2-methylnaphtho-
[1,2-~]thiazole 
OCH3 
s 
I N>-R 
Cpd. 
211 
,-J 
212 
_..._. 
213 
,,......,,, 
214 
......_ 
R 
NH2 
NH-C6H5 
NH-CH -CH=CH 2 2 
CH3 
0 
m.p., C 
235-7 
180-1 
88-90 
140-1 
Yield, % 
65 
90 
95 
88 
-...J 
\0 
TABLE VII 
10,11-DIHYDR0-7,8-DIMETHOXY-(AND 7,8-DIHYDROXY)PHENANTHRO[l,2-~]PYRAZOLES 
R 
R" 
Compound Name Cpd. R R' R" 0 m.p., C Yield, % 
-
10,11-Dihydro-7,8-dimethoxy-3H-phenanthro-
[1,2-~]pyrazole - 215 OCH3 OCH3 H 277 .5 98 
-
10,11-Dihydro-3_!!-phenanthro[l,2-~]pyra-
zole-7,8-diol 216 OH OH H 324-6 74 
--
10,11-Dihydro-7,8-dimethoxy-3-(p-fluoro-
phenyl)phenanthro[l,2-~]pyrazole 217 OCH3 OCH3 :e-C6H4F 195-7 64 
--
10,11-Dihydro-3-(p-fluorophenyl)phen-
anthro[l,2-~]pyrazole-7,8-diol 218 OH OH :e-c6H4F 256-8 51 
--
00 
0 
Compound Name 
3-(Chloromercurio)-10,ll-dihydro-7-
methoxy-3H-phenanthro[l,2-c]-
pyrazole - -
3-B-D-Glucopyranosyl-10,ll-dihydro-7-
methoxy-3H-phenanthro[l,2-c]pyra-
zole tetraacetate (ester) -
3-B-D-Glucopyranosyl-10,11-dihydro-7-
methoxy-3~-phenanthro[l,2-~]pyra­
zole 
TABLE VII (Continued) 
Cpd. R R' 
219 ,__. H OCH3 
220-
......._, 
H OCH3 
221 
.....-
H OCH3 
R" 
HgCl 
CH OAc 
1P-\ 2 
\JtAc I 
AcO 
CH 20H 
. o_J ~ HO OH 
0 
m. p. , C 
>300 
116 
210-2 
Yield, % 
100 
52 
14 
co 
~ 
TABLE VIII 
NMR DATA OF STARTING MATERIALS, INTERMEDIATES, AND PRODUCTS 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
222 XLIX DCC13 2. 75 (t) 2 CH2 (b) 
---(d) 0 
CH3J:Q:r)(a) 3.30 (t) 2 CH2 (a) (e) (b) 3.70 (s) 3 co2cH3 (c) CH 0 
3 (d) co2cH3(c) 
3.90-3.95 (2s) 6 OCH3 (e) 
6.90-7.60 (m) 3 ArH (d) 
(f) (b) 
CH30@)(a) 223 L DCC13 1. 95 (qt) 2 CH2 (a) (e) (c) __, 
CH 0 2. 35 ( t) 2 CH2 (b) 3 (f) co2cH3 
2.60 (t) 2 CH2 (c) 
3.65 (s) 3 CH3 (d) 
3.80-3.85 (2s) 6 OCH3 (e) 
6.70-6.80 (m) 3 ArH (f) 
00 
N 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(e) (b) 224 LI DCC13 1. 98 (qt) 2 CH2 (a) 
cu3om(·l -(d) 2.35 (t) 2 CH2 (b) CH 0 (c) 
3 (e)co H (f) 2. 65 (t) 2 CH2 (c) 2 
3.85-3.88 (2s) 6 OCH3 (d) 
6.60-6.85 (m) 3 ArH (e) 
8.55 (s) 1 co2H (f) 
(e) (f) (b) Hfil(a) 
Q (f) (c) 225 LIV DCC1 3 2.00 (qt) 2 CH2 (a) 
-CH3o 2.35 (t) 2 CH2 (b) co2H 
(d) (e) 
2.60 (t) 2 CH2 (c) 
3.90 (s) 3 0 CH3 (d) 
5.20-6.20 (b) 2 co2H,OH (e) 
6. 72 (m) 3 ArH (f) 
00 
w 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(d) 0 226 XLVIII Pyridine-:!5 2. 05 ( t) 2 CH2 (a) CH3ofil{b) -(c) 3.45 (t) 2 CH2 (b) CH 0 d (a) 
3 ( )co2H (e) 3. 70 (s) 3 OCH3 (c) 
3. 72 (s) 3 OCH3 (c) 
6.85 (s), 6.95 (s), 3 ArH (d) 7.80 (d) 
7.55 (s) 1 co2H (e) 
CHJ§x) (d) 3 Q . (c) 182 LV DCC1 3 2.15 (qt) 2 CH2 (a) 
----CH 0 (a) 
3 (e) (b) 2.60 (t) 2 CH2 (b) 
2.90 (t) 2 CH2 (c) 
3.90-3.92 (2s) 6 OCH3 (d) 
6.62 (s) 1 ArH (e) 
7.55 (s) 1 ArH (f) 
co 
~ 
• 
(d) 
Structure 
H°Tnl I~~~ 
(b) 
(g) 0 
Cpd. 
m 
CH o~~H3 (e) 
(d) 3  co21H2 ~ 
CH30 (f) (c) · CH3 
(a) 
Plate 
LIII 
LIX 
TABLE VIII (Continued) 
Solvent o(p.p.m.) a 
DMS0-~6 2.60 (t) 
3.15 (t) 
6.80-7.50 (m) 
10.00 (b) 
DCC13 1.18 (t) 
1. 50 (s) 
2.55-2.95 (m) 
3.95-3.96 (2s) 
4.15 (q). 
6.60 (s) 
7.50 (s) 
Integ. Assignments 
2 CH2 (a) 
2 CH2 (b) 
3 ArH (c) 
3 co2H,OH (d) 
3 -CH2CH3 (a) 
3 -CH3 (b) 
l;. CH2-cH2 (c) 
6 OCH3 (d) 
2 -CH2CH3 (e) 
-
1 ArH (f) 
1 ArH (g) 
00 
Vl 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(e) 0 
w LVIII DCC13 2.5-3.4 (m) 4 CH2-cH2 (a) CHOW' (c) (b) 3 c=) Br 3.88-3.91 (2s) 6 OCH3 (b) CH 0 
3 (d) (a) 
4.70 (t) 1 C(O)-C!!_-Br(c) 
6.70 (s) 1 ArH (d) 
7-. 55 (s) 1 ArH (e) 
(c) 
0 H O (d) 
CH 0 OCH 3 (e) 3 klQ LX DCC1 3 2.45 (m) 2 CH2 (a) 
CH30 (f) (b) 2.98 (t) 2 CH2 (b) 
3.60 (t) 1 C(O)-C!!_- (c) 
3.80 (s) 3 co2-c.!:!_3 (d) 
3.90-3.92 (2s) 6 OCH3 (e) 
6. 70 (s) 1 ArH (f) 
7.55 (s) 1 ArH (g) 
OJ 
0\ 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent cS(p.p.m.) a Integ. Assignments 
(f) 0 w LVII DCC13 1. 30 (d) 3 CH3 (a) CHO~H(b) (d) 3 0 CH3 (a) 2.00-2.50 (m) 1 C(O)-CH-CH3 (b) 
CH30 (e) (c) 
· 2 ~90 (m) 4 CH2cH2 (c) 
3. 91-3. 93 (2s) 6 OCH3 (d) 
6.65 (s) 1 ArH (e) 
7. 55 (s) 1 ArH (f) 
(b) (f) 
~~ 
232 LVI DCC1 3 2.50 (t) 2 CH2 (a) 
-
2.80 (t) 2 CH2 (b) 
CHP~ \eJ 3.90 (s) 6 OCH3 (c) (c) OCH3 
6.70 (s) 1 ArH (d) 
7. 35 (s) 1 =CH-0- (f) 
7.48 (s) 1 ArH (e) 
14.50 (s) 1 =C-OH (g) 
CXl 
-....J 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(a) (d) 193 LXI DCC13 2.70-2.90 (m) 4 CH2CH2 (a) ~ -,,
3. 75 (s) 3 OCH3 (b) N 
• H (f) 3.90 (s) 3 OCH3 (c) CH30" I (d) 
6. 75 (s) 1 ArH (e) (c) OCH3 (b) 
7.35 (s) 2 ArH, N=CH (d) 
. 
9.40-9.75 (bs) 1 N-H (f) 
(a) 
1" 
194 LXII DMS0-!4 2.70 (s) 4 CH2-cH2 (a) 
-
6.80 (s) 1 ArH (b) 
7.39 (s) 1 ArH (c) 
7.18 (s) 1 N=CH (d) 
8.80 (bs) 2 Ar-OH (e-) 
9.50 (bs) 1 N-H (f) 00 
00 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(a) (f) 195 LXIII DCC1 3 2.60-2.90 (m) 4 CH2cH2 (a) 
-
3.40 (s) 3 OCH3 (b) 
3.90 (s) 3 OCH3 (c) 
CH a' T '"J (/~ 
3 " {+:\ 6.38 (s) 1 ArH (d) 
6.80 (s) 1 ArH (e) 
7.40-7.60 (m) 6 ArH, N=CH (f) 
I 
;J.29 LXIV Pyridine-~5 2.60-2.80 (m) 4 CH2CH2 (a) 
HO, '-..,./ (c) C6HS (c) 4.55-5.90 (bs) 2 ArOH (b) 
(b) OH 6.80-8.75 (m) 8 ArH, N=CH (c) 
00 
l..O 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(a) 
- 197 LXV DCC1 3 2.60-2.80 (m) 4 CH2cH2 (a) 
·-
3.42 (s) 3 OCH3 (b) 
CH30' l ¥(f) 3.85-3.87 (2s) 6 OCH3 (c) 
(c) OCH 1 6.40 (s) 1 ArH (d) 
6.80 (s) 1 ArH (e) 
6.90-7.50 (m) 5 ArH, N=CH (f) 
(a) 
198 LXVI DMS0-~6 .....- 3.50-3.85 (m) 4 CH2CH2 (a) 
6.35 (s) 1 ArH (b) 
(f) OH y 
6. 75 (s) 1 ArH (c) 
6.90-7.50 (m) 4 ArH (d) 
8 .15 (s) 1 N=CH (e) 
8.75-9.80 (b) 3 ArOH (f) 
'° 0 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(b) (g) 199 LXVII DCC13 2.35 (s) 3 CH3 (a) ,.-
2.75 (m) 4 CH2CH2 (b) 
3.86 (s) 3 OCH3 (c) 
CH o-'-./ -~ 3 I 3.90 (s) 3 OCH3 (d) (d) ~c~3 Q (h) 
6.70 (s) 1 ArH (e) 
7.44 (s) 1 ArH (f) 
7. 78 (s) 1 N=CH (g) 
7.20-7.30 (2s) 
(e) 7.80-7.90 (2s) 4 ArH (h) 
~ 
I f 203 LXVIII DCC13 2.60-2.95 (m) 4 cH2-ca2- (a) N I 
-c6H5 (d) 3. 74 (s) 3 OCH3 (b) CH30' Cc) 
(b) 6. 72 (s) 1 ArH (f) 
6.40 (d), 6.55 (d), 2 ArH (c) 6.82 (d~ 7.40 (m 5 ArH (d) 
7.55 (s) 1 N=CH (e) 
\0 
f-" 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(a) (d) 204 LXIX DMS0-~ 6 2.60-3.90 (m) 4 CH2-cH2 (a) 
v 
-
' 
6.50 (s) 1 ArH (b) 
(b ~ (c) C6H5 
HO 6.30-6.60 (m) 7 ArH (c) 
(e) (c) and 7.50 (m) 
6.55 (s) 1 N=CH (d) 
9.30-9.60 (bs) 1 ArOH (e) 
(e) 
--'.'.. 
185 LXX DCC1 3 2.65-3.15 (m) 4 CH2-cH2 (a) 
-
3.88-3.90 (2s) 6 OCH3 (b) 
6.80 (s) 1 ArH (c) 
I 
OCH3 7.20 (s) 1 ArH (d) 
8.12 (s) 1 N=CH (e) 
\0 
N 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent cS(p.p.m.) a Integ. Assignments 
(a) (e) 186 LXXI DCC13 2.60-2.80 (m) 4 CH2-cH2 (a) 
--~ 
3.88-3.90 (2s) 6 OCH3 (b) 
6.78 (s) 1 ArH (c) 
7.45 (s) 1 ArH (d) 
8.14 (s) 1 ArH (e) 
OH (d) 
207 LXXIII DMSO-~ 2. 50' 2. 80 (2 t) 4 CH2-cH2 (a) 
3.78 (2s) 6 OCH3 (b) 
CH30y(c) 6.90, 7.24 (2s) 2 ArH (c) 
(b) OCH 10.0-12.6 (vb) 2 =C-OH, NH (d) 3 
OH (c) 
233 LXXII DMSO-~ 2.55, 2.85 (2t) 4 CH2-cH2 (a) 
--
3. 74 (s) 3 OCH3 (b) 
CH3~ 6.70-7.50 (m) 5 =C-OH, ArH, (c) ~ 
(b) NH (c) w 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(c) w LXXIV DMSO-~ 2.65, 2.85 (2t) 4 CH2-cH2 (a) 
I 'N-@ 3.80-3.81 (2s) 6 OCH3 (b) N/ 
I H (c) 6.90-7.90 (m) 7 ArH (c) 
(d) 
OCH3 11.1-11.15 (bs) 1 N-H (d) (b) 
209 LXXV DMSO-~ 2.65, 2.85 (2t) 4 CH2-cH2 (a) 0 (c) -
-@-F 3.80-3.81 (2s) 6 OCH3 (b) 
6.90-7.90 (m) 6 ArH (c) (c) 
cH3oy(c) (d) 10.2-11.0 (vb) 1 N-H (d) 
(b) CH30 
\O.J 
(h) gH,,~ 
210 LXXVI DCC1 3 1. 35 (s) 3 CH3 (a) (e) -
2. 0, 3. 0 (m) 4 CH2-cH2 (b) 
CH3D"'""y\.aJ 3.80-4.01 (2s) 6 OCH3 (c) 
(c) OCH3 6.68, 7.25 (2s) 2 ArH (d) 
9.25 (bs) 1 NH (e) \0 +:'-
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
234 LII DCC13 
-
2.62 (t) 2 CH2 (a) 
3.00 (t) 2 CH2 (b) 
3.92 (s) 6 OCH3 (c) 
6.80...:7,45 (m) 3 ArH (d) 
9.38 (s) 1 NH (e) 
s . 
I TNH2 211 LXXVII DMS0-:!-6 2.80 (m) 4 CH2-cH2 (a) 
--(d) ("",......,. "y"' -N (c) 
3. 75 (s) 6 OCH3 (b) (d) 
6.76-6.78 (2s) 2 NH2 (c) 
7.18 (s) 2 ArH (d) 
«s 212 LXXVIII DMSO-% 2.95 (m) 4 CH2-cH2 (a) f-NHc6H5 -(c N (e) . (d) 3.81-3 .. 84 (2s) 6 OCH3 (b) 
) 7.75 (s) 1 ArH (c) CH30 1 
OCH3 8.00-8.40 (m) 6 ArH (d) (b) 
8.92-9.20 (bs) 1 NH (e) \.0 
U1 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(f) 213 LXXIX DCC13 2.88 (m) 4 CH2-cH2 (a) 
!' I-NH-rH2 (b) - 3.89-3.91 (m) 8 OCH CH2 (b) 
CH (e) 3, p 6.70 (s) 1 ArH (d) 
CH30' f ,~, CH2 (g) 
(b) 0CH3 7.30 (s) 1 ArH (c) 
5.25 (qt) 1 -CH= (e) 
5.60-6.10 (m) 2 =CH (g) 2 
6.35 (s) 1 NH. (f) 
s 
I .?-cH3 214 LXXX DCC13 2.60 (s) 3 CH3 (a) N (a) 
-
2.90 (s) 4 CH2-cH2 (b) 
I 
OCH3 3.86-3.92 (2s) 6 OCH3 (c) 
6.74 (s) 1 ArH (d) 
7.48 (s) 1 ArH (e) l.O (j\ 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
235 LXXXI DCC1 3 1.25 (t) 2 CH2 (a) 
(h) H?Cco2cH3 -- 1. 90 (qt) 2 CH2 (b) 
(")H l (d) 
J '-.. H (i) 3.35 (t) 2 CH2 (c) 
M 3.75 (s) 3 CH3 (d) CH30 (c) 3.88-3.91 (2s) 6 OCH3 (e) (e) CH 0 (b) 6.65 (d) 1 =CH (h) 
3 (f) (a) 
5.88 (d) 1 =CH (j) 
6.55 (s) 1 ArH (f) 
7.15 (s) 1 ArH (g) 
7.94 (2d) 1 =CH (i) 
(a) 
(c) 
CH30:©@l C02H 236 LXXXII DCC13 2.15 (qt) 2. CH2 (a) 
(d) 0 0 (e) - 2.55 (t) 2 CH2 (b) 
CH30 (f) 3.10 (t) 2 CH2 (c) 
3.98-4.00 (s) 6 OCH3 (d) 
5. 55 (bs) 1 C02H (e) 
7.10-7.65 (m) 5 ArH (f) 
'° 
" 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(a) 188 LXXXIII DCC1 3 2.25 (qt) 2 CH2 (a) 
-
CH OJ§r§r"'U 
2.70 (t) 2 CH2 (b) 
(d) 3 0 0 3.28 (t) 2 CH2 (c) CH30 (e) 
.5. 99 (2s) 6 OCH3 (d) 
7.15 (s), 7.25 (s), 
7.48, 7.58 (d), 4 ArH (e) 
7.98 (d) 
(b) (d) 
~ ~ 
237 LXXXIV ncq13 2.70 (t) 2 CH2 (a) 
I 
-CH30~Q H 3.26 (t) 2 CH2 (b) (c) 0 0 (d) 
CH30 (d) 4.08 (s) 1 6 OCH3 (c}· 
7.10, 7.30, 7.55,(s) 6 ArH, C=CH, 7. 65' 7. 88' 8. 00 
=C-OH (d) 
"° 00 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
215 LXXXV Pyridine-~5 2.92 (t) 2 CH2 (a) 
-
3.35 (t) 2 CH2 (b) 
CH~N' (c5 0 0 H 3.88-3.92 (Zs) 6 OCH3 (c) 
c (d) H3 (d) 5.62, 7.15, 7.30, 
7.52, 7.64, 7.70, (s) 6 ArH, NH, 7.84, 8.28, 8.35, N=CH, (d) [im-
8.68 purities in 
pyridine-~5 ] 
216 LXXXVI DMSO-~ 2. 88 (t) 2 CH2 (a) 
- 3.16 (t) 2 CH2 (b) 
7.18-8.26 (m) 5 ArH, N=CH (c) 
~ ,_, 
(c) 9.44-9.62 (Zbs) 3 ArOH, NH (d) 
190 LXXXVII DCC13 2.90 (t) 2 CH2 (a) 
-- 3.38 (t) 2 CH2 (b) 
CH30-" '""(d)'-" 3.99-4.00 (Zs) 6 OCH3 (c) 
7.15, 7.24, 7.62, (s) 
7. 66' 8 .15 5 
ArH, N=CH (d) 
\0 
\0 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent c(p.p.m.) a Integ. Assignmen.ts 
(c) 217 LXXXVIII DMS0-~6 2.84, 3.34 (2t) 4 CH2-cH2 (a) -~ -CH3°)§J§J~/l 3.90 - 3.94 (2s) 6 OCH3 (b) (b) 0 0 ArH, N=CH (c) 
CH3if (c) r8J (c) 6.68 - 7.64 (m) 9 
F 
(c) 218 LXXXIX Pyridine-~5 2. 76, 3.32 (2t) 4 CH2-cH2 (a) 14'N ,,...__ 4.60-6.15 (vb) 2 ArOH (b) NI 
(b) ~© HO / , 0 (c) 6. 98-8. 72 (m) 9 ArH, H=CH (c) 
F 
238 xc DCC1 3 2.02-2.10 (3s) 14 OC(O)CH3, ,_.. 
CH20Ac (a) 
/R (c) 4.32 (m), 4.85 (q), 
I vn1.- I 4 -C(0)-0-CH (b) (a) H (a) Br 5.15 (t), 5.55 (t) (b) r-
6.60 (d) 1 H-CBr (c) 0 0 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(c) (e) 206 XCI DCC13 1. 88 (s) 2 C(O)-O-CH2 (a) I~ (a) --
N' CH20Ac 2.05 (2s) 12 OC(O)CH3 (b) (d)~ ~ (b) 2. 72 (m) 4 CH2-cH2 (c) AcO 
CH3 e) (£) 
OAc 3.82 (s) 3 OCH3 (d) AcO (f) (b) 
(b) 4.25 (m), 
5.20-5.65 (m), 9 ArH, =N-CH (e) 
6.75 (s), 6.84 (d), 
7.35 (s), 7.80 (d) C(0)-0-CH (£) 
• 
(d) 201 XCII Pyridine-~5 1.8-2.1 (3s) 14 C(0)-0-CH2 , f'~N - 0-C(O)CH3 (a) I 
~20Ac 2. 70 (m) 4 CH2-cH2 (b) 0 (a)
AcO 3. 78 (s) 6 OCH3 (c) OCH3 OAc 
4.04 (s), 4.46 (m), ArH, N=CH, AcO (a) 8 
4.80 (s) C(0)-0-CH (d) 
5.50-8.70 (s,m) [Impurities in ...... Pyridine-g5] 0 ...... 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent . o(p.p.rn.)a Integ. Assignments 
(f) 202 XCIII Pyridine-is 2.02 (d) 2 -CH -0 (a) ~ 
-
2 
I / <a> 3.70-3.75 (m) 4 CH2-cH2 (b) (f~ - CH20H 
(f) ~ 3.70-3.82 (2s) 6 OCH3 (c) CH30 HO (d) (c) . 4.25-4.40 (rn), 4.90 OCH OH 7 -C!!-0!! (d) 3 HO (d) (rn), 5.85 (d) 
7.55-7.70 (2s) 3 ArH, N=CH ( f) 
(e) 220 XCIV DCC1 3 
--
1. 90 (s) 2 0-CH - (a) 2 ,, 2. 05-2 .15 (3s} 12 OC(O)CH3 (b) 
I (a) 
~20Ac 2.90 (t), 3.30 (t) 4 CH2-cH2 (c) 
CH3CJ ~ ~ (e) :co 3. 95 (s) 3 OCH3 (d) 
(d) OAc 
AcO (b) 4.25 (m), 5.30 (m) ~ 
5.62 (s), 7.10-7.20 11 ArH, N=CH, 
(rn), 7.40 (s), 7.15 -C(0)-0-CH- (e) 
( d) ' 8 . 00 ( d ) 
I-' 
0 
N 
TABLE VIII (Continued) 
Structure Cpd. Plate Solvent o(p.p.m.) a Integ. Assignments 
(d) 221 xcv Acetone-~ 2.90, 3.35 (2t) 4 CH2-cH2 (a) I) (1') ,_ 
3.60 (d) 2 0-CH (b) ~2(:~ 2 (c)~ 3.95 (s) 3 OCH3 (c) CH3 (dJ 
(d) OH 5.25 (s), 5.34 (s) 15 ArH, N=CH, HO 7.10-8.15 (m) C-OH, 0-CH (d) 
a Chemical shifts are measured down.field from TMS. The multiplicity is as follows: singlet, s; doub-
let, d; triplet, t; multiplet, m; broad, b; broad singlet, bs; quartet, q; quintet, qt; very broad, vb. 
All sweep widthswere 1000 Hz at 100.1 MHz (1H) in all solutions. The lone methoxy group of 6-methoxytetra-
lone has a signal at 03.81 while the corresponding 2-hydroxymethylene compound has an absorption at 03.79 
(J. G. Morgan, Ph.D. dissertation, O.S.U., 1971). It was noted that all signals for methyl protons on the 
CH30 group in all compounds in our work occurred as two singlets (six exceptions were ~, ~· W• -~· 
234, 392 which displayed lone singlets below 03.90). Thus, it is conceivable that the signal at higher 
fuld-~fresponds to the methyl protons of the 6-methoxy group in our compounds while the signal at lower 
field corresponds to the methyl protons for the 7-methoxy function. Final confirmation would require addi-
tional experiments. The methylene signals of the keto ester 222 and ester 223 and related compounds were 
- -"""" assigned on the basis of comparison with the spectrum of 3-benzoylpropanoic acid (found in Sadtler NMR 
Spectra). 
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Figure 8. Synthesis of Some Pyrazoles and Pyrazolones From 6-Methoxy-1-tetralone 
I-' 
I-' 
0 
0 CH30ro 
CH 0 
3 182 
CH30, 
CH30 
188 
0 
+ BrZnCH2CH=CHCo2cH3 
.... 
115% 
..,. PPA 
100°, 15 min. CH30 
6 
1. C6H6/(C2H5)20 11111. 
fll"'" 
+ 2. H30 
236 
CH3 
CH30 OH 
----+ 2. H30 CH 30 
246 
-
co2cH3 
10% Pd/C 
220°-240° 
2 hrs.' co2 
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Figure 11. Synthesis of N-Glucosides From 6,7-Dimethoxy-l-tetralone 
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Figure 13. Synthesis of N-Glucosides from 7-~thoxy-3,4-dihydro-1(2~)phenanthrone f--1 f--1 Vl 
I A key starting ketone 182 for all heterocycJ.ic compounds synthe-
.--
352 
sized in this study was obtained by several different approaches. 
116 
Maximization of yield of tetralone 182 via elimination of side reactions 
__., 
required considerable innovations and modifications of known reactions 
as well as the development of new techniques. The classical method of 
Haworth, i.e., Friedel-Crafts succinoylation of veratrole (239) and 
~ 
Clemmensen reduction (or Wolff-Kishner reduction) followed by acid-
catalyzed cyclization of the resulting acid,gave usually an overall 
yield of 7-10%, 3 •174 •194 compared to yields in this study of 40-51% 
(overall): 
0 
+ c) 
0 
(b) 
239 
- -
I 
l 
182 
--(a) A1Cl3 , c6H5No2 + Cl2CH-CHC12 , 24 hrs., room temperature. 
(b) Zn(Hg)-HCl, 18-24 hrs., boiling; or H2N-NH2/KOH, HOCH2-cH20H, 
200-240°, H3o+. 
(c) Cone. H2so4 , ~; or P2o5 , ~. 
The synthetic problems which have been commonly noted in the total 
synthesis of alkoxy-substitated tetralones and have contributed to poor 
yields can be summarized as follows: 
1. Partial methoxyl group cleavage in the initial acylation step 
caused by long reaction time (24 hours) in the presence of excess HCl 
186,173 gas. 
117 
2. Partial cleavage of methoxyl groups during steam distillation 
of the acidic succinoylation mixture. 186 
3. Partial cleavage of methoxyl groups in th:;! Clemmensen reduction 
of keto acid ~ caused by long exposure (18-24 hours) in presence of 
concentrated HCl.103,172,190,264,267,276,341,352 
4. Partial cleavage of methoxyl groups and apparent polymerization 
3 during the cyclization by hot concentrated H2so4 . 
5. Undesirable cyclization in the Wolff-Kishner reduction 
81 369 
method; ' a pyridazinone derivative 250 was obtained as the exclu-
--.... 
175 
sive product in a case related to our work. This pyridazinone deri-
vative 250 could be, however, converted to reduced acid 251 by treating 
- -175 the heterocyclic derivative with NaOC 2H5 . 
0 R)o/) N2H4 R0:@-00 RQ/ 0 0 H KOH, /:,. ~ 0 ~-RO H I 
RO 2 RO 244 
-
245 
--
NaOC 2H5 
-i 
RO~ 0 
RO 
co2H RO 
Because of these synthetic difficulties, the preparative methods to 
6,7-dimethoxy-l-tetralone (182) were reinvestigated (Figure 2). Route 
---(b) in Figure (2) gave the highest yield (51%) possible of ketone 182 
..---
in our hands. The condensation step was effected by heating a mixture 
of 3-carbomethoxypropanoic acid 3:2.]84 [or its acid chloride84 ~>which 
gave a slightly higher yield (15% more of 11_2) in this specific step], 
veratrole (239), and 115% PPA366 at 40-50° for 2 hours. The condensing 
--
agent PPA has been reported to act as an acylating-type catalyst32 •250 • 296 
13 293 for many similar cases, among which are, for example: ' 
PPA 
118 
(62%) 
(51%) 
In none of those cases has any methoxy-group cleavage been reported; 
this renders PPA a superior acylating catalyst compared to the classical 
Lewis acids. In the case of veratrole, the acylation step may occur via 
this mechanism: 
PPA 
CH3~ .-J-HCl 
cup'& dcH 
2 3 
222 
-Since the Clemmensen reduction method gave only 40% yield of acid 
224, the Wolff-Kishner process was tried. Triethylene glycol was used 
,,-_,. 
as the solvent with the intention to prevent the formation of pyridazinone 
119 
derivative 235. The carbonyl function of keto acid 229 was readily re-
~ ,,_., 
duced but one of the methoxyl groups was cleaved under these drastic 
226 
--
N2H4 , KOH 
Triethylent' 
0 glycol, 220 
(80%) 
225 
alkaline conditions to give hydroxy acid 225 (80%). Partial demethyla-
~
. 153 204 tion using H2NNH2/KOH has been occasionally used ' as a standard 
technique for 1,2-dimethoxy compounds as shown by the example . 
Diethylene 
glycol 
. o-~o 
The position of the hydroxyl group in acid 225 was determined on the 
-
b . f . h bl" h d k152 . h . f asis o comparison wit pu is e war concerning t e preparation o 
isomeric acid 254 as illustrated: 
---
CHPJ§J 
. 0 
HO 
120 
-
o 
m.p. 120-1 
152 o While reported hydroxy acid 254 had a melting point of 120-1 our 
. ___, 
acid 225 had a melting point of 87-88°. Spectral and elemental analyses 
--
showed the presence of one OH and one OCH3 group in our acid ~· More-
over, an attempt to cyclize the hydroxy acid 225 to the tetralone below 
~
with PPA was unsuccessful while 254 gave a tetralone melting at 150-1°. 
' -
0 
HO~ 
CH30~ 
m.p. 150-1 0 
The reaction of keto acid 323 with 95% N2H4 in boiling ethanol 
(Figure 3) is a straightforward, high-yield reaction, giving pyridazinone 
234. Structurally similar compounds have been recorded113 recently; 
_._, 
biological evaluation revealed high antihypertensive activity. When 
pyridazinone ~ was subjected to boiling 48% HBr (under N2) for the 
purpose of obtaining a more water-soluble heterocyclic compound, a 
121 
dihydroxy keto acid 227 was formed exclusively (Figure 3). 
--
Due to the poor yields and side-reactions encountered in the Clem-
mensen and Wolff-Kislner reductions, a more efficient process was sought. 
Catalytic hydrogenation using 10% Pd-c79 , 145 ' 188 proved successful in 
reducing the carbonyl group in nearly quantitative yield. Polyphos-
h . ·d 366 d . i h 1 l" . p oric aci was use again n t e ast step as a eye izing agent 
(Figure 2). 
239 
. 134 189 Many other related systems are known in literature. ' ' 
C~H 0 ~ PPt\, 165 • (93%) 3 min. 
CH3o CH30 
C~02H 0 ~ PPA, 160 ~ (99%) 20 min. 
CH3o CH30 
0 
__ P_P_A,_90_0 _ ;i3°:©)..... . (61%) 
15 min. CH30 co2H 
Our yields in this cyclization step were comparable, 82-88% from sub-
stituted butyric acid 224 to tetralone 182 (Figure 2). According to 
,......_, --
literature, PPA functions simultaneously as a protic acid, a Lewis acid, 
122 
16 
and a phosphorylating agent. Although the reaction of benzene and 
304 4-butyrolactone gave 1-tetralone (68-95%) using AlC1 3 as a catalyst, 
surprisinglyveratroledid not react. When AlC13 was replaced by 105% 
PPA, the reaction was also unsuccessful. However, anisole condensed 
191 
readily with 4-butyrolactone in PPA to the corresponding keto alcohol. 
Such random behavior in the series benzene, anisole, and veratrole to-
ward Lewis acids defies immediate explanation. 
@ + 
0 
+ 0 
CH OJ§J 
. 3 
+ 
0 
+ 0 
A1Cl 3 @O 
68-95% 
A1Cl 3 
___ __;~--111J.~ No useful reaction 
0 
__ P_P_A _ ___,...,,_CH3J§J~OH 
PPA 
-------11llJ.• No useful reaction 
The efficiency of the commercial 115% PPA used in our study as a 
versatile agent is apparently due to its constituents. Polymeric acids 
and a certain weight percent (83.2%) of P2o5 had been added to H3Po4 to 
produce this PPA. Experiments (electrophilic substitution reactions run 
in this laboratory) using 105% PPA and the calculated amount of P2o5 
added to produce 115% PPA did not provide an acid medium capable of 
initiating the above acylations. 
93 283 Berlin, Durham, and co-workers ' discovered that indazoles 
123 
247a and 247b demonstrate in vivo activity against a variety of micro-
-- - ---
organisms. Another major objective of our study was, in part, to obtain 
analogs of this model system for biological evaluation. Two vicinal 
methoxyl groups on positions 7 and 8 were included and were converted to 
hydroxyl groups. The latter should increase the water solubility of the 
pyrazole. ]!-Substituted(aryl) compounds could also provide other TI sys-
terns potentially capable of forming TI complexes with a conjugated group 
of an anticancer agent such as actinomycin D, mitomycin C, and metho-
trexate. 
RO 
R CH3 , R' H (193 ' 72%) R CH3 (247a) 
--
--
R H, R' = H (194' 50%) R H (247b) 
_.... 
--
R CH3 , R' = C6H5 (195, 85%) ,,....., 
R H, R' = C6H5 (196, 78~~) 
--
R CH3 , R' = :e-c6H4-ocH3 (197, 52%) 
...--
R H, R' = p-C H -OH ( 198, 74~0 
- 6 4 
--
R CH3 , R' = p-SO -C H -CH 
- 2 6 4 3 C22J, 30%) 
Figure 4 illustrates the synthesis of novel dimethoxy and dihydroxy 
pyrazoles 193 through 199 from the starting ketone 182. 
~ .--- ........_, 
The action of ethyl formate in the presence of methoxide ion on 
tetralone ~ produced a 1,3-dicarbonyl compound. The latter exists 
mainly in the enolic form 232 as evidenced by spectral data (see IR 
-
124 
Plate IX and NMR Plate LVI) and the formation of a dark green color with 
FeC13 . Hydroxymethylene ketone J.23 cyclized readily with 95% H2NNH2 to 
give unsubstituted pyrazole ~ (80%). Yields varied from 30-85% for 
substituted hydrazines, depending on the stability of the hydrazine it-
self (see Table II). Aqueous 48% HBr cleaved the methoxyl groups on 
positions 7 and 8 and gave dials 194, 196 and 198 in yields of 50-70% 
__...,,, ,,,,..-- ,.-....,,., 
(Table II, Figure 4). 
Cleavage of the methoxyl groups to the hydroxyl functions may occur 
simultaneously or stepwise. A monomethyl ether intermediate has not 
been isolated in this study since an excess of HBr reagent and prolonged 
reaction times were both employed. 
While alkylhydrazines usually give rise to a mixture of N-1 and N-2 
substituted pyrazoles (see Chapter I, P· 17), arylhydrazines yield a 
specific product, the !!-1 derivative. 102 As mentioned before, this may 
be due to the difference in the nucleophilicity of the two N atoms in 
the two hydrazines. It was evident (via NMR studies of the cyclization 
of hydroxymethylene ketone 232 to pyrazole 195) that the phenyl group is 
- _......._,. 
undoubtedly located on N-1 of pyrazole 195. 
(Numbers in parentheses are o values in p.p.m. from TMS). 
125 
Upfield shifts of the protons on C(9) and OCH3 on C(S) can only be rea-
sonable if the phenyl ring is on N(l) in such a way that it shields both 
the neighboring proton on C(9) and OCH3 group on C(S) (see Plate LXIII). 
The NMR spectra of 12.§ was measured in DMS0-~ 6 (Plate LXIV, Table VIII) 
and in pyridine-~5 , and showed the· following features. 
(a) The two CH2 groups coalesce in one large singlet peak. 
(b) The aromatic region of the spectrum is complicated (after ex-
eluding those peaks belonging to residual protons in pyridine or the 
aromatic protons of the original molecule). Measuring the spectrum at 
sweep width 50 MHz did not separate the singlet peaks (integration = 4 
H). 
No clear conclusion could be drawn as to the reason for coales-
cence of the two methylene protons except that it may be a solvent-de-
pendent phenomenon. Possibly the complexity of the downfield region is 
due to some sort of solute-solvent interaction via hydrogen bonding. 
DMSO and pyridine are both strong hydrogen-acceptor solvents. 
The novel 4,5-dihydro-7-methoxy-l-phenyl-l.!:!.-benz[~]indazole (~) 
and 4,5-dihydro-l-phenyl-1H-benz[g]indazol~7-ol (204) were prepa;ed for 
- - ~__, 
NMR analysis (Figure 8) as well as for biological screening. Two 
R 
0 H ,Hb,H 
a c 
CH3 , lQJ 
H, 204 
~
6.40-6.55 0 H ,Hb,H 
a c 
6.51-7.74 
126 
doublets for protons (H ) and (H ) of indazole 203 experienced some b c ,,....._, . 
shielding effect due to the steric positioning of the benzene ring on 
N-1. This diamagnetic anistropic effect was not found for the same 
protons of the N(l) substituted indazole 'f!:2· The values are included 
here for comparison (DCC13). With no exception all B.-1-aryl substituted 
pyrazole derivatives 193-199 showed this diamagnetic shielding effect. 
,,.._ ............ 
Thus, at least one aromatic proton lies above the plane of benzene ring. 
Two previously unknown isomeric isoxazoles 185 and 186 were pre-
...--....... . _,......_ 
pared from 6,7-dimethoxy-l-tetralone (182) in an attempt to determine if 
------
a structure-activity relationship existed in going from pyrazoles to 
isoxazoles. 4,5-Dihydro-7,8-dimethoxynaphth[2,l-d]isoxazole (185) was 
- ..---...-
obtained from the hydroxymethylene ketone 232 by the action of hydroxyl-
---...... 
p? 
CH30 I 
OCH 3 
186 
-[2, 1-~] isomer [1,2-~] isomer 
amine hydrochloride in acetic acid (Figure 5). If the reaction was con-
ducted in pyridine, however, the isomeric 4,5-dihydro-7,8-dimethoxy-
naphth[l,2-c]isoxazole U86J resulted. These findings agree with re-
- ·-
. h i· 37 f h 1 ports 1n t e 1terature or somew at ana ogous systems. A difference 
of only 0.05 ppm had been reported between the chemical shifts of the 
heterocyclic protons of isomers 255 and 256 . 
.,,,-._, ----
127 
H (6 8. 07) H (6 8.02) 
~ Cb 
255 256 
-
In the case of our isoxazoles, an even smaller difference (0.02 
ppm) was observed. However, a dramatic shift was observed in the PMR 
spectrum of 185 and 186 regarding the proton located on C(9) (6 7.45 
-- -
H (6 8.12) (6 8.14) 
(6 7.20) (6 7.45) 
-
[2,1-~] isomer [1,2-c] isomer 
ppm in the [1,2-c] isomer 186). Possibly a long-range shielding effect 
- -
shifted the corresponding proton signal to 8 7.20 ppm in the [2,1-~]-
isomer ~· This can be probably attributed to the close proximity of 
the two lone pairs of the 0 atom in the [2,1-d]-isomer 185. The lone 
- ---
electron pair on the N atom in the [1,2-d]-isomer 186 may invert rapid-
- -
ly but the proton on C(9) only "sees" an average shielding value which 
is less than the provided by the two fixed lone pairs on oxygen in the 
[2,1-~]-isomer. 
The following suggested experiments could be instructive in making 
128 
definitive the structure assignments £or many isoxazoles including 185 
and 186: 
,,----
(1) Spectral work: (a) Determine the 13cMR spectra of isomers 185 
and 186, 
~ 
. 132 257 321 13 Analogous differences ' ' in C chemical shifts of 
-
simple azole compounds should be evident in 13c values in ppm relative 
to TMS (compare related examples). 
1008108 
117.7 r .. 117.7 
N 
H 
105.8c· )· 134.6 
134. 6 ~ 
N 
H 
0 109.6 
142.6 
0 
(b) Shift reagents could also be used to distinguish between the 
h . h f . 1 d . . 97 two structures sue as in t e case o certain pyrazo e erivatives. 
(c) Investigating the effect of the nitrogen lone pair orientation 
· . 1 15N 1H · · l" 230 i · 1 257 on vicina - spin-spin coup ing n isoxazo e -· Analogous to 
the two forms of oximes, isoxazole 257 was considered as an oxime locked 
-
R' D C = N......_ "syn" 
H·/ OH 
259 
-
257 
-
129 
. h . f. . 230 in t e anti-con iguration. 15 . The measured N=CH coupling for the 
oximes were 16 Hz ~nti form 258 )and 3 Hz for the syn form 259. Corn-
-- -
paring these values with the coupling observed in compound 257 showed 
/""'-
a splitting of 16 Hz and was also observed for !!=C-H3 in ill. 230 
Consequently, with 15N and FT, 13cMR experiments could be devised to 
determine unambiguously the structure of our isoxazoles 185 and 186. 
- __..._... 
(2) Chemical and Spectral Work: To confirm assignments for H(6) 
208 
and H(9), one could replace H(3) with a CH3 group and compare the 
chemical shift difference of CH3 groups of the two isoxazoles 
0 
produced. 
RO 
OR 
('('cH3 
(1.) morpholine, Jf> ~· ~O 
(2) CH3C(O)Cl .... 0 l RO/ (3) H+ H2N·OH OR 
I ~3 1~s3 
-al IF)i~N; 
+RO~ RO 
OR OR 
One could replace H(3) with D(3) [DC02H is available] and deter-
mine the position (o value) of H(3) in both isomeric isoxazoles. 
0 
RO RO 
OR 
D 
RO 
OR 
OR 
+ 
D 
0 
I 
0 H 
OR 
It is also possible to effect a cleavage of 
RO 
OR 185, R 
___. 
RO.,,, 
NaOCH3 
RO 
OR 
Na0CH3 
~~~~___;..~~~·-- No useful reaction 
/':, 
-~' R = CH 3 
the heterocyclic ring. Simple systems related to 185 are reported to 
_,....,._, 
ff . . 144,166,215,247,265,269 su er ring opening. 
It was not surprising to note that [2,1-d]isoxazole 185 was bio-
- ----
130 
logically active against Bacillus subtilis while the [1,2-c]-isomer 186 
- .............. 
was inactive. Similar findings for some other isoxazole systems have 
265 been reported. The screening experiments will be discussed in details 
at the end of this chapter. 
R' 0 H O 
R CH30 
R 233 ,___... 
R OCH3 , R' = H, R" H (_~) 
R OCH3 , R' H, R" C6H5 ( 208) 
---
R OCH3 , R' H, R" £~c6H4F (209) ,,.._,. 
R OCH3 , R' = CH3 , R" = H (210) ~ 
Incorporation of a carbonyl function into the heterocyclic ring of 
model steroidal systems have been accomplished through the preparation 
131 
of pyrazolones 207-210. This type of compounds were intentionally 
- ......._ 
synthesized to provide an additional site for complexation with anti-
tumor agents. The oxygen atom of the carbonyl groups could donate extra 
electron pairs and serve as an electron-donor. 
A series of pyrazolones 207-210 
- """-" 
(Figure 6, Table IV) were pre-
pared from the keto ester 230 precursor. This novel keto ester 230, ,,....._ 
namely, methyl 1,2,3,4-tetrahydro-6,7-dimethoxy-l-oxo-2-naphthoate (230), 
.-.... 
was synthesized (92-96%) by the reaction of dimethyl carbonate with 
tetralone ~in the presence of NaOCH3. Cyclization with hydrazines to 
pyrazolones (Figure 6) was easily accomplished in high yields (65-92%) 
(see Table IV). 
When arylhydrazines were used, the cyclized product formed was 
characterized by its IR spectrum (Plate LXXIV, and Plate LXXV). A FeC13 
test was negative, i.e., no color change occurred. This suggested that 
the five-membered heterocyclic ring exists mainly in the keto form. A 
triplet in the NMR spectrum was expected at o 3.5-3.8 ppm for the 
angular proton at 3a position (similar to the precursor keto ester, 
Plate LX) if the pyrazolone existed in the keto form. 
RO RO 
OR I OR 
230, R = CH3 208, Ar = C6H5 
.r--
-w, Ar = :e-C6H4F 
0 3.6 ppm 0H(3a) = absent H(3a) 
132 
This expected bridgehead . proton absorption was absent in the NMR 
spectrum and instead a broad singlet at o 11.10-11.15 was detected (one 
proton integration). This suggests that the proton resides on N-1 at 
low field. Accordingly, we propose the following structure for 1-N-
arylpyrazolones: 
H 
CH 30 1685-1690 -1 vC=O cm 
OCH3 
0N-H 11-12 ppm (bs). ··-
x = H,F 
It seems probable that 13c NMR studies of these ~ompound would be diag-
. 132, 
nostically useful regarding hybridization of the ring carbon atoms. 
257 
Cyclization with unsubstituted hydrazine starting from the keto 
ester 230 and 241 led to the formation of pyrazolones 207 and 233 
.............. ........_...... ............._. ...-....--
(Figure 6 and Figure 8). The absence of C=O absorption in the IR spec-
OCH3 
207 
H 0 
CH 30 
H 0 
233 
-
tra of those compounds and the presence of strong OH bands at 3100-3200 
-1 
cm suggested an enolic form such as 207a or 207b or 207c or 207e 
......--......- ~ --- .--...--
OH OH H OH 
RO RO 
OR 207a OR 207b OR 207c 
--
-
--
133 
OH 
RO RO 207e 
-OR OR 
(See Plate XXV and Plate XXVI). Forms 207c and 207d were ruled out on 
~ ...---....-
the basis of the NMR spectra. A triplet signal (one proton) was not 
present as in the precursor keto ester (Plate LX). Form 207e was also 
....-,.__.. ' 
eliminated on the basis of NMR analysis since a singlet would be ex-
pected for the angular proton somewhere between o 4-6; this was not ob-
served. Forms 207a or 207b appear the most reasonable candidates for 
~ ~
the actual structure and a FeC13 test was also positive (brownish-
violet). 
We suggest that form 207a predominates 
-
on the grounds that 
usually a double bond at the junction of bicyclic compounds are more 
stable than related systems with exocyclic double bonds. The litera-
115,144 h . . h. 116,118,144,214, ture · is, owever, not consistent in t is matter. 
340 It is also probable that both forms, 207a an<l 207b, are tautomeric 
- ~ 
and thus rapidly interconvertible. This could at least account for the 
broad OH band (or OH and NH bands) in the IR spectrum. 
CH30 
OCH3 RO 
OR 210 
-
H R = R' = CH 3 
CH3 
OCH3 
134 
When the bridgehead. position 3a was occupied by a CH3 group, pyra-
zolone 210 resulted. To prepare this compound, 2,3a,4,5-tetrahydro-7,8-
..-.._,, 
dimethoxy-3a-methyl-3!!_-benz[1!i]inJazol-3-one ~ / the first step con-
sisted of treating tetralone 182 with excess diethyl carbonate in the 
,,,,-..._. 
presence of Na0CH3 and then boiling with methyl iodide. The intermedi-
ate solid ethyl 1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-l-oxonaphtho-
ate (228) formed (50%) (Figure 6). Cyclization with 95% hydrazine was 
~
228 
-
easily accomplished to give pyrazolone 210 (82%) (Figure 6, Table IV) . 
.....__ 
The IR spectrum exhibited a C=O absorption band at 1700 cm-l (Plate XII) 
and without a broad OH band as found in structures 210 as discussed 
_,,.....__. 
previously. The NMR spectrum (Table VIII) did agree with that structure 
expected for pyrazolone 210. This suggests that the 3a-methyl-substi-
~
tuted pyrazolone exists mainly (or exclusively) in the keto form ~dnce 
the possibility of enolization via the NH group is prevented. 
It is possible that the presence of an aryl substituent at N(2) im-
poses minimum steric interactions in the hybrid which may have a near 
planar arrangement of the 0-C-N-N sequence. In view of the absence of a 
H OJ ~n 
.. J~.L N:J "==./- 4t-4----·· 
135 
signal for the bridgehead proton, the keto group for H(3a) in the PMR of 
~ in DMS0-~6 , one must consider that two tautomers could exist such as 
(A) and (B). Unfortunately the compounds with the Ar-N group were only 
0 OH 
x.>-@ X)-© 
H 
(A) (B) 
soluble in "basic" DMS0-~6 . Our work is reminiscent of the observa-
tions of others in the study of 119, the structure of which was based 
__.....__ 
on an IR spectrum in a nujol mull. The IR spectrum of our Ar-N compounds 
-1 (KBr pellet) showed a strong VC=O near 1680-1700 cm like that of hydra-
zides. However, in DMS0-~6 the H(3a) undoubtedly migrates to nitrogen 
or oxygen such as in 
Ultraviolet spectral studies of these series of compounds might provide 
f 1 . 131 support or our cone us1ons. 
R NH2 (llJ-) 
R = NHC 6H5 (Jl3_) 
R NHCH2CH-CH2 (31]_) 
R CH3 (~) 
The physiological importance of the thiazole ring in many compounds 
has been cited (see Historical). Starting from 6,7-dimethoxy-l-tetra-
lone (182), bromo derivative 229 was prepared (60-70%) as a white solid 
-- -
136 
by the action of Br2 in HCC13-c2H50H medium at 0°C (Figure 7). Conden-
sation of2-bromo ketone 229 with thioureas gave the thiazole compounds 
.~ " 
130 211 through 214. We propose this mechanism for the forrhation of 
........_. _....,.__... 
these compounds: 
CHP 
OCH3 
229 
--
OCH3 
cir ~~ R ~ 'c/ 
0 II -Br 8 
NH .. 
H 
s 1-R 
NEE> 
H 
H Ee 
... 
OH 
1l 
H 
-Ho® 
3 
H~8 
H ~ Br I© 
s )-R 
N 
H 
I 
OCH3 
l -HBr 
H 
187 
-
The NMR spectra of these compounds were as expected (Table VIII) 
except for one; that i~when R = CH3 (Plate LXXX), the CH2-cH2 groups 
coalesced to one sharp singlet (on the 100 MHz instrument) which did 
137 
not separate at S. W. 50 MHz (DCCl}. The difference of the NMR split-, 
ting patternj of the first three thiazoles 211, 212, and 213 from that of 
~ -~ ---
the fourth thiazole ~- (R = CH3) is also probably due to some change 
in the electronic environment. 
The key starting phenanthrone 188 for preparing certain hetero-
----... 
steroids was synthesized for the first time from tetralone 182 (30% 
r--
overall yield). Other substituted phenanthrones are known and yields 
have been low (8-10%). 361 
0 
188 
--
OCH3 
260 
~ 
A literature search to December 1974 revealed 3,4-dihydro-6,7-
203 dimethoxy-1(2_!!)-phenanthrone (188) had been reported in 1969 (Japan-
___..._ 
ese journal) as a by-product (1%) in the total synthesis of 260. NMR 
and the melting point of 188 were recorded. 
----
'""'--
Our synthetic approach to phenanthrone 188 was based on lengthen-
_......__. 
ing the tetralone 182 system by four carbon atoms in one process. This 
~
1 . h d i R f k". . 351,361 C d . was accomp is e v a a e ormats 11-type reaction. on ensation 
of 6,7-dimethoxy-l-tetralone (182) with the Reformatskii reagent of 
,.--._.. 
commercial methyl 4-bromocrotonate C;!S) (in 3:1 c6H6 :ether at reflux 
for 10-12 hours) gave the dienic ester methyl 3,4-dihydro-6,7-dimethoxy-
61(2_!!),Y naphthalenecrotonate (235) (52%) (Figure 9). 
~ 
Data on the use of various solvents to optimize a Reformatskii 
reaction have been published. 104 We exercised special care in the puri-
fication of all starting materials and reagents involved in the Reform-
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atskii reaction. The commercial 85% methyl 4-bromocrotonate was frac-
tionally distilled on 2.5-foot Vigreaux column and the tetralone was re-
crystallized and sublimed. The small-cut zinc pieces were carefully 
washed, amalgamated and dried. Also, the reaction was carried out under 
N2 atmosphere. Despite these precautions, unchanged ketone 182 was re-
--
covered (20%) together with a high-boiling (b.p. 190-5°/1.5 mm) reddish 
liquid (3-4%). Repeated runs gave the same data. The high-boiling by-
product has been partially characterized via IR analysis (see Experi-
mental). The structure has been tentatively assigned as either 26la or 
..--..-
26lb: 
/"'--' 
26la 
-- 26lb 
-
Ester 26la is a conceivable intermediate resistant to dehydration which ,,_..__ 
could lead to dienic ester 235. Analogs of ester 26lb are not unknown 
....---
. l" 104 in iterature. 
The double bond in the ester 235 has been shown to be exocyclic by ,,.......__,. 
361 UV analysis and other methods . Analogously, we assumed that ester 
235 and not ester 235a was our product as was supported by NMR analysis. 
............ ,,,....__ 
Moreover, it was concluded that ester 235 exists in the trans-trans 
_..__ 
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configuration because the spin-spin coupling constant J for protons H , 
a 
H had the same value (J=7 Hz). If one pair of the alkenyl protons 
c 
Hc-yo2CH3 
Rb 
235 
,...._... 
CH30 
existed in the cis configuration, a "mixed" J value would have been ex-
327 pected Moreover, compound 235 was obtained as yellow-orange crys-
_._ 
tals after purification (m.p. 140-2°); the observation supports the all-
trans configuration,as one might expect an all cis-isomer to exist as a 
liquid. 
Isomerization of the dienic ester 235 to the fully aromatic ester 
--
~was performed (Figure 9) by using 10% Pd-Cat 220-240° (under co2). 
h . h d h b f 1 d108 •361 b f T is met o as een requent y use as a valua le procedure or 
dehydrogenating saturated rings with unsaturated side chains. The re-
sulting ester was saponified directly to the naphthalenebutyric acid 
derivative 236. Cyclization of the latter with 115% PPA at 100° for 
---
15-20 minutes afforded the desired phenanthrone 188 (Figure 9). 
--
Synthesis of the heterocyclic steroid systems in our study were 
all initiated from the hydroxymethelene ketone 237, namely, 3,4-dihydro-
,.-. 
2-(hydroxymethylene)-6,7-dimethoxy-1(2.!!)-phenanthrone. The latter com-
pound was prepared from the precursor ketone 188 by reaction with ethyl 
,,......-
formate in the presence of sodium methoxide. The reaction resembles the 
preparation of hydroxymethylene ketone 232 (Figure 10). 10,11-Dihydro-,........._ 
140 
7,8-dimethoxy-3_!!-phenanthro[l,2-.s:_]pyrazole (3-!3) was obtained (95-98%) 
by cyclization with 95% hydrazine. To obtain the diol 216, the dimethoxy 
--
pyrazole ~ was boiled with 48% HBr (under N2) for 14-16 hours. Longer 
reaction times for the model systems was found necessary since NMR 
analysis of the reaction mixture after 8-12 hours showed some residual 
OCH3 absorption. The order of complete ether cleavage observed was 
found to be: 
> ~>CH3o 
CH O~~ CH30 3 I 
7-8 hrs. 
OCH3 14-18 hrs. 
10-12 hrs. 
The fact that certain fluorinated chemotherapeutic agents,especial-
396 ly steroidsJ have greater physiological activity than the parent non-
fluorated systems prompted us to incorporate fluorine into our compound. 
The stability of the C-F bond, the small volume of the fluorine atom, 
and its highly electronegative character have resulted in unusual activ-
ity in correspondingly substituted compounds of pharmacodynamic and 
. 80 91 
chemotherapeutic value. ' 
The synthesis of the E-fluorophenylpyrazole (~) was performed 
usually by reacting E-fluorophenylhydrazine hydrochloride with the 
ketone 237 in glacial acetic acid. Spectral analysis and the sharp 
,,,._ 
melting point of the purified compound indicated the presence of only 
one compound, the N-1 substituted isomer. The reason for preferential 
formation of N-1 aryl compounds was discussed previously (see Page 124). 
Complete cleavage of methoxy groups in 217 to give the dial 218 (51%) 
- -...... 
took place in about 18 hours. 
141 
Starting from hydroxymethylene ketone 237 cyclization occurred in 
-
acetic acid with hydroxylamine hydrochloride, to give the novel isoxazolo-
steroid 190 (35%) (Figure 11). ,.......___., 
Steroidal B_-glycosides are absolutely unknown in the literature. 
Some steroidal Q-glycosides have been prepared and isolated from natural 
249 
sources. Indeed some have shown tumor-inhibitory activity, e.g., 
S-solamarin (262) isolated from Solanum dulcamara. 249 Sodium estriol 
-----
glucuronide (~) and sodium estrone sulfate <;6~ are the only two con-
CH3 
'·CH 3 
262 
OH 
·-·--o 
H --+---. 
HO 0 Nao3so 
264 
---
263 
--
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jugates isolated from natural sources. The term conjugation is applied 
to the process whereby an estrogen becomes chemically bound to an acid 
by a biological process. This action, in the case of estrone, renders 
257 the estrogen water-soluble and facilitates its transport. 
Virazole (~, a synthetic !!_-nucleoside analog,was discovered to 
be active in tissue culture against sixteen DNA and RNA viruses. 348 
178 
-
This fact combined with our interest in synthesizing more soluble stero-
idal systems incorporating a sugar molecule led us to derive methods to 
prepare !!_-glucosides of 15,16-diazasteroids. 
66 323 Although a silylation method ' was reported to give high yields 
323 ( ) ( ) for fully aromatic indazole systems , isomeric !!_ 1 and !!_ 2 glvcosides 
323 
were obtained. Other methods were first attempted including 
condensation of the free sugar and indazole in the presence of poly-
312,345 
phosph:>ric ester. Boiling a dioxane solution of indazole 247 
-
Polyphosplnric Ester (PPE) 
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with acetobromoglucose (238) for several hours did not effect glycosida-
. 99 tion. 
__, 
Metallation at ~(l) proved applicable with all indazole systems. 
Direct metallation with Hgc12117 (94-100%) proved superior to that with 
AgN03262 (40-60%). R 1 h d . H (CN) dll, 397 ecent y, a met o using g 2 was reporte 
to give higher yields. The hazard of this reaction with the involvement 
of HCN evolution as a by-product led us to use this method only once, 
despite the higher yield obtained (42% vs. 25% from HgC12). 
The literature is void of any studies on the nature of the metal-
heteroatom bond. We therefore assume that the metallation reaction 
could proceed most probably by the following pathway . 
+ Na OH .. 
R'O R'O 
R R 
R' CH3, R = OCH3 (193) 
--
R' CH3, R = H (247) ,...._ 
.. 
R'O R' 
R R 
The negative charge on N(l) could be delocalized over the hetero-
cyclic ring stabilizing the aromatic TI-electron system. Thus many 
authors pref er to denote similar structures by this formula: 
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Quantitative yields of the chloromercurio derivative were realized 
for our compounds which could be stored at room temperature for months 
with no apparent decomposition. The following chloromercurio derivatives. 
were prepared (Figures 11, 12, and 13). 
R' 
R' = 
R' 
I HgCl 
= OCH3 (~, 100%; 
= H (205), 94%. 
-
I 
RO Hg Cl 
R CH3 (;2J), 100%; 
As a general procedure, the chloromercurio derivative was condensed 
with the commercially available acetobromoglucose (238) (see Figures 11, 
-
12, and 13) in boiling xylene. It may be that the heterogeneous nature 
of this kind of reaction accounts for the lack of publications on mech-
anistic pathways. The only mechanistic picture suggested for aceto-
38 halo sugar reactions with some !-heterocycles involved a double in-
version to explain the retention of configuration observed on C(l) of 
the sugar molecule. 
Hal H H 0 E0 B H }R Base H OCOR .... .... 
H- 0 H OCOR 
0 
I 0 0 
i I 
a-acetohalosugar intermediate B base 
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Possibly the reaction of the merc:urio derivative with the halo sugar 
proceeds via an SN2-type displacement since inversion of an anomeric 
192 34 
carbon atom has been report.~d ' in similar systems. Consequently, 
we propose a very tentative mechanism. 
{ 
N-Glucoside derivatives 201, 202, 206, 220, and 221 were made from 
- ~ ---- .,,.___. ,,,__, .,,,.___ 
the chloromercurio derivatives 200, 205 and 219, respectively. 
-- -
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Methanolic ammonia has sometimes been the reagent of choice in 
carbohydrate chemistry for removing the acetate residues on the sugar 
. f 1 'd 370,404 moiety o nuc eosi es. We successfully employed this reagent to 
deblock two N-glucosides to form crystalline 202 and 221. One deblocked 
- ........_. .......... 
!i_-glucoside from 206 (R=H) was obtained in a syrupy form and could not be 
~ 
crystallized (Figure 12). 
An attempt was made to assign a partial configuration of the glu-
case residue in our compounds 201, 202 206, 220 and 221, 
,,.-,_ _,... '-- ' ......,__ ~ .....-....... NMR analy-
sis in different solvents was carried out. The chemical shift value of 
the anomeric H(l) of a-acetobromoglucose (238) was o 6.62 ppm (J=2Hz) . 
......,__. 
Glucosides 201 and 206 (DCC13) showed this signal at o 5.65 with J=2Hz. ,...._,. ~
R 
/ AcOCH2 N~.--. OAc 
OAc 
OAc 
H 
lQl, R 
3.2.§' R 
The chemical shift of the heterocyclic proton at o 7.95 did not change 
with two solvents (DCC13 and DMS0-~6 ). This solvent-induced shift has 
131 11 been reported and employed to determine the site of glycosidation 
in similar systems. However, the shift from o 6.62 to o 5.55 of H(l) 
of the sugar moiety suggested a S-configuration [trans H(l), H(2)] 11 for 
one system. 
Also, the coupling constant J 1 , 2 would be expected to be larger in 
the !i_-glucoside than 253 the J in a-bromo sugar. That was not ob-1,2 
served in the J values of the two molecules 201 and 206. 
......___. __..._.. 
This does not, 
however, totally preclude the possibility of having a S-configuration 
at C(l) since a few exceptions of higher J 1 2 values of already known 
' 342 S-configuration have been reported. Measurement of the specific 
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rotation (a) of both the starting material and the halo sugar may be 
appropriate to determine the configuration at C(l) of the sugar moiety. 
An inversion of the sign of (a) might indicate inversion of configura-
tion, say, from a-halosugar to S-_!!-glycoside. 
Biological Activity 
A cooperative program between Professor Durham (Microbiology) and 
Professor Berlin (Chemistry) has permitted a fruitful collaboration es-
pecially with respect to rapid evaluation of activity of compounds on 
the growth of microorganismsand the human tumor cell live KB. The pri-
mary screen was growth alteration of Bacillus subtilis. If the inhibi-
tion was positive at a concentration of 91 µg/ml of test compound, 
additional testing was done with Pseudomonas fluorescens and KB cells 
before employing mice. Although inhibition of growth of KB cells is not 
mandatory for a compound to be of chemotherapeutic significance in 
humans, it is one of the best and relatively inexpensive screens av~il-
able. 
Preliminary data on 215 revealed complete inhibition of B. subtilis 
......._ 
215 216 190 
-- '- -
(in glucose medium) at 91 µg/ml (24 hours) but no effect was observed 
with Ps. fluorescens, or KB cells. In .contrast, dial 216 showed no 
~
inhibition of B. subtilis or Ps. fluorescens. The isoxazole analog 190 
,.,....,; 
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did inhibit (91 µg/ml) ..!!· subtilis growth up to 10 hours. 
The small model systems 193, 194, and 185 showed striking inhibi-
-""- ,,,,,..._. . ...--. 
tion of growth in certain instances. Pyrazole 193 inhibited B. subtilis 
----.... 
OH 
193 194 
- -
CH3o 
OCH3 OCH3 
185 186 
-- -, 
growth overnight and KB cells (at 50 µg/ml, 69% inhibition of cell 
growth resulted). Diol 194 completely inhibited _!!. subtilis after 5 
---
hours and up to 23 hours at 91 µg/ml in DMSO. The following procedure 
was found appropriate for the preparation of a solution of the test 
compound: 5.0 mg. of compound was added to 0.5 ml. of DMSO + 4.5 ml. of 
H20; 0.5 ml. of this aqueous DMSO solution was added to 5.0 ml. glucose 
minimal, and then incubate with 0. 2 ml. of culture with 5. 7 ml. total 
149 
volume. Ps. fluorescens was also inhibited by diol 194; this is unique 
- ........... 
among the families of compounds we have studied. Most important was the 
finding that 194, at 12.5 µg/ml, completely inhibited growth of KB 
......._ . 
cells. This result is of sufficient value that 194 has been put into a 
--
program with leukemic mice. Preliminary studies using mice bearing L-
1210 have shown a T/C ratio of 1.14 at 1 mg/mouse. L-1210 is a trans-
plantable acute lymphoblastic leukemia grown in BDF1 mice. Analysis 
using higher concentrations of these has yet to be completed. In con-
trast, the model isoxazole 185 inhibited B. subtilis growth overnight 
.~ 
but only at high concentrations~ Ps. fluorescens was unaffected. 
Isomeric isoxazole 186 did not inhibit B. subtilis or Ps. fluorescens. ,,.,.,_, 
Thus, the position of the N atom appears crucial for activity. One 
current theory for activity in heterocycles is the distance between 
heteroatoms in a polycyclic system and two other hetero atoms, with 
h b . 1 d . h f" . 90 one sue atom eing ocate in t e irst ring. Possibly the charge 
transfer ~bility or hydrogen-bonding propensity are highly dependent 
upon size, electronegativity, and hybridization bf the Y atom in the 
hypothetical system shown. Distances (a), (b), and (c) may be crucial 
for binding to the cell membrane, critical metabolites, or other primary 
compounds vital to cell function. 
Substitution on nitrogen, in general, reduced activity of 195, 196 
""'-"' _..._., 
or 198. 
_...,, 
Although in glucose medium B. subtilis was inhibited (in DMSO) 
150 
n 0 NI NI I 
CH3o HO @ CH3o so2 OCH3 OH CH30 
c$J I x 
X = H, }...25 x H, 196 CH3 
--
x = E-CHJOC6H4' 197 x = OH, 198 199 
--- - -x = 2,3,4,6-glucose-
tetraacetate, 201 
--
by~ (X = E-CH3oc6H4) at 91 µg/ml., Ps. fluorescens was unaffected and 
KB cells were not affected up to concentration of 250 µg/ml of 197. The 
~
glucose tetraacetate derivative 201 did not affect either microorganism . 
............ 
Dial 194 inhibited B. subtilis, at 91 µg/ml for 10 hours while 198 showed 
~ - ...-"'\.... 
no inhibition. The tosyl derivative 199 was void of any activity at the 
_...... 
primary concentration. 
Replacing other atoms in the five-membered ring as in 211, 213, and 
~~
207 altered activity sharply. Inhibition of B. subtilis at 25 µg/ml by 
-""'--
211 in DMSO was observed and KB cells were inhibited completely at 150 
-"'--
µg/ml. The allyl derivative 215 is still in the primary screen. 
-"'--
Inter-
estingly neither of the B_-aryl compounds ~ and 2~ showed inhibition 
of B. subtilis or Ps. fluorescens. It was shown previously (Page 132) 
that pyrazolones 208 and 209 underwent tautomerization easily in DMSO. 
--- ---
Coincidentally, the activity test was also performed in aqueous DMSO 
solution. The N-H analog 207 has yet to be tested. However, the mono-
~ 
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H 0 
-C H -X 6 4 
CH 30 CH30 
OCH3 OCH3 
R = H, 211 x H, 208 
H 0 
,.._ 
R = -cH2 CH=CH2, ~ x :e-F, 209 
-
H 
CH 0/ 207 
3 OCH --
methoxy derivative 265 was ineffective 3as was the larger compound 266. 
~ ,,,_ 
265 266 
- -
With only one methoxyl group and substituting nitrogen with the 
tetracetate derivative of acetoglucose gave the remarkably potent sys-
tem 206. Complete inhibition of B. subtilis for 24 hours was observed, 
~
as was also recorded with Ps. fluorescens. 
I cH20Ac N~Ac 
OAc 
H OAc CH 3 
220 
-
206 
-
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Moreover, at 50 µg/ml. of 206, KB cell growth was terminated. A 
,......._ 
recent clinical isolate of Staphylococcus aureus, shown to be oxacillin-
. so ( h . d f 1 f 1 t" t t resistant t e organism prove ata to a young ema e pa ien a 
Georgia Medical College Hospital in 1974),was also inhibited at 91 µg/ml. 
This organism is particularly resistant to penicillin-type antibiotics 
and infections involving it are therefore difficult to treat. Compounds 
such as 206 may result in improved chemotherapeutic agents able to com-,,....._ 
bat such drug-resistant organisms. Screening of the steroidal system 
220 is still in progress • 
............ 
In summary, our work has uncovered several valuable clues to struc-
ture-activity relationships in the families of compounds represented by 
267 and 268. Construction of new related compounds such as 269-276 
~ /'-- ~ ......,_. 
RO 
OR 
267 268 
- ·--
(\ 
NI R' l~::.~.~~r2 OR CH3o CH 0 3 
R' RO OR 
H R' = H 273· 
' ' ,,,,,__ ' H, R' = OCH 3 , JJj ; 
COCH3 , R = H, .lZ}; 
H, R' = OCH3 , JJJ· 
R H, R' = H, 269· __ , 
R H, R' = OCH3 , ll,9; R = 
R = COCH3 , R' = H 271 · R ' ,.._' R = 
R H, R' = H, JJJ· R = 
could well provide improved activity against growth of bacterial and 
culture systems and therefore in humans. The incorporation of a sugar 
residue could be most fruitful. It is known that nucleotides do not 
153 
pass through some membranes in contrast to nucleosides, which do per-
280 
meate. Thus, there is precedent for the iden that a sugar moiety can 
facilitate membrane penetration and possibly carrying heterocycles other 
than nucleotide bases into a ceJl. 
Dial 216 did not inhibit B. subtilis growth while indazole 190 wa::; 
........._.. ~
highly active against this organism. Presumably, :i slight change .in 
structure, trying to preserve all atomic distances between heteroatoms/ 
may prove worthy of investigation. Analogous to a procedure applied by 
176 133 284 Hecker (1962) and Evans (1964) and Morrow the following scheme 
is suggested for the synthesis of a fluorine derivative. 
n 
'-NI 
HO H 
HO 
216 R=H, NH2 
- j\N 
..._N/ ~ 
H 
R=H,F 
Whether or not the pyrazole and [2,1-~]isoxazole in the hetero-
cyclic steroids are vital to the activity of these families could be 
investigated. For instance, l,2,3-triazoles48 of the type 277 could be 
~
examined and thus provide insight as to the influence of carbon versus 
nitrogen or activity in the small ring. A proposed sequence is: 
154 
277 
Actually, very few examples of those triazolosteroids have been found in 
1 . . 122 1terature. 
Numerous examples have been published168 •404 in which a sugar resi-
due is attached to one N atom of a heterocyclic cowpound. Most of these 
cases included a pyrimidine or purine ring systern. 404 No examples ~ere 
found, however, attempting the glycosidation of pyridazinones. Our: 
available compound 234 could introduce a novel mimic of nucleoside mole-
--
cules 278 and 279 the activity of which is unknown: 
,...__. _.....,,? 
(1) HgX2 
__ ...;.__ ___ .,.. 
(2) Halo sugar 
234 H 
--
279 
-HO OH 
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Mass spectral data for most model compounds and heterosteroid sys-
terns are provided in Tables IX-XI. Relatively little such data have 
been recorded for heterosteroids. Quite possibly the use of mass 
spectrometry to detect traces of such steroids in in vitro systems could 
be instructive as to the mechanism and rate of breakdown to products. 
Except for certain hydroxy derivative 198, 202, 221 and 227, the M+ is 
"""- ,...,._,_ ,...._ ~
the !!!./5:.. of highest intensity. Obviously, considerable interpretation 
is needed here for rapid and accurate structural analysis. 
TABLE IX 
INTENSE IONS IN MASS SPECTRA (70 eV) OF SOME MODEL HETEROSTEROIDS AND THEIR PRECURSORS 
Vacuum Probe Source 
Cpd. (mm) 0 Temp. ( C) 0 Temp. ( C) ~/~ (% RI) 
193 2.6 x 10 -6 110 230 189(17), 203(12), 217(49%), 
~ 229(62), 230(100). 
194 -6 50(9), 52(13), 63(12), 155(23), 2.3 x 10 150 230 
.,,,...._... 174(25), 175(20), 200(20), 
201(40), 202(100), 203(13). 
197 4 x 10-6 40 200 37(4), 91(7), 109(9), 168(6), 
--- 206(4), 321(26), 336(100). 
198 8 x 10-6 50 190 17(8j), 18(87), 31(15), 32(37), 
........_ 
43(100), 58(10), 149(26), 
167(23), 279(38). 
207 -6 185 200 77(17), 101(17), 111(30), 2.2 x 10 
~ 145(20), 162(22), 175(30), 
203(17), 217(10), 231(31), 
246(100). 
208 5 x 10-6 llO 210 29(5), 39(17), 51(42), 63(20), 
........,,,, 
64(17), 65(14), 75(9), 77(79), 
91(20), 103(25), 115(50), 
128(20), 131(24), 145(71), 
161(29), 189(38), 294(45), 
322(100). I-' V1 
(]\ 
TABLE IX (Continued) 
Vacuum Probe Source 
Cpd. (mm) 0 Temp. ( C) 0 Temp. ( C) ~/~ (% RI) 
210 -6 90 220 151(90), 161(26), 176(28), 3.4 x 10 ,,,..._. 
189(40), 201(18), 217(13), 
245(19), 260(100). 
185 -6 60 220 78(21), 90(47), 103(30), 7.8 x 10 
~ 121(13), 130(12), 150(29), 
160(17), 170(13), 178(17), 
189(9), 202(10), 216(23), 
230(9) 231(100). 
186 4 x 10-6 60 200 57(15), 69(8), 150(44), 20~18~ 
/""- 231(100). 
211 2.8 x 10 -6 80 210 63(7), 115(11), 134(10), 175 
-"""'-"" (12), 176(12), 177(11), 204 
(11), 217(12), 219{25), 247 
(47), 260(15), 261(38), 262 
(100), 263(56), 264(19). 
213 4.6 x 10 -6 105 200 39(20), 43(31), 56(39), 107 
~ (100), 119(67), 202(4), 302 
(18). 
214 -6 105 205 34(7), 215(14), 246(25), 261 3.6 x 10 
,,,........., (100). 
I-' 
V1 
-.J 
TABLE IX (Continued) 
Vacuum Probe .Source 
Cpd. (mm) 0 Temp. ( C) 0 Temp. ( C) 
~ 3 x 10-6 60 200 
229 3. 6 x 10 -6 65 205 
---..-
230 3.8 x 10 -6 90 240 
~ 
225 2.8 x 10 -6 70 225 
.----v-
227 2.2 x 10 -6 135 250 
--...../ 
IE_/~ (% RI) 
15(2), 39(7), 51(7), 63(9), 
77(15), 91(7), 92(12), 107(9), 
150(95), 151(11), 179(47), 
220(100). 
39(14), 51(27), 63(47), 77(42), 
91(35), 103(23), 115(34), 131 
(23), 150(32), 171(16), 177 
(4J), 178(100), 206(36), 284 
(31)' 286 (29). 
50(3), 89(4), 91(50), 115(22), 
135(5), 177(39), 197(43), 232 
(30)' 264 (100). 
45(3), 87(8), 65(8), 77(14), 
91(9), 94(15), 107(11), 122 
(21), 137(65), 150(93), 210 
(100). 
27(42), 45(41), 52(20), 63(48), 
81(20), 109(41), 137(100), 161 
(8), 192(22), 210(28). 
I-' 
\.J1 
co 
Cpd. 
lM., 
236 
.---..... 
215 
~
216 
~
TABLE X 
INTENSE IONS IN MASS SPECTRA (70 eV) OF SOME HETEROSTEROIDS AND THEIR PRECURSORS 
Vacuum Probe Source 
(mm) 0 Temp. ( C) 0 Temp. ( C) ~/~ (% RI) 
2 x 10-6 110 200 114(12), 153(6), 180(16), 185 
(17), 200(14), 228(13), 241 
(13), 256(100). 
4 x 10-6 100 200 77 (3)' 114(5)' 115(23)' 127(10), 
128(21), 139(11), 141(11), 157 
(23), 183(22), 187(25), 201 
(100), 202(14), 214(15), 274 
(78). 
3.4 x 10 -6 125 200 140(18), 194(17), 237(18); 
280(100), 281(18). 
1 x 10-5 280 200 103(24), 126(43), 152(19), 
197(16), 205(23), 224(42), 
252(100). 
..... 
U1 
l.O 
Cpd. 
~ 
206 
/"..--
220 
,,_.__.. 
221 
__..,,,, 
TABLE XI 
INTENSE IONS IN MASS SPECTRA (70 eV) OF SOME PYRAZOLO N-GLUCOSIDES 
Vacuum Probe Source 
(mm) 0 Temp. ( C) 0 Temp. ( C) ~/~ (% RI) 
3.5 x 10 -6 150 220 171(10), 186(29), 215(21), 
230(100), 392(5). 
4 x 10-6 llO 210 43(66), 81(20), 97(18), 109 
(74), 115(17), 169(67), 185 
(19), 200(100), 213(25), 229 
(27), 255(15), 530(5). 
3 x 10-6 100 230 27(24), 42(27), 43(100), 50 
(65), 91(41), 96(41), 115(21), 
250(18), 580(10). 
3 x 10-6 185 250 235(8), 249(6), 250(100), 
263(5), 412(6). 
I-' 
Q'\ 
0 
CHAPTER III 
EXPERIMENTALa-f 
The reactions described in this chapter were performed several 
times on various scales with slight variations in procedure. The follow-
ing are representative descriptions of the procedures employed. 
of 3-Carbomethoxypropanoic Acid84 ~) and 3-Carbo-
methoxypropanoyl Chloride84 (253). A mixture of 300 g. (3.0 moles) of 
~~~----------~--"~~~~~~ ----
Preparation 
succinic anhydride (Eastman Organic) and 121.6 g. (3.8 moles, 145;5 ml.) 
of absolute methanol (Mallinckrodt Co.) in a one-liter, round-bot-.:omed 
flask was heated at reflux on a steam bath. After about 30 minutes, the 
8Melting points were determined with a Thomas-Hoover capillary 
melting point apparatus and are uncorrected. 
bProton magnetic resonance spectra were determined on a Varian 
XL-100 (15) high resolution spectrometer operating at 100.1 MHz with 
tetramethylsilane (TMS) as the internal standard. 
c Infrared spectra were determined on a Beckman IR-SA spectrophotom-
eter as films on sodium chloride plates or as potassium bromide pellets. 
dMicroanalysis were performed by Galbraith Laboratories, Knoxville, 
Tennessee, and by Instranal Laboratory, Inc., Rensselaer, New York. 
eHigh resolution mass spectra were obtained on a CEC 21-110 B double-
focusing mass spectrometer. 
fCommercially available reagents were used without further purifi-
cation unless otherwise stated. Polyphosphoric acid was obtained from 
FMC Corporation, Inorganic Chemical Division, New York, New York, by the 
gracious aid of Mr. J'. P. Cassidy. 
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mixture was swirled until all the solid dissolved. The flask was then 
half-immersed in a steam bath for an additional 30 minutes. Excess 
methanol was removed by distillation on a rotary evaporator, and residu-
al liquid was poured into a large evaporating rHsh which was cooled in a 
shallow pan of cold water. As the half ester~ crystallized, it was 
stirred and scraped off the dish in order to prevent formation of a hard 
solid cake. The sample was dried to constant weight in a vacuum oven at 
0 40 /25 mm. The yield was 400 g. (98%). 
To 66.0 g. (0.05 mole) of the half ester 252, 119.0 g. (1.0 mole) 
--
of thionyl chloride (Fisher Scientific Co.) was added in one batch, and 
the mixture was heated (40°) for 4 hours. The excess thionyl chloride 
was distilled at aspirator pressure, and the crude acid chloride 253 was 
-
distilled at reduced pressure; (b.p. 65° /3 mm.} yield 70 g. (93%) of 
pure m (lit. 84 ' b.p. 93° /18 mm.' 90-93% yield). 
Preparation of Methyl 4-(3 ,4 -Dimethoxyphenyl)-4-oxobutanoate 
(222). ll4 M th d A e o . 1,2-Dimethoxybenzene (Aldrich Chemical Co.) (27.0 
-
g., 0.2 mole) was stirred with 3-carbomethoxypropanoic acid (40 g., 0.3 
0 
mole) in 200 g. of 115% PPA (FMC Corp.) at 45-50 for one hour and was 
then left overnight at room temperature. The dark-brown reaction mix-
ture was poured onto one liter of ice-water. The yellowish product ob-
tained solidified upon standing in ice-water for several hours with 
occasional stirring. The crude product was collected by suction filtra-
tion and washed with excess cold water, 5% NaHco 3 solution, and then 
with water until the filtrate was neutral to pH paper. The crude 'air-
dried ester 222, which was recrystallized from 50% aqueous ethanol, 
-h d 35 0 (64 5%) 89 900 (l' 114 900). weig e . g. . • , m.p. - it. m.p. 
Method B. A solution of 1,2-dimethoxybenzene (13.8 g., 0.1 mole) 
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and 3-carbomethoxypropanoyl chloride (31.0 g., 0.2 mole) was added in 
small portions with vigorous stirring to 230 g. of 115% PPA contained in 
a beaker pre-warmed to 40-50°. A gas was evolved, presumably HCl. Stir-
ring was continued for 1 hour and the reaction mixture was left for 2 
hours at room temperature until the gas evolution ceased. The dark-
violet, viscous reaction mixture was poured onto approximately one kilo-
gram of crushed ice and worked up as in Method A above. The yield of 
ester 222 was 19.9 g. (80%). IR and NMR spectra (Plates II and XLIX) 
-
support the proposed structure of 222. 
--.J 
Preparation of Methyl 4-(3 , 4 -Dimethoxyphenyl)butanoate (ill). A 
solution of 10 g. (0.04 mole) of methyl 4-(3 ,4 -dimethoxyphenyl)-4-
oxobutanoate (222) in 150 ml. of glacial acetic acid was hydrogenated at 
about 60° with 2 g. of 10% palladium on charcoal catalyst (Matheson Co.) 
at 40 psi in a Parr apparatus. The reaction mixture was cooled and fil-
tered through a filter cake of Celite in a medium-sized, sintered glass 
funnel. The filter cake was washed with 20 ml. of ether, and the sol-
vents were removed on a rotary evaporator to yield crude ester 223 (9.1 
-
g., 96%) as a light yellowish oil. An analytical sample was obtained by 
0 distillation, b.p. 152-4 /0.1 mm. 
Anal. Calcd. for c13H18o4 : C, 65.54; H, 7.56. 
Found: C, 65.36; H, 7.60. 
IR and NMR spectra (Plates III and L) support the proposed struc-
ture for 223. 
,,._ 
Preparation of 4-(3 ,4 -Dimethoxyphenyl)butanoic Acid (224). 174 
-
Method A. Methyl 4-(3 ,4 -dimethoxyphenyl)butanoate (223) (23.8 g., 0.1 
-
mole) was boiled with 250 ml. of 10% KOH for 6 hours (under N2). The 
cold hydrolyzate was extracted with ether (2 x 100 ml.), and the aque-
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ous layer was cooled in ice and acidified with excess cone. cold HCl. 
Ether extraction (3 x 100 ml.) gave a solution which was evaporated to 
yield 4-(3 ,4 -dimethoxyphenyl)butanoic acid (224) (13.7 g., 62%), m.p. 
,,.......__, 
0 174 0 58-59 , from hexane (lit. m.p. 58-60 ). IR (Plate IV), NMR (Plate 
LI). 
Method B. 1,2-Dimethoxybenzene (55.2 g., 0.40 mole) and succinic 
anhydride (Eastman Organic) (40 g., 0.40 mole) were dissolved with me-
chanical stirring in 200 ml. of 1,1,2,2-tetrachloroethane (Aldrich Chern-
ical Co.) and 50 ml. of nitrobenzene (Fisher Scientific Co.). The re-
sulting mixture was cooled to 0-5°. Reagent-grade, anhydrous AlC1 3 
(Fisher Scientific Co.) (60.0 g., 0.45 mole) was added in small portions 
over a period of 2 hours keeping the temperature between 5-10°. Stirring 
was continued (24 hours) at room temperature with the exclusion of rnois-
ture (CaC1 2 tube). The dark, bluish-violet reaction mixture was decom-
posed by the addition of 200 ml. of ice-cold 10% HCl, and the mixture 
was steam-distilled. The aqueous mixture in the distilling flask was 
filtered hot. The crude product~ which crystallized on cooling, was 
removed by suction filtration. The keto acid thus obtained was purified 
by dissolution in a boiling 5% NaOH solution which was treated with 
Nuchar, filtered, cooled, and acidified with excess 6 N HCl. The crude 
keto acid 3:3:.,.6 precipitated and was recrystallized from H20; m.p. 158° 
(lit. 174 m.p. 159-160°). The yield was 52.0 g. (54%). 
The keto acid prepared was reduced catalytically in glacial acetic 
acid. Thus, 10 g. (0.04 mole) of the acid226 in 150 ml. of glacial 
.............. 
acetic acid and 1.0 g. of 10% Pd-C were shaken at about 60° at 40 psi of 
H2 pressure in a Parr apparatus for about 40 minutes [theoretical uptake 
of H2 (pressure drop of ca. 7.5 lbs) was observed]. The catalyst was 
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removed using Celite, and the acetic acid solution was concentrated 
(rotary evaporator) to about 15 ml. The concentrate was then poured on-
to 500 ml. of ice-water to precipitate pure acid 224; yield 9.0 g. (97%), 
~
0 . 174 0 
m.p. 58-60 (lit. m.p. 58-60 ). 
Keto acid 226 was also obtained by the saponification of keto ester 
-
222. 
--
Thus keto ester 222 (10.0 g., 0.04 mole) was boiled with 100 ml. 
-
solution of 10% NaOH for 4 hours. After cooling in ice, 6 ~ HCl was 
added dropwise with stirring to give an acid (pH = 1-2) medium. The white 
precipitate obtained was collected by suction filtration, washed with 
water and air dried. Crude keto acid~ was recrystallized from H20; 
m.p. 158-159° (lit. 174 m.p. 159-160°). The yield of pure keto acid 226 
--
was 79% based on keto ester 222. 
-
Preparation of 3,4-Dihydro-6,7-dimethoxy-1[2B]-naphthalenone174 
(182). 4-(3 ,4 ~Dimethoxyphenyl)butanoic acid (4 g., 0.018 mole) was ,,,_,_ 
added in small portions with stirring to 50 g. of 115% PPA pre-warmed to 
70-75°. Heating and stirring was continued for 10-15 minutes. An addi-
tional 30 g. of PPA were added, and the mixture was stirred (10 minutes) 
while warming at 70-75°. The brown, viscous mixture was cooled, poured 
onto 250 ml. of ice-water and stirred, a process which initiated solidi-
fication. The product was moved by suction filtration and washed sue-
cessively with H20, saturated NaHC03 solution, and H20 again. After 
drying, crude ketone 182 was recrystallized from _g_-heptane to give 3.65 
0 . 174 0 g. (83%) of 182; m.p. 99-100 (lit. m.p. 99-100 ). IR and NMR spectra; 
-(Plates VIII and LV) supported the proposed structure for 182. 
-
Attempted Synthesis of 6,7-Dimethoxy-3,4-dihydro-1[2H]-naphthalenone 
Using (A) A1Cl 3 or (B) PPA in One Step: 
304 Method A. 1,2-Dimethoxy-
benzene (veratrole) (Aldrich Chemical Co.) (34.5 g., 0.25 mole) and 4-
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butyrolactone (Aldrich Chemical Co.) (21.5 g., 0.25 mole) were placed in 
a three-necked flask equipped with a condenser (capped with CaC12 tube), 
a mechanical stirrer, and a wide-bore rubber tube leading to a 250-ml. 
Erlenmeyer flask. The Erlenmeyer flask was charged with reagent-grade 
anhydrous A1Cl 3 (Fisher Scientific Co.) (66.75 g., 0.50 mole) and mount-
ed on the 3-necked flask. The AlC1 3 was added during a period of 2 
hours with stirring. The reaction mixture turned grey and some gas (HCl) 
was evolved. After all the catalyst was added, the mixture was heated 
on steam bath (1 hour) with continuous stirring. The reaction mixture 
was cooled and poured onto ice-water drenched with about 100 ml. of dil. 
HCl. The mixture was extracted twice with 100 ml. of ether, and the 
ether layer was dried (MgS04). The ether was filtered and evaporated 
to give a colorless oil. The oily material was made strongly alkaline 
by adding 20 ml. of 1 ! NaOH, and the resulting Solution was extracted 
with ether. The ether layer was washed (H20), dried (MgS04), and con-
centrated. An IR spectrum of the product obtained from the ether ex-
traction was identical with that of 1,2-dimethoxybenzene. 
Method B. Use of Polyphosphoric Acid. PPA [105% (FMC Corp.), 40 
g.] was placed in 250 ml. Erlenmeyer flask and heated to 90° on a steam 
bath. Veratrole (14 g., 0.1 mole) and 4-butyrolactone (9.0 g., 0.1 
mole) were added immediately in one batch with stirring. Heating was 
continued (15 minutes) followed by the addition of 20 g. of cold PPA. 
The reaction mixture was rewarmed ori a steam bath at 90° (3 hours). 
During that time, the color changed from light pink to light brown. 
Left to cool overnight the reaction mixture was poured onto ice-water. 
From the resulting mixture there was deposited an oil. The aqueous mix-
ture was then extracted with ether. The ether layer was washed with 
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saturated NaHC03 solution, H20, NaOH (1 B), and H20 and was then c1ried 
(MgS04). An IR spectrum of the product from evaporation of the ether 
showed unchanged veratrole. 
Preparation of 4-(3 -Hydroxy-4 -methoxyphenyl)butanoic Acid~). 
4-(3 ,4 -Dimethoxyphenyl)-4-oxobutanoic acid (226) (7.14 g., 0.03 mole) 
,.--..... 
was boiled with 3 ml. of 85% hydrazine hydrate (Fi:.',her Scientific) and 
4.5 g. of solid KOH in 30 ml. of triethylene glycol (Aldrich Chemical 
Co.) in standard apparatus with a condenser. After 1 hour, the condenser 
was removed and the dark-brown mixture was allowed to boil to 220° for 
20 minutes. The condenser was reattached and the mixture was boiled (3 
hours). After cooling to room temperature, the reaction mixture was 
acidified (cone. HCl) and extracted with ether (2 x 100 ml.). The ether 
was washed successively with H20, Na2co3 solution (10%), and H20 and was 
then dried (Na2so4). The ether was filtered from Na 2so4 and evaporated 
(rotary evaporator) to yield 5.05 g. (80%) of a solid, m.p. 75-77°. Re-
crystallization of the crude acid 225 from ether-petroleum ether (30-60°) 
·-
and sublimation at 80°/5 x 10-4 mm. gave a product melting at 87-88°. IR 
and NMR sp~ctra (Plates VII and LIV) suggested that the product had one 
methoxyl and one hydroxyl group (acid 22~ and was not the acid 224 ex-
.,.__, ,~ 
pected from this Wolff-Kishner reduction. A sample of the sublimed 
product was submitted for microanalysis: 
Anal. Calcd. for c11H14o4 : C, 62.86; H, 6.67. 
Found: C, 63.17; H, 6.60. 
IR and NMR spectra (Plates VII and LIV) supported the proposed 
structure for 225. 
-
Reduction of 4-(3 ,4 -Dimethoxyphenyl)-4-oxobutanoic Acid ~) to 
4-(3 ,4 -Dimethoxyphenyl)butanoic Acid (224) by Clemmensen Reduction: A 
-
168 
267 
modified Clemmensen procedure was used to reduce acid 226 to acid 224. 
- --
Cone. HCl (6.0 ml.) and H20 (lSO ml.) were added with stirring for S 
minutes to 120 g. (1.8 g. at.) of mossy zinc and 12 g. (O.OS mole) of 
HgC12 . The aqueous solution was decanted and lSO ml. of fresh H20 were 
added. The amalgamated zinc was transferred to a SOO ml., 3-necked, 
round-bottomed flask to which were added 17S ml. of cone. HCl and SO g. 
(0.21 mole) of 229 (the keto acid) in 120 ml. of t:-'1luene. The reaction 
--
mixture was boiled with vigorous stirring (mechanieal) (24 hours) with 
addition of SO ml. of cone. HCl every 8 hours. The reaction mixture was 
then cooled and diluted (200 ml. of H20). The toluene layer was sepa-
rated and saved and the aqueous layer was extracted with ether (2 x 100). 
The ether and toluene solutions were combined, washed with water, Na2co3 
solution (S%), and H20 and then dried (Mgso4). Evaporation of the or-
ganic solvents (rotary evaporator) gave a heavy viscous syrup, slightly 
brown in color. When crystallization from HCC13/petroleum ether fail-
ed, a TLC analysis using silica gel plates and CH30H:HCC1 3 [1:9] as the 
solvent was performed. It showed a two-component-mixture indicating a 
side reaction had occurred which was believed to be the formation of the 
substituted butanoic acid~ (contains one OH and one OCH3 group). 
Spectral analysis (NMR and IR) were suggestive of the presence of a mix-
ture. 
An aqueous ·mixture of the previous product, therefore, was made 
alkaline (20% NaOH)and treated with excess (CH3o) 2so2 (100 g.). The 
reaction mixture was extracted with ether (3 x 100 ml.). The solution 
was washed with H20, with O.S ~ HCl, and with H20 to neutrality (pH 
paper). Evaporation of ether gave 18.0 g. (40%) of the expected acid 
224. This experiment was repeated four times on different scales and 
-
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the yield of 80% claimed in the literature267 was never attained. 
Attempted Cyclization of the Mixture Resulting From Clemmensen Re-
duction of Acid JJJ Using 105% PPA; Attempted Preparation of Ketone~· 
The mixture (8 g.) from the previous experiment was added with stirring 
to 20 g. of 105% PPA preheated to 90°. Stirring was continued (20 min-
utes), keeping the temperature between 85-90°. The reaction mixture was 
then cooled and poured onto 200 ml. of ice water. When solidification 
did not occur after several hours of cooling and stirring, the aqueous 
reaction mixture was extracted with ether (2 x 100 ml.). The ether 
layer was washed with water, 10% NaOH (to remove phenolic compounds), 
H20, and dried (Na2so4). The ether solution was filtered from Na2so4 
and evaporated to dryness. A resulting brown oil did not crystallize 
from many different solvents. A chloroform solution of the oily product 
was passed through a 2 x 50 ml. neutral alumina column but the 6 frac-
tions collected were all identified by spectral (IR and NMR) analysis to 
' 
be unchanged starting material. 
Cyclization of Acid 224 to Ketone 182 Using 95% H SO 174 A mix-
- - 2 4 ~~~~~~~~~~ 
ture of 4 g. (0.02 mole) of acid~ and 8 ml. of 95% H2so4 in a 100-ml. 
Erlenmeyer flask was heated on a steam bath for 0.5 hour with stirring. 
The reaction mixture, which turned dark violet, was cooled, diluted with 
200 ml. of cold H20 (carefully) and extracted with ether (3 x 50 ml.). 
The ether layer was washed (H20, sat. NaHco3 solution, H2o) and dried 
(Na2so4) and concentrated. Recrystallization of the residue from petro-
leum ether (40-60°) gave 0.4 g. of the ketone 182 (11%), m.p.96-99° 
-174 0 (lit. m.p. 99-100 ). Characterization by NMR spectrum (Plate LV, 
Table VIII) and IR spectrum (Plate VIII) supported the structure of 
tetralone 182. 
-
170 
Catalytic Hydrogenation of the Keto Acid 1!:J to Give Acid J:.!:!;- Using 
10% Pd-c. 79 , 145 , 188 In a 500-ml., pyrex pressure flask were placed 10 
g. (0.04 mole) of the keto acid 226 dissolved in 100 ml. of glacial 
-
acetic acid containing 1.5 g. of 10% Pd-C catalyst (Matheson Co.). The 
experiment was run in a Parr apparatus at 40 psi of H2 and about 60° 
[using an external heat lamp (Westinghouse, 150W)] to warm the flask 
while shaking. After the theoretical uptake of H2 pressure drop (ca. 
7.5 lbs.) was observed, the reduction was stopped and the reaction flask 
was cooled. The catalyst was filtered through aCelite cake. Concen-
tration of the clear filtrate to about 15 ml. (rotary evaporator) gave a 
liquid which was poured onto 200 of ice-water. A white precipitate 
was filtered out and the yield was 8.4 g. (90%), m.p. 58-60° (lit. 174 
0 
m.p. 58-60 ). The acid 224 was sufficiently pure to use in the follow-
-
ing synthetic step, i.e., the cyclization to the tetralone 182. IR and 
. ·~
NMR spectral data (Plates IV and LI) supported the structure proposed 
for acid 224. 
-
Preparation of 6-(3 ,4 -Dimethoxyphenyl)-4,5-dihydro-3[2H]-pyrid-
azinone (234). A .solution of 1.0 g. (0.004 mole) of the keto acid 235 
- ,.-...... 
in 50 ml. of 95% ethanol was boiled with 1 ml. of 95% H2NNH2 for 30 
minutes. The resulting yellowish solution was evaporated to half its 
original volume and left to cool. A crystalline product separated out 
and was filtered out; weight 0.95 g. (93%), m.p. 168-170°. Recrystalli-
zation from 95% alcohol gave pure pyridazinone 234, a sample of which 
-
was submitted to microanalysis: 
Anal. Calcd. for c12H14N203 : N, 11.96. 
Fourid: N, 12.01. 
IR and NMR spectra (Plates V and LII) supported the proposed struc-
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ture for 234. 
-
Attempted Reaction of 3-Carbomethoxypropanoic Acid84 (123) With 
Veratrole Using 105% PPA. 1,2-Dimethoxybenzene (veratrole) (65.0, 0.49 
mole) was mixed with 3-carbomethoxypropanoic acid84 (252) (65.0 g., 0.5 
-
mole) at room temperature. The mixture was then added in small portions 
over a period of 2 hours to 690.0 g. of 105% PPA366 0 prewarmed to 50 . 
The reaction mixture was heated to 80-90° for 15 minutes, cooled to room 
temperature and poured onto about one kilogram of crushed ice. An oily 
layer separated on the top of the water mixture when all the ice melted, 
but solidification, as expected, did not occur. After the oil had been 
distilled (b.p. 84-86°/10 mm.), NMR and IR spectra analysis showed un-
changed veratrole (see Table VIII). 
Preparation of 3-Protocatechuoylpropanoic Acid (227). This experi-
-
ment was originally planned for preparation of the dihydroxy derivati·1e 
of 6-(3 ,4 -dimethoxyphenyl)-4,5-dihydro-3[2H]-pyridazinone (234) via 
- -
reaction of the latter with 48% aqueous HBr. The procedure resulted, 
however, in the formation of another compound, the keto acid 227. ,,_ 
Thus, pyridazinone ~ (6.0 g., 0.026 mole) was boiled (under N2) 
with 100 ml. of 48% HBr for 9 hours with magnetic stirring. A straw-
yellow color developed and soon changed to deep purple and finally to 
deep brown. The reaction solution was cooled under N2 overnight. Fil-
tration was then carried out to remove the brownish-black precipitate 
that separated on cooling. The aqueous mother liquor was concen-
trated (rotary evaporator) to one-fourth of its original volume. After 
storage under a hood for 3 days, the solution deposited additional solid. 
Dissolving the combined two solid products in about 20 ml. of 5% NaOH 
gave a grey-colored solution. Acidification of that alkaline solution 
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with 6 !!_ HCl (while cooling) yielded a greyish-white, crude keto acid 
']:.2].· Recrystallization (95% alcohol) gave 0.9 g. (16% based on~) of 
0 0 -4 
somewhat purified acid m.p. 190-1 . Sublimation at 180-190 /10 mm. 
gave a pure, colorless sample of 227, 
--
m.p. 194-5°: 
Anal. Calcd. for ClOHlOOS: c, 57.10; H, 4.76. 
Found: c, 57.31; H, 5.03. 
IR and NMR spectra (Plates VI and LIII) were in agreement with the 
proposed structure of keto acid 227. 
-
Preparation of 3,4-Dihydro-2-(hydroxymethylene)-6,7-dimethoxy-1-
83 (2H)-naphthalenone (232). A solution of 7.0 g. (0.09 mole) of ethyl 
- -
formate (Eastman Organic) in 50 ml. of dry benzene was added to a cooled 
0 (10 to 15) suspension of sodium methoxide (4.8 g., 0.09 mole) in 75 ml. 
of dry benzene under N2 . While the mixture was magnetically stirred, a 
solution of 9.0 g. (0.044 mole) of 6,7-dimethoxy-l-tetralone (182) in 
-
benzene was added at one time. Only a small amount of yellow precipi-
tate separated after about 20 minutes, but the quantity of precipitate 
increased sharply after 1 hour of stirring. The reaction mixture was 
left at room temperature for 30 minutes and was then hydrolyzed with 
300 ml. of ice-water. The organic layer was separated and washed with 
H20, washed with 5% NaOH solution, and then washed with H20. The com-
bined aqueous extracts were washed (ether), and the ether was discarded. 
The aqueous extracts were cooled (ice) and acidified (excess 6 !! HCl). 
The yellowish product, which was obtained upon acidification, was fil-
tered out and weighed (after drying) 7.8 g. (76%). The hydroxymethylene 
ketone 234 was recrystallized from hexane, m.p. 157-9° (lit. 83 m.p. 
-
157-9°). IR and NMR spectra (Plates IX and LVI) supported the proposed 
structure for 232. 
-
173 
Preparation of 4,5-Dihydro-7,8-dimethoxy-lH-benz[g]indazole (193). 
- -
To a magnetically stirred mixture of 232 (7 g., 0.03 mole) in 125 ml. of 
-
methanol in a 250 ml. flask was added 5 ml. (0.15 mole) of 95% hydrazine 
(Fisher Scientific Co.) under N2 . A clear brown solution developed as 
soon as the hydrazine was added. The reaction was slightly exothermic, 
as a few droplets of methanol condensed on the condenser. The reaction 
mixture was stirred (3 hours) whereupon a large amount of a yellow pre-
cipitate appeared and increased with time. The reaction mixture was 
left at room temperature for 1 hour and was then poured onto 600 ml. of 
ice-water. A yellow crystalline product was removed by filtration and 
air-dried. The yield was 5 g. (72%); m.p. of a sample recrystallized 
from dilute, aqueous alcohol (ca. 75%) was 178-180°. Sublimation of the 
recrystallized indazole at 160°/0.05 mm. gave an analytical sample, m.p. 
179.5-180°. 
Anal. Calcd. for c13H14N202 : C, 67.83; H, 6.08; N. 12.12. 
Found: C, 67.90; H, 6.16; N, 12.25. 
IR and NMR spectra (Plates XIV and LXI) were consistent with the 
proposed structure for 12]. 
Preparation of 4,5-Dihydro-l!!_-benz[g]indazole-7,8-diol (194). 
-
Indazole ]:.23 (4 g., 0.02 mole) was boiled with 150 ml. of aqueous 48% HBr 
for 10 hours under N2 . The dark-brown reaction mixture was cooled to 
room temperature whereupon shiny, pinkish needles separated out. The 
needles were removed by filtration and redissolved in 50 ml. of 10% NaOH 
solution. The alkaline solution was filtered and neutralized (cooled 
6 ~ HCl). The beige-colored precipitate (m.p. 276-8°) was filtered out 
and recrystallized (H20); yield of diol }~was 2.6 g. (65%); m.p. 
294-298°. An analytical sample was sublimed twice at 260°/10-3 mm. to 
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yield a flaky, brittle, white solid, m.p. 300-1°. 
Anal. Calcd. for c11H1002N2 : · C, 65.35; H, 4.95; N, 13.86. 
Found: C, 65.51; H, 4.86; N, 13.79. 
IR and NMR spectra (Plates XV and LXII) were consistent with .the 
proposed structure of 194. 
-
Preparation of 4,S-Dihydro-7,8-dimethoxy'"""l-phenyl-lH-benz[g]indazole 
< ..195). 2-(Hydroxymethylene)-6, 7-dimethoxy-1-tetralone (232) (1.5 g., 0.006 
-
mole) was dissolved in 50 ml. of glacial acetic acid in a lOO~ml., round-
bottomed flask. Phenylhydrazine (2.0 g., 0.018 mole) (Fisher Scientific 
Co.) was added to the solution, and the mixture was gently boiled with 
magnetic stirring (under N2). The dark-reddish mixture was concentrated 
(rotary evaporator) to about one-fourth volume of its original volume. 
When the reaction mixture was poured onto 500 ml. of ice-cold water, a 
light-brown, gummy product (crude 195) formed. Solidification was ef-
-
fected by decanting the acidic, supernatant liquid and adding an equal 
volume of fresh, ice-cold water with stirring and trituration. Indazole 
(crud~ 195 was filtered out on a small Hirsch funnel, washed generously 
-
with cold water, and air dried. Recrystallization (twice) (95% c2H50H) 
gave 1.75 g. (85%) of pure .12J,m.p. 125-126°: 
Anal. Calcd. for c19H18N202 : C, 74.51; H, 5.88; N, 9.15. 
Found: C, 74.10; H, 6.28; N, 9.25. 
IR and NMR spectra (Plates XVI and LXIII) supported the proposed 
structure for 195. 
-
Preparation of 4,5-Dihydro-l-phenyl-lH-benz[g]indazole-7,8-diol 
(196). A suspension of 1.0 g. (0.003 mole) of 4,5-.·dihydro-7,8-dimethoxy-
-l-phenyl-1!'!.-benz(..s_]indazo~~ ·_{195) in 40 ml. of aqueous 48% HBr (J. T. 
Baker Chemical Co.) was boiled gently for 7 hours under N2 . Magnetic 
175 
stirring was used. A dark-purple color developed after about 1 hour of 
boiling. Upon cooling (N2), the solution deposited a pinkish-white pre-
cipitate. This precipitate was filtered out with suction. Purification 
of the product (presumably the hydrobromide of 196) was achieved by 
--
adding 20 ml. of 20% NaOH; undissolved impurities were removed by fil-
tration. A grey clear filtrate was obtained which was chilled in ice 
and treated dropwise (with manual stirring) with 6 !!_ HCl just to the 
neutral point (using a pH paper) to form a shiny white, crystalline 
product. When crude indazole (dial) 196 was dried in air for several 
-
hours, the shiny white precipitate turned slightly grayish-tan. The 
yield was 0.65 g. (78%) of crude indazole (dial)~. m.p. 271-276°. 
An analytical sample sublimed at 250°/10-4 mm., m.p. 276-278°. 
Anal. Calcd. for c17H14N202 : C, 73.38; H, 5.04. 
Found: C, 73-13; H, 5.00. 
Spectral measurements by IR and NMR (Plates XVII and LXIV) were con-
sistent with the expected structure proposed for substituted indazole 
(dial) 196. 
-
Preparation of 4,S-Dihydro-7,8-dimethoxy-l-(p-methoxyphenyl)-lH-
benz[g]indazole <J,21). E_-Methoxyphenylhydrazine hydrochloride (Aldrich 
Chemical Co.) (2.1 g., 0.012 mole) was suspended in a solution of 2-
(hydroxymethylene)-6,7-dimethoxy-l-tetralone (232)(1.0 g., 0.004 mole) in 
--
100 ml. of methanol. A solution of sodium acetate trihydrate (4.09 g., 
0.03 mole) in 20 ml. of water was added to the suspension, and the reac-
tion mixture was magnetically stirred (under N2 - 1 hour) at room tern-
perature. Stirring was continued for an additional 2 hours while warm-
ing the reaction gently at about 50°. The brown solution which resulted 
was allowed to cool to room temperature and was then diluted (300 ml. of 
176 
H20). Extraction of the solution was performed with ether (2 x 200 ml.). 
The ether layer was dried (Na2so4), filtered, and evaporated to a light-
brown solid. Recrystallization (!!_-heptane) gave 1.15 g. (86%) of pure 
indazole 197, 
-
0 
m.p. 132-3 . 0 -3 Sublimation at 120 /10 mm. gave a product 
0 
melting at 136-7 , a sample of which was submitted for microanalysis. 
Anal. Calcd. for c20H20N203 : C, 71.43; H, 5.95; N, 8.33. 
Found: C, 71.75; H, 6.07; N, 8.29. 
IR and NMR spectra (Plates XVIII and LXV) were consistent with the 
structure proposed for 197. 
,..-
Preparation of 4,5-Dihydro-l-(.E._-hydroxyphenyl)-l!!_~bi:,nz[~Jindazole-7,8-
diol (198). The appropriate indazole which we have designated as 
-
197 
·-
(1.2 g., 0.004 mole) was suspended in 100 ml. of 48% aqueous HBr. 
Under an N2 atmosphere (to prevent undesirable oxidation of the resulting 
polyol 197), the reaction mixture was boiled gently (3 hours) with slow 
..--
magnetic stirring. When cooled overnight (N2), the reaction mixture de-
posited dark-purple needles. These needles (presumably the hydrobromide 
of 198) were filtered out by suction, which removed excess hydrobromic 
-
acid solution, and dried. Cold 3 !! NaOH (ca. 20 ml.) was added to this 
purple product contained in a small flask. A deep-grey, alkaline solu-
tion resulted which was carefully neutralized (ca. pH 7) with cold 6 N 
HCl. The faint-purple precipitate was removed by filtration under 
aspirator pressure. Recrystallization from aqueous ethanol (1:1) gave 
indazole (trial) 198, weight 0.70 g. (74%), m.p. 290-292°. An analyti-
-
cal sample was prepared by sublimation of recrystallized indazole (trial) 
J:,.2§. at 220°/10-4 mm., m.p. 295°. 
Anal. Calcd. for c17H14N203 : N, 9.52. 
Found: N, 9.51. 
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IR and NMR spectra (Plates XIX and LXVI) were consistent with the 
structure given to indazole (triol) 198 . 
-
Preparation of 4,5-Dihydro-7,8-dimethoxy-1-(£-tolysulfonyl)-l~-
benz[!a]indazole <21.2>· £-Tolylsulfonyl hydrazine [1.2 g. (0.006 mole), 
Aldrich Chemical Co.] was added to 2-(hydroxymethylene)-6,7-dimethoxy-
1-tetralone (232) (1.5 g., 0.006 mole) in 40 ml. of glacial acetic 
-
acid. The solution was shaken manually for 4-5 minutes and then boiled 
under reflux for 2 hours under N2 . A wine-red solution resulted. This 
was cooled to room temperature and then poured onto about 300 ml. of 
ice-water with stirring. A yellow solid formed and was filtered out. 
The melting point determined showed a wide range and suggested an im-
pure or amorphous material. When the solid was allowed to dry in air, 
some noticeable decomposition occurred on the filter paper giving oily 
products. Thus, the remaining solid was transferred quickly to 40 ml. 
of 95% ethanol and stored to permit slow evaporation. Crystallization 
took place after 3-4 hours and crude tosyl indazole 199 was collected 
-
by filtration; weight 0.6 g. (26%), m.p. 178-181° (decomp.). Recrys-
tallization from 95% ethanol and subsequent sublimation (160°/10-4 
mm.) gave the tosyl indazole 199, m.p. 185-187°. 
---
Found: N, 7.36; S. 8.38. 
IR and NMR (Plates XY and LXVII) spectra support the structure of 
tosyl indazole 199 proposed here. 
-
Preparation of 4,5-Dihydro-7-methoxy-l-phenyl-l~-benz[~]indazole 
(203). Phenylhydrazine [(3.0 g., 0.028 mole), Aldrich Chemical Co.] 
-
was dropped into a solution of 2-(hydroxymethylene-6-methoxy)-l-
tetralone in 40.0 ml. of glacial acetic acid. The reddish-brown solu-
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tion was boiled and magnetically stirred (3 hours) under N2 . It was 
then concentrated to one-fifth original volume (rotary evaporator) to 
give a dark-red, viscous syrup. When the syrup was poured onto ice-cold 
water (ca. 400 ml.), a gummy light-brown residue formed. After the resi-
due stood in ice-water several hours (with occasional changes of water 
above the gummy residue and then trituration), solidification was ef-
fected. In order to crystallize the amorphous, brown solid obtained, 
about 20 ml. of 95% ethanol was added and the suspension was warmed to 
effect solution. Crystalline indazole 203 was obtained as light-brown 
-
prisms; 1.81 g. (93.8%), m.p. 103-5°. An analytical sample was sublimed 
(100°/5 x 10-4 mm.) and melted at 105-106°. 
Anal. Calcd. for c18H16N20: N, 10.14. 
Found: N, 10.25. 
Both IR and NMR spectra (Plates XXI and LXVIII) supported the struc-
ture proposed for substituted indazole 203. 
-
Preparation of 4,5-Dihydro-l-phenyl-l~-benz[~]indazol-7-ol ~). 
4,5-Dihydro-l-phenyl-7-methoxybenz[g]indazole (203) prepared above 
- -
(1.0 g., 0.004 mole~ was suspended in 50 ml. of 48% aqueous HBr (J. T. 
Baker Chemical Co.). The suspension was boiled under N2 for 8 hours 
with magnetic stirring. Bright-purple needles were collected by filtra-
tion after the HBr reaction mixture had been allowed to cool to room 
temperature under N2 . This product was worked up like previous ones. 
To free the indazole from its purple hydrobromid~ the needles were 
taken up in 20 ml. of 30% NaOH solution and the solution was cooled. 
Upon acidification (cold 6 ! HCl) to just the neutral point (pH paper), 
a white-to-grey precipitate was formed. Suction filtration separated 
the crude substituted indazole product 204. It was dried in air to con-
__,, 
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stant weight and sublimed (200°/10-3 mm., weight-0.75 g., 72%), m.p. 
238-240°. Characterization by spectral analysis using IR (Plate XXII) 
and NMR (Plate LXIX) supported the proposed structure of B_-substituted 
indazole 204· 
,..._ 
Anal. Calcd. for c17H14N20: C, 77.86; H, 5.34; N, 10.69. 
Found: C, 77.84; H, 5.19; N, 10.79. 
Preparation of Methyl 1,2,3,4-Tetrahydro-6-methoxy-l-oxo-2-naphtho-
ate (241). Dimethyl carbonate (Aldrich Chemical Co.) was distilled from 
-
NaH and stored over molecular sieve [Linde type 3A (1/16"), Matheson, 
Coleman and Bell]. In a 250-ml., three-necked flask was placed 90.0 g. 
(1.0 mole) of dimethyl carbonate. The flask was fitted with a mechani-
cal stirrer and a Friedrich condenser (with N2 inlet). To the flask 
were added 10.4 g. (0.2 mole) of pure sodium methoxide (Fisher Scientific 
Co.) and 17.6 g. (0.1 mole) of 6-methoxy-1-tetralone (240). The mixture 
-
was boiled (4 hours) with mechanical stirring. During that period the 
reaction mixture developed a shiny pink color. It was cooled and 50 ml. 
of CH30H was added to dissolve some of the precipitate formed. Hydro-
chloric acid (6 B_) was added dropwise to the cooled mixture until it 
was just slightly acidic (ca. pH 6.5). Excess methanol was evaporated 
0 
on a rotary evaporator to leave a light pink-colored solid, m.µ. 76-79 . 
This crude ester recrystallized from 95% ethanol (m.p. 89-90°) gave 
" 117 0 20.5 g• (87.5%) of pure keto ester 241 (lit. 88-89 ). 
-
Preparation of 2,3a,4,5-Tetrahydro-7-methoxy-3H-benz[g]indazol-3-
. - -
one (233). To 4.0 g. (0.017 mole) of keto ester 253 was added 100 ml. 
- ,........, 
of anhydrous methanol (Mallinckrodt) in which the amount of ester was 
only partia11y soluble. Hydrazine [95% (Eastman Organic)(5.0 g., 0.16 
mole)] was added to the ester~ in methanol, and the reaction was in-
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itiated by stirring the mixture magnetically with boiling under N2 . 
Boiling was continued for 12 hours. A straw-yellow colored solution re-
sulted after only 1 hour of boiling. The resulting solution was concen-
trated to one-fourth of the original volume. Cold water (ca. 250 ml.) 
was added with stirring whereupon a white precipitate separated. Suction 
filtration removed the precipitate, which was allowed to air-dry to con-
stant weight. Thus crude indazolone 233 was obtained, 3.0 g. (82%), as 
-
a white producq m.p. 218-220°. Recrystallization (50% aqueous ethanol) 
afforded pure, colorless needles m.p. 219-220°. Sublimation at 200°/10-4 
mm. gave a sample melting at 220-1°. IR analysis (Plate XXV) showed no 
carbonyl band;which indicates this compound exists predominantly in the 
enol form (see Results and Discussions Chapter). NMR (Plate LXXII) and 
mass spectral data support the proposed structure for indazolone, or 
more correctly indazolenol, 233,in the media examined. A specimen of 
-
the sublimed sample was submitted for microanalysis. The following re-
sults were obtained: 
Anal. Calcd. for c12H12N202 : N, 12.96. 
Found: N, 13.00. 
Preparation of Methyl 1,2,3,Lf-Tetrahydro-6, 7-dimethoxy-l-oxo-2-
naphthoate (230). The procedure was essentially the same as for the 
-
keto ester 241 prepared above. In a 250-ml., three-necked flask was 
-
placed 90.0 g. (1.0 mole) of dimethyl carbonate (Aldrich Chemical Co.), 
(which was previously distilled from NaH and stored over molecular 
sieve). The flask was equipped with a mechanical stirrer and a Fried-
rich condenser with N2 inlet. Reagent grade sodium methoxide [(Fisher 
Scientific Co.)(10.0 g., 0.2 mole)] was added to dimethyl carbonate 
followed by 10.0 g. (0.048 mole) of 6,7-dimethoxy-l-tetralone (182). 
-
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The mixture was boiled (4 hours) with mechanical stirring. The color of 
the reaction mixture was greyish-tan initially and then changed to deep 
pink and finally to purple. Methanol (about 50 ml.) was added to dilute 
the solid suspended in the reaction medium which was rendered slightly 
acidic by the addition of 6 N HCl dropwise. Residual reactants and sol-
vents were removed by evaporation (aspirator). Crude keto ester 230 
-
was collected from the evaporation flask by dispersing in water and fil-
tering it out. After drying, the crude ester weighed 11.7 g. (93%) and 
was pink in color, m.p. 129-132°. Recrystallization (95% alcohol) gave 
pure keto ester 230 (11.0 g., 92%), m.p. 139-140°. Sublimation at 130°/ 
-
10-4 mm. afforded a colorless sample of the keto ester 230;m.p. 140-141°. 
-
IR and NMR spectra (Plates XIII and LX) support the structure of 230. 
-
Anal. Calcd. for c14H16o5 : C, 63.64; H, 6.06. 
Found: C, 64.09 H, 5.94. 
Preparation of 2,3a,4,5-Tetrahydro-7,8-dimethoxy-3~-benz[~]indazol-
3-one (207). The procedure was similar to that described for indazolone 
-
233. Thus, 1.0 g. (0.004 mole) of methyl 1,2,3,4-tetrahydro-6,7-di-
-
methoxy-l-oxo-2-naphthoate ~) and 2.5 g. (0.063 mole) of 95% H2N-NH2 
(Matheson Co.) and 2 drops of glacial acetic acid were boiled (2 hours) 
in 30 ml. of anhydrous methanol (under N2). Evaporation of most of the 
excess organic solvents and pouring the concentrate into cold water (ca. 
250 ml.) gave a white, crude indazolone 3Q.Z.· Recrystallization (95% 
alcohol) gave pure, colorless indazolone 207; 0.9 g. (91.5%),m.p. 258-
-0 260 (decamp.). Sublimation (240°/0.0l mm.) afforded a highly pure sub-
0 
stance, m.p. 265 (decamp.). Again, as in the case of the monomethoxy 
derivative 233, IR analysis (Plate XXVI) of this product 207 showed no 
- --
carbonyl band; the NMR spectrum (Plate LXXIII) showed no signal for 
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angular H signal at position 3.85. This strongly suggested the compound, 
like 233, existed mainly in the enolic form. Mass spectral data con-
"""' 
firmed the structure proposed for the product 207 of this experiment; 
-
Found: 
Found: 
+ TE_/!5_ 246.100435 (M ). 
TE_/!5_ 246.105069 (M+). 
TE_/!5_ 230.105521. 
TE_/!5_ 230.102257. 
Preparation of 2;3a,4,5-Tetrahydro-7,8-dimethoxy-2-ph~nyl-3.!!_-benz[g]-
indazol-3-one (208). Methyl 1,2,3,4-tetrahydro-6,7-dimethoxy-l-oxo-2-
-
naphthoate (230) (1.0 g., 0.004 mole) was dissolved in 30 ml. of abso-
,--
lute methanol and 2 drops of glacial acetic acid. The solution was 
placed to a 100-ml., round-bottomed flask to which was added 2.0 g. 
(0.019 mole) of phenylhydrazine (Matheson Co.). Heating was initiated 
and the solution was boiled for 2 hours with magnetic stirring· (under 
N2). A reddish-brown solution resulted; this was cooled and concentrated 
to about one-fourth of the original volume. While concentrating on a 
rotary evaporator, an orange-red crystalline solid separated out. Sue-
tion filtration isolated those crystals from the methanolic solution. 
The crude crystalline product (indazolone 208) weighed 1.18 g. (92%); 
-0 
m.p. 198-200 . Recrystallization (95% ethanol) gave material melting 
at 200-201°. Sublimation (200°/10-3 mm.) gaye a solid, m.p. 202°. 
Spectral analysis [IR and NMR (Plates XXVII and LXXIV)] showed that 
the structure proposed for indazolone 208 was correct. 
-
Anal. Calcd. for c19H18N2o3 : N, 8.69. 
Found: N, 8.55. 
Preparation of 2-(e-Fluorophenyl)-2,3a,4,5-tetrahydro-7,8-dimethoxy-
3~-benz[~]indazol-3-one (209). 
--
In a 100-ml., round-bottomed flask with 
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a condenser and a magnetic stirrer was placed a solution of 1.0 g. 
(0.004 mole) of methyl 1,2,3,4-tetrahydro-6,7-dimethoxy-l-oxo-2-naphtho-
ate (230) in 50 ml. of 95% ethanol. To that solution was added a sus-,__ 
pension of E-fluorophenylhydrazine hydrochloride [Aldrich Chemical Co. 
(1.3 g., 0.008 mole)] in 10 ml. of 95% ethanol containing 2 ml. of 10% 
acetic acid. Sodium acetate trihydrate (1.0 g., 0.008 mole) was added 
to the previous mixture. The reaction mixture was bbiled (under N2) 
for 2 hours. The reddish-brown solution initially formed turned to 
yellow after about 0.5 hour of boiling. Concentration of the reaction 
solution to about one-half of the original volume resulted in formation 
of some crystalline substance. Those crystals of crude indazolone 3..Q2 
were filtered out and dried; weight, 0.86 g. (65%). Crude indazolone 209 
-
was recrystallized from 95% ethanol; m.p. 243-244°. An analytical sample 
0 -4 0 
was sublimed at 210 /10 mm., m.p. 244-5. 
Anal. Calcd. for c19H17N203F: N, 8.23; F, 5.60. 
Found: N, 8.14; F, 5.48. 
Spectral analysis [(IR and NMR) Plates XXVIII and LXXV] were also 
in excellent agreement with the proposed structure of indazolone 209. 
-
Preparation of 2,3a,4,5-Tetrahydro-7,8-dimethoxy-3a-methyl-3~-benz-
[g]indazol-3-one (210). 
- -
Diethyl carbonate (Aldrich Chemical Company) 
(100 g. 0.847 mole, distilled from NaH) was mixed with 6,7-dimethoxy-l-
tetralone (.1§l) (5.0 g., 0.024 mole.) and NaOCH3 (4.2 g., 0.048 mole.) 
in a 250-ml., three-necked flask equipped with a mechanical stirrer and 
a Friedrich condenser. The reaction mixture was boiled under N2 (2.5 
hours) during which time the color changed from dark purple to brown. 
Enough methanol (ca. 150 ml.) was added to dissolve the precipitate 
formed after allowing the reaction mixture to cool to room temperature. 
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To the previous solution in methanol (which had a light-brown 
color) was added reagent CH3I (Fisher Scientific .o.) (9.0 g., 0.063 
mole). Stirring was initiated at room temperature and was continued for 
18 hours followed by gentle boiling (1 hour). The reaction mixture was 
allowed to cool and was neutralized with 2 M acetic acid. Concentration 
on a rotary evaporator gave a brown syrup. This solidified during tritu-
ration with hot hexane (several times) and cooling. The amorphous solid 
obtained from the hexane extract was filtered and crystallized (95% 
ethanol), m.p. 74-76°; weight of pure ester JJJ was 3.3 g. (46%). A 
0 
sample was recrystallized again (95% ethanol) and sublimed at 70 /0.001 
mm. Mass spectral analysis gave the following data. 
Found: 
+ !!!1~ 292.125911 (M ). 
+ !!!/~ 292.131064 (M ). 
IR and NMR spectra (Plates XII and LIX) supported the proposed 
structure 228. 
-
Ethyl 1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-l-oxo-2-naphthoate 
(228) (1.2 g., 0.004 mole) obtained above was dissolved in 15 ml. of 
-
anhydrous methanol and treated with 3 g. (0.094 mole) of 95% hydrazine. 
The reddish-brown solution obtained was stirred under N2 with gentle 
heating (2 hours). Cooled to room temperature and diluted with about 
150 ml. of ice-cold water, the reaction mixture deposited a nearly pure 
solid. Filtration of that solid and air drying yielded 0.85 g., (82% 
0 based on 228) of indazolone 210, m.p. 215-218 . 
- --
An analytical sample was sublimed at 200°/0.005 mm. and was sub-
mitted for microanalysis: 
Anal. Calcd. for c14H16N203 : N, 10.77. 
Found: N, 10.59. 
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IR and NMR spectra (Plates XXIX and LXXVI) were in agreement with 
the expected structure for 210. 
-
Preparation of 2-Methyl-6,7-dimethoxy-l-tetralone c.12}-). Sodium 
ethoxide (8.0 g., 0.12 mole) (Aldrich Chemical Co.) was suspended in 150 
ml. of denatured ethanol and transferred i.nto a lOO~ml. , round-bottomed 
(N2). To that suspension was added 1.5 g. (0.007 mole) of methyl 1,2,3,-
4-tetrahydro-6,7-dimethoxy-l-oxo-2-naphthoate (230) which was followed 
--
by the addition of 14.0 g. (0.1 mole) of CH3I. An exothermic reaction 
occurred as soon as the reactants were stirred magnetically. A brown 
solution resulted. The mixture was stirred (17 hours) at room tempera-
ture (under N2). An additional amount of sodium ethoxide (2.0 g., 0.03 
mole) was added, and the reaction was boiled for 0.5 hour and then 
stirred for an additional 4 hours at room temperature. It was acidified 
with dil HCl (6 N) to pH 6-6.5. Excess solvents were evaporated (aspira-
tor pressure) and the residue was suspended in water and extracted with 
ether (2 x 50 ml.). Ether was evaporated after the solution had been 
dried (Na2so4). A yellowish-white solid was obtained, m.p. 110-113°. 
This compound was recrystallized (hot hexane), m.p. 114-115°; yield 0.8 
g. (52%). An NMR spectrum (Plate LVII) and an IR spectrum (Plate X), 
together with mass spectral analysis, proved that the product was 2-
methyl-6,7-dimethoxy-l-tetralone (231). 
-
0 -4 A sublimed (100 /10 mm.) 
sample gave the following mass spectral data: 
M.S. Calcd. for Cl3Hl603: m/e 256.109937 (M+). 
Found: "i!!_/~ 256.108282 (M+). 
Calcd. for fragment c13H12o2 : "!!!._/~ 200.083724. 
Found: "!!!._/~ 200.083825. 
Preparation of 4,5-Dihydro-7,8-dimethoxynaphthf2,l-~]isoxazole 
186 
(~). A solution of HONH2 ·HC1 (1.0 g., 0.14 mole) and sodium acetate 
trihydrate (1.0 g., 0.007 mole) in 5 ml. of water was added to a solu-
tion of 2-(hydroxymethylene)-6,7-dimethoxy-l-tetralone (232) 83 (2.0 g., 
-
0.086 mole) in 25 ml. of glacial acetic acid. The combined solutions 
were boiled (1 hour) under N2. The reaction mixture was cooled to room 
temperature whereupon shiny, golden needles separated out. The needles 
were filtered out with a suction funnel (aspirator pressure) and washed 
with 80% acetic acid and then with cold water, and dried; m.p. 186-189°. 
Recrystallization from 50% CH3co2H afforded 1.7 g. (84%) of pure~· 
0 
m.p. 189-190 • An analytical sample was prepared by subliming a speci-
men of the recrystallized isoxazole at 160°/0.025 mm. 
Anal. Calcd. for c13H13No3 : C, 67.53; H, 5.62; N, 6.06. 
Found: C, 67.71; H, 5.75; N, 5.98. 
IR and NMR spectra (Plates XXIII and LXX) were consistent with the 
proposed structure of 185. 
-
Preparation of 4,5-Dihydro-7,8-dimethoxynaphth[l,2-~]isoxazole 
(~).A mixture of 2-(hydroxymethylene)-6,7-dimethoxy-l-tetralone (ld3) 83 
(2.0 g., 0.086 mole), HONH2 ·HC1 (1.0 g., 0.14 mole) in 2 ml. of water, 
and 8 ml. of pyridine was boiled under N2 (3 hours). A dark-green color 
developed quickly in the solution at reflux. The reaction mixture was 
allowed to cool overnight whereupon a brownish, crystalline solid sepa-
rated out. It was filtered and allowed to dry in air; crude yield was 
0.8 g. Thi l .d · · · 166 f h · 1 185 s so i was an isomeric mixture o t e two isoxazo es 
. -
and 186 which was separated as follows: The crude mixture was parti-
-
tioned between 200 ml. of ethyl acetate and 100 ml. of 1 N HCl solution. 
The organic layer was washed twice with 30 ml. of 1 N HCl and 30 ml. of 
saturated sodium chloride solution; it was then dried (Na2so4). Solvents 
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were removed using a rotary evaporator. The residue was redissolved in 
100 ml. of dry THF (from NaH) containing 0.7 g. (0.012 mole) of Na0CH3 . 
The resulting reddish solution was stirred at room temperature (1 hour) 
using a magnetic stirrer. The reaction mixture \vas then washed with 50 
ml. of saturated NaCl solution, 20 ml. of 2% NaOH solution, and then 
with 100 ml. of H2o. Drying the organic layer (Mgso4) and concentrating 
it on a rotary evaporator gave crude.J&.9 as a light brown solid. Re-
crystallization from c2H50H-H2o (9:1) gave 0.5 g. (38%) of pure~· 
m.p. 176-178°. A sample sublimed at 160°/10-2 mm. 
Anal. Calcd. for c13H13No3 : N, 6.06. 
Found: N, 6.12. 
IR and NMR spectra (Plates XXIV and LXXI) supported the proposed 
structure for 210. Mass spectral data obtained were: 
-
Found: 
Found: 
Calcd. for fragment c9H10o2 : 
Found: 
+ !!!:./~ 231.089537 (M ). 
+ !!!_/~ 231.088599 (M ). 
!!!_!~ 202.086798. 
!!!_!~ 202.087017. 
!!!_I~ 150.068075. 
!!!_!~ 150.068382. 
Attempted Cleavage of the Methoxyl Groups of 4,5-Dihydro-7,8-di-
-
methoxynaphth[2,l-~]isoxazole (185) by 48% Aqueous HBr. 
-
Isoxazole 185 
(1.2 g., 0.006 mole) was boiled under N2 with 50 ml. of 48% aqueous HBr 
for 5 hours. A brown solution resulted and was left to cool overnight. 
This solution was diluted with 100 ml. of cold H2o and extracted with 
ether (2 x 100 ml.). The ether layer was washed with saturated NaHC03 
solution (50 ml.) and then water and was finally dried (MgS04). Filtra-
tion of the solution removed the drying agent and the clear solution was 
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concentrated to a brown oil; weight 0.2 g. The identity of the oil was 
not examined further since a spectral analysis (IR and NMR) did n•)t sup-
port the presence of the expected dihydroxy compound. It was assumed 
that HBr had cleaved the isoxazole heterocyclic ring, presumably to 
give the corresponding 2-cyano-l-tetralone215 
Preparation of 2-Bromo-3,4-dihydro-6,7-dimeth?xy-1(2_!!)naphthalenone 
(229). A solution of 10.3 g. (0.05 mole) of 6,7-dimethoxy-l-tetralone 
.,..__,. 
(182) in 100 ml. of chloroform-ethanol medium (1:1) was placed in a 
~
three-necked, 250-ml. flask. A mechanical stirrer, a Friedrich conden-
ser (with N2 inlet) and a dropping funnel were fitted to the flask. 
Reagent-grade bromine [(Fisher Scientific Co.)(8.8 g., 0.055 mole)] was 
dissolved in 10 ml. of pure HCC13 , and the solution was charged in the 
dropping funnel. The reaction flask was cooled in ice-bath and the 
dropwise addition of Br2 solution proceeded in 50 minutes. A yellow 
precipitate began first to appear after about 1 hour of stirring at room 
temperature. That yellow precipitate disappeared in solution with fur-
ther stirring, which was allowed to continue for an additional 3 hours. 
Washing the resulting solution (dark-yellow to light-brown) successively 
with H20, with saturated aqueous NaHS03 , and with H2o and finally drying 
(Mgso4) it gave a clear and almost colorless solution. Evaporation of 
the organic solvents (rotary evaporator) gave a brown syrup. Tritura-
tion of that syrup with HCC13-ether (1:4, v/v) yielded 8.5 g. (60%) of 
crude bromo ketone 229, m.p. 103-5°. Sublimation of the recrystallized 
.......... 
bromo ketone 229 at 110°/0.l mm. afforded a highly pure product melting 
,,,....., 
at 107-8°. 
Anal. Calcd. for c12H13o3Br: C, 50.53; H, 4.56. 
Found: C, 50.19; H, 4.59. 
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Spectral measurements (NMR and IR data Plates XI and LVIII)support-
ed the structure proposed for the bromo ketone 229. 
-
Preparation of 2-Amino-4,5-dihydro-7,8-dimethoxynaphtho[l,2-d]thia-
zole (211). 122 The procedure of Doorenbos was modified. To a solution 
---
of the bromo ketone 33:J (2.0 g., 0.007 mole) in 75 ml of HCC13-c2H50H 
(1:1) was added 3.0 g. (0.039 mole) of reagent-grade thiourea (J. T. 
Baker Chemical Co.). The mixture was boiled with magnetic stirring 
(under N2) for 6.5 hours. The clear solution that resulted was cooled 
under N2 overnight. Unchanged thiourea (ca. 1.0 g., 0.013 mole) precip-
itated out upon cooling and was removed by filtration. Evaporation of 
the filtrate to complete dryness (rotary evaporator) resulted in the 
formation of a white solid (presumably the hydrobromide of thiazole 211). 
-
Dissolution of the white solid in 250 ml. of 95% ethanol and treatment 
with about 15-20 ml. of cold 2 N KOH (until pH 10-11) gave another white 
precipitate (thiazole 213) which was collected by suction filtration. 
-
The crude thiazole 211 obtained, weight 1.2 g. (65%), melted at 228-230°. 
-
0 Sublimation of a sample at 190-200 /0.01 mm., surprisingly, resulted in 
a color change from white to a bright yellow. The yellow, crystalline 
0 
compound melted at 235-7 ; the proposed structure for thiazole 211 
-
was supported by IR, elemental, and NMR analysis (see Plates XXX and 
LXXVII). 
Anal. Calcd. for c13H14N2o2s: N, 10.68. 
Found: N, 10.64. 
Preparation of 2-Anilino-4,5-dihydro-7,8-dimethoxynaphtho[l,2-~l-
thiazole (212). 2-Bromo-6,7-dimethoxy-l-tetralone (229) (1.8 g., 0.063 
- -
mole) was dissolved in 50 ml. of HCC13-c2H50H (1:1) in a 100-ml., round-
bottomed flask attached to a condenser. B_-Phenylthiourea [(Eastman Or-
190 
ganic) 1.0 g., 0.066 mole] was added and the resulting mixture was 
stirred magnetically and boiled for 6 hours under N2 . The slightly 
yellowish solution was cooled and then evaporated completely to dryness 
on a rotary evaporator. The white solid obtained was dissolved in 
cold ethanol (ca. 25 ml.). A solution of 2 N KOH was added dropwise 
with cooling, whereupon a shiny white precipitate separated out (crude 
thiazole 212). Filtration and drying in air yielded 1.9 g. (90%), m.p. 
-
174-177°. IR and NMR spectra (Plates XX.XI and LXXVIII) supported the 
presented structure of thiazole 212. 0 -4 A sample sublimed at 160 /10 mm.; 
-
m.p. 180-181°. 
Anal. Calcd. for c19H18N202s: N, 8.58. 
Found: N, 8.85. 
Preparation of 2-(Allylamino)-4,5-dihydro-7,8-dimethoxynaphtho-
[l,2-~]thiazole (213). _!'!-Allylthiourea [(1.5 g., 0.0013 mole), Eastman 
-
Organic] was dissolved in 50 ml. of mixed HCC1 3-c2H50H (1:1). To that 
solution was added 2.0 g. (0.007 mole) of 2-bromo-6,7-dimethoxy-l-tetra-
lone ~), and the resulting solution was boiled under N2 for 16 hours. 
A slightly yellow but clear solution developed. The solution was cooled 
to room temperature overnight under N2 with continuous magnetic stirring. 
After evaporation to remove all solvents (rotary evaporator), a yellow, 
viscous oil formed. Cold 95% ethanol (ca. 25 ml.) was added to that oil 
and triturated for a few minutes. A white precipitate appeared when the 
flask was allowed to cool in ice-bath. Water was added to dilute the 
ethanolic mixture (ca. 20 ml.), and the mixture was made alkaline (ex-
cess cold 2 .!! KOH). By reducing the volume of the resulting alkaline 
solution to about half volume (rotary evaporator) and cooling in an ice-
bath for several hours, a grayish-tan precipitate was obtained. Crude 
191 
thiazole 213 weighed 2.3 g. (95%), m.p. 85-87°. 
-
IR and NMR spectra (Plates XXXII and LXXIX) were consistent with 
the proposed structure for thiazole 213. Sublimed thiazole 2]3 (100° I 
- -
-4 0 5 x 10 nnn.) melted at 88-90 . Mass spectral data were: 
M.S. Calcd. for c16H18N2o2s: '!!I~ 302.136820 (M+). 
Found: m/~ 302.136094 (M+). 
Preparation of 4,5-Dihydro-7,8-dimethoxy-2-methylnaphtho[l,2-~]-
thiazole (214). ThiQacetamide [(3.0 g., 0.041 mole), Eastman Organic] 
-
was added to a solution made from dissolving 2.0 g. (0.007 mole) of 2-
bromo~6,7-dimethoxy-l-tetralone (229) in 75 ml. of chloroform-ethanol 
. -
(1:1). Magnetic stirring was initiated, and the solution was boiled for 
10 hours under N2. A change of color was observed during the time of 
boiling, from clear colorless to clear yellow. Upon cooling under N2 
and evaporating to dryness, some odor of H2S was detected (presumably 
due to the side reaction between HBr in the medium and excess thioaceta-
mide). A white solid was obtained from the evaporation process and was 
washed by decanting with 10 ml. of H2o (to remove inorganics). After 
dissolving the solid in hot 95% ethanol and adding a cold solution of 2 
~KOH (ca. 10 ml.) (followed by the addition of about 25 ml. of cold 
water), a shiny, white precipitate was produced. This crystalline 
material, thiazole 214 (1.6 g., 88%), melted at 140-141°. An analytical ,...._., 
0 -4 0 
sample sublimed (130-140 /5 x 10 mm.) and then melted at 140-141 . 
Anal. Calcd. for c14H15No2s: C, 64.37; H, 5. 75; N, 5.36; S, 12.26. 
Found: C, 64.11; H, 5.84; N, 5.24; S, 12.12. 
Characterization by spectral analysis (IR and NMR, Plates ~III 
and LXXX) supported the structure of thiazole 214 given. 
-Preparation of Methyl 3,4-Dihydro-6,7-dimethoxy-~ 1 ( 2H),Y_naphtha-
lenecrotonate (Z35). 
,,......,, 
19Z 
In a one-liter, three-necked flask equipped with 
a Friedrich condenser (with NZ inlet), a mechanical stirrer and a Z50-ml. 
pressure-equalizing separatory funnel, was placed 75 g. (1.15 g. at.) of 
zinc pieces. The Zn pieces were previously cut from Zn ribbon (J. T. 
Baker Chemical Company) into strips about~ x ~cm., washed with dil. 
HCl for Z-3 minutes, rinsed with water, acetone, ether and then dried in 
an oven above 150° for Z-3 hours. To the activated zinc covered with 
150 ml. of dry benzene (dried over sodium) was added 4 g. (0.015 mole) 
of HgClz. The suspension was mechanically stirred for 10 minutes at 
room temperature, warmed with continuous stirring under NZ for ZO minu-
tes, and allowed to cool to room temperature. After this had stood for 
30 minutes at room temperature, a solution of 40.0 g. (O.ZZ3 mole) of 
methyl 4-bromocrotonate (Z45)(Aldrich Chemical Co.) (fractionally dis-
,,..._, 
tilled at 109°/ZZ mm.) in 100 ml. absolute ether (dried over Na) and sub-
limed 6,7-dimethoxy-l-tetralone (18Z) (61.8 g., 0.3 mole) in 300 ml. of 
........... 
dry benzene were added all at once. A crystal of iodine was then added. 
The mixture was boiled under reflux with mechanical stirring for 1.5 
hours. The reaction mixture, which began to acquire a greenish color 
(after about 10 minutes of boiling) soon changed to deep yellow after 
another 15 minutes and finally to orange (after another ZO minutes) and 
then to brick red which persisted throughout the remaining reaction 
period. After 1.5 hours of stirring and boiling, an additional 15 g. 
(0.084 mole) of the bromo ester 245 was added followed by Z5 g. (0.382 
,,......_. 
g. at.) of the activated zinc and a crystal of iodine. Boiling was con-
tinued for an interval of 1.5 hours, and the above addition process 
(with the same amounts of chemicals) was repeated twice. Thus, a total 
of 150 g. of Zn (Z.3 g. at.), 85 g. (0.475 mole) of methyl 4-bromo-
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crotonate (245), and 61.8 g. (0.3 mole) of ketone 182 were used in this /"-' .,.........,,, 
experiment. After the last addition was completed, the reaction mixture 
was allowed to boil with continuous stirring overnight (under N2). The 
reaction mixture was cooled and diluted to twice its volume with cold 
water. Then 150 ml. of 2 N HCl was added. The organic layer was sepa-
rated and the aqueous layer was extracted with benzene (2 x 100 ml.). 
The deep orange-colored organic extracts were combined, washed with H20, 
and dried (Cacl2). Evaporating most of the solvents on a rotary evapor-
ator and allowing the deep-orange, oily product to stand at room temper-
ature in an open beaker under hood resulted in formation of an orange-
colored, crystalline product. The solid was filtered using 
a medium-sized, sintered glass funnel and washed with some dry ether to 
give 42 g. (48.6%) of ester 235, m.p. 136-9°. Recrystallization from 
,,..._ 
0 -4 95% ethanol and subsequent sublimation at 130 /5 x 10 mm. yielded a 
bright yellow sample, m.p. 142-3°. 
Anal. Calcd. for c17H20o4 : C, 70.83; H, 6.94. 
Found: C, 70.67; H, 7.28. 
IR and NMR spectra (Plates XXXIV and LXXXI) were consistent with 
the structure proposed for 235. ,..._. 
Concentration of the benzene-ether filtrate from the orange crystal-
line product 235 (rotary evaporator) and vacuum distillation gave a vis-
~ 
cous, yellowish distillate (180-190°/1.5 mm.) which solidified immedi-
ately (11-12 g., ca. 5-6% recovery); m.p. 95-97°. IR and NMR analysis 
indicated the solid was unchanged 6,7-dimethoxy-l-tetralone (182). 
·--
0 Another oily fraction was also collected at 190-195 /at 1.5 mm. 
during the same fractional distillation. This oil (yield was ca. 2.09 
g.) did not solidify but turned red upon standing for 2-3 days. IR 
194 
analysis showed the presence of a hydroxyl group. Further identifica-
tion was not attempted. It is believed that the side product is either 
alcohol-ester 26la or 26lb. 
~ ........___ 
Preparation of 6,7-Dimethoxy-l-naphthalenebutanoic acid (~). A 
mixture of 12.2 g. (0.043 mole) of recrystallized ester 235 and 3.0 g. 
,--....; 
of 10% Pd-C (Matheson Co.) was heated in a carbon dioxide atmosphere to 
220-250° for 1.5-2 hours. After cooling under co2 , ether was added (ca. 
50 ml.), and the catalyst was filtered off using a medium-sized, sin-
tered glass funnel. Ether was evaporated (rotary evaporator) to give 
the crude intermediate methyl 4-(6,7-dimethoxy-l-naphthyl)butanoate 
(246); weight 10.0 g. (83% yield based on 235). Crude isomerized ester 
/-v' ~ 
246 was not purified further but saponified directly to the correspond-
,,...._ 
ing acid 236. Thus, crude ester 246 (10.0 g., 0.035 mole) was placed 
/'--" 
in a 250 ml., round-bottomed flask and dissolved in 100 ml. of methanol. 
To this methanolic solution was added a solution of 3.2 g. (0.057 mole) 
of KOH in 30 ml. of water. This mixture was boiled, under N2 , for 3-4 
hours using a Friedrich condenser and a magnetic stirrer. Cooling the 
hydrolyzate (a dark-brown solution) in ice and acidification with excess 
cold 6 B_ HCl precipitated crude 6,7-dimethoxy-l-naphthalene butanoic 
acid (236) as an off-white solid. Crude acid 236 was removed by filtra-
..-......_. ,,,.___ 
tion from the aqueous acidic solution, washed several times with water 
until neutral to pH paper, and air dried. Recrystallization from H20 
0 
afforded pure, colorless needles of acid 236, m.p. 132-133 ; yield 9.1 
......._ 
g. (95% based on ester 246 and 76% based on ester 235). An analytical 
~ .......... 
sample of acid 235 was prepared by subliming the recrystallized product 
~ 
0 -4 0 
at 120-130 /10 mm., m.p. 135 . 
195 
Anal. Calcd. for c16H18o4 : C, 70.07; H, 6.57. 
Found: C, 69.89; H, 6.68. 
IR and NMR spectral analyses (Plates XXXV and LXXXII) supported 
the suggested structure of acid 236. 
-
Preparation of 3,4-Dihydro-6,7-dimethoxy-1[2~]-phenanthrone (~). 
Polyphosphoric acid (150 g., 115%) was heated to 90-100° in a 600-ml. 
beaker. Heating was momentarily halted, and acid~ (20.0 g., 0.073 
mole) was added in small portions while stirring the PPA mixture 
with a thermometer. Stirring was continued for 10-15 minutes followed 
by an addition of another 50 g. of PPA; the mixture was reheated to 
110°. A deep greenish-brown, viscous mixture resulted, and this was 
cooled to room temperature with continuous stirring. That deep-colored 
syrup was poured onto about 800 ml. of ice-water. Crude 6,7-dimethoxy-
3,4-dihydro-l-[2~]-phenanthrone (l~ obtained as a grey precipitate was 
filtered out by suction and washed generously with water, saturated 
aqueous NaHco3 solution, and finally with water until the filtrate was 
neutral to pH paper. The residue obtained was extracted (500 ml. of 
_g_-heptane) in a So~hl~t apparatus for 48 hours. Pure ketone 188 sepa-
.__.. 
rated out in the hot heptane as the extraction proceeded. Pure ketone 
188 (11.3 g.) was obtained by filtering the cooled heptane suspension . 
........... 
However, another crop (4.8 g.) of ketone 188 was collected by evaporating 
. ~
the heptane mother liquor for a total yield of the beige-colored ketone 
188 of 15.4 g. (83%); m.p. 198-200°. Sublimation of the sample at 
0 -4 0 • 203 160 /5 x 10 mm. gave highly pure ketone 188; m.p. was 210-211 (lit. 
215-215.5°). Mass spectral data obtained were: 
·!!:!/~ 220.109937, (M+). 
Found: !E:_f~ 220.108976, (M+). 
196 
Calcd. for fragment: c12H13o3 : TE:_/~ 205.086463. 
Found: !!::./~ 205.085130. 
Calcd. for fragment: c6H5 : TE:_/~ 77.039123. 
Found: TE:_/~ 77.037689. 
IR and NMR spectra (Plates XXXVI and LXXXIII) combined with MS data 
were sufficient evidence for the proposed structure of ketone 188. 
Preparation of 3,4-Dihydro-2-(hydroxymethylene)-6,7-dimethoxy-1(2!!)-
phenanthrone (237). In a 500-ml., round-bottomed flask was placed a 
--
solution of 6,7-dimethoxy-3,4-dihydro-1[2H]-phenanthrone (188) (8.0 g., 
- "-' 
0.03 mole) in 250 ml. dry benzene. Sodium methoxide (Fisher Scientific 
Co.) (3.8 g., 0.07 mole) was suspended in 50 ml. of dry benzene and add-
ed to the ketone solution in benzene. Ethyl formate (Eastman Organic) 
(6.0 g., 0.07 mole) was added to the previous mixture, and the reaction 
was initiated by mechanical stirring at room temperature under N2 . After 
1 hour of stirring, a gelatinous precipitate began to form which made 
stirring somewhat difficult. Enough dry benzene (ca. 100 ml.) was added 
to redissolve some of the gelatinous precipitate and to facilitate the 
agitation. Stirring was continued (24 hours) at room temperature under 
N2 . Ice-water (ca. 800 ml.) was used to hydrolyze the reaction product; 
the benzene layer was separated. The benzene solution was added to 
about 200 ml. of fresh water and the two layers were extracted with 
ether (2 x 150 ml.). The alkaline, aqueous layer was saved. The organic 
phase was washed with about 50 ml. of 5% NaOH. Combining the alkaline 
washings and the extracts gave a solution which was cooled and made 
acidic (pH = 1-2) by adding excess 6 B:_ HCl. A finely divided, yellow 
precipitate was formed and was isolated by suction filtration. The 
solid 237 obtained was air-dried for 2 days to constant weight. This 
,,......., 
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experiment afforded 8.3 g. (94%) of crude hydroxymethylene ketone 237, 
-
m.p. 145-147°, which was sufficiently pure to use in to the next syn-
thetic step, i.e., cyclization to the corresponding pyrazole. Subliming 
0 -3 
a specimen of this hydroxymethylene ketone 237 at 120-130 /3 x 10 mm. 
-
gave pure 237 as a yellow, crystalline product, m.p. 147-8°. 
--
Anal. Calcd. for c17H16o4 : C, 71.83; H, 5.63. 
Found: C, 71.74; H, 5.73. 
NMR and IR spectral data (Plates XXXVII and LXXXIV) were indicative 
of the correctness of the structure proposed for 237. 
-
Preparation of 10,11-Dihydro-7,8-dimethoxy-3!!_-phenanthro[l,2-.~_Jpy-
razole ~). 2-(Hydroxymethylene)-6,7-dimethoxy-l-phenanthrone (237) 
-(4.0 g., 0.014 mole) was dissolved in 250 ml. of methanol in a 500-ml. 
round-bottomed flask. Magnetic stirring was usecl to agitate the solu-
tion under N2 . To that solution was added 6 ml. of 95% H2N-NH2 (Eastman 
Organic) whereupon a clear, wine-red color developed. The temperature 
. 0 
rose to about 35 and then dropped to room temperature during about 30 
minutes of stirring. Stirring was continued (4 hours) at room tempera-
ture under N2. During that period a golden-yellow, fine precipitate 
(which increased with time) began to appear in the stirred reaction mix-
ture. Filtration by suction using a medium-sized, sintered glass funnel 
removed the precipitate from the methanolic mixture; weight of crude 
0 pyrazole 215 was 2.40 g., m.p. 273-5 . The yellowish, methanolic fil-
trate was evaporated (rotary evaporator) to complete dryness. Suspend-
ing the yellowish, fine residue obtained in about 150 ml. of cold water 
and filtering that suspension by suction (using a sintered glass funnel) 
0 furnished a second crop (1.5 g.), m.p. 272-5 , of crude pyrazole 215 as 
a fine, straw-yellow colored product. Thus a total yield of pyrazole 
198 
215 was 3.9 g. 
---
Recrystallization from THF-benzene afforded 3.7 g. (97%) 
of pure pyraiole 215, m.p. 276-7°. 
..._ 
0 -4 A doubly sublimed sample (270 /10 
mm.), m.p. 277.5°, was submitted for analysis. 
Anal. Calcd. for c17H16N202 : C, 72.86; H, S.71; N, 10.00. 
Found: C, 72.81; H, 5.77; N, 10.06. 
Spectral NMR and IR analyses (Plates XXXVIII and LXXXV) were con-
sistent with the structure proposed for 215. 
Preparation of 10,11-Dihydro-3!!_-phenanthro[l,2-.£_]pyrazole-7,8-diol 
(216). Recrystallized pyrazole 215 (3.0 g., 0.011 mole) was suspended 
-- -
in 100 ml. of 48% aqueous HBr solution. In standard apparatus, the re-
action mixture was boiled for 8 hours (under N2) with magnetic stirring. 
A purple-to-brown color in the solution resulted after about 1 hour of 
boiling. The reaction mixture was allowed to come to room temperature 
gradually under N2 . A deep purple solid (presumably the hydrobromide of 
216) precipitated; it was removed by suction filtration. That solid was 
-
suspended in about 30 ml. of cold water, and the resulting mixture was 
made strongly alkaline (addition of 15-20 ml. of 30% NaOH solution). 
This alkaline solution was deep-grey in color and was filtered from sus-
pended impurities through a glass-wool plug. The filtrate was cooled 
in ice, and 6 ! HCl was added dropwise just to the neutralization point 
(pH = 7). A grey-white, crude pyrazole (diol) 216 was formed and was 
--
filtered out. Recrystallization from 50% aqueous alcohol afforded 2.0 
g. of~ (74% based on m> as a white, microcrystalline product;m.p. 
295-8°. 0 A sample of the pyrazole (diol) 216 was sublimed at 280 /5 x 
-
-4 10 mm. and was again recrystallized from 50% aqueous alcohol, Nuchar 
being used to remove traces of colored impurities. Finally, the sample 
0 -4 
was resublimed at 280 /5 x 10 mm. to give pure pyrazole (diol) 216 
-
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melting at 324-6°. Microanalysis and gave the following results: 
Anal. Calcd. for c15H12N202 : C, 71.33; H, 4.76; N, 11.11. 
Found: C, 70.97; H, 4.50; N, 11.07. 
IR and NMR spectra (Plates XXXIX and LXXXVI) furnished a further 
proof for the structure 216 . 
..--..-
Preparation of 10,11-Dihydro-l-(£-fluorophenyi)-7,8-dimethoxy-3_!!.-
phenanthro[l,2-_s.]pyrazole (~). e-Fluorophenylhydrazine hydrochloride 
[(0.6 g., 0.002 mole~ Aldrich Chemical Co.] was mixed with sodium ace-
tate trihydrate [(0.5 g., 0.002 mole) Mallinckrodt] in 20 ml. of acetic 
acid and 5 ml. of water. The mixture was shaken manually for 2-3 minutes 
and added to a solution of hydroxymethylene ketone 237 (1.0 g., 0.004 
,.....__ 
mole) in 30 ml. of acetic acid. Heat was applied to boil the reaction 
mixture (red) for 2.5 hours under N2 . Most of the acetic acid was re-
moved on a rotary evaporator. After the suspension in cold water was 
cooled for several hours, crude pyrazole 217 separated out. Filtered 
~
from water and dried, the crude pyrazole 217 weighed 0.45 g. (64%); m.p. ,..._..,, 
195-7°. IR and NMR (Plates XLI and LXXXVIII) analysis suuport the struc-
o -4 Sublimation (180 , 10 mm.) gave a colorless ture proposed for 217 . 
............ 
pure productjm.p. 197-8°. 
Anal. Calcd. for c23H19N202F: N, 7.49; F, 5.08. 
Found: N, 7.40; F, 5.01. 
Preparation of 10,11-Dihydro-l-(£-fluorophenyl)phenanthro[l,2-_s.]-
pyrazole-7 ,8-diol (218). Hydrobromic acid [48% aqueous solution, 50 
.,,......__, 
ml. (J. T. Baker Chemical Company)] was used to cleave the two methoxyl 
ether linkages in pyrazole .3.[?· Boiling (under N2) 0.8 g. (0.002 mole) 
of the pyrazole 217 in the acid for 17 hours gave a brownish-purple sol-
~
ution. Upon cooling this deposited a fine deep burgundy-colored powder. 
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Filtration removed the powder which was air dried. The purple powder 
was dissolved in alkali (NaOH, 2 B_, about 15 ml.) to give a deep-grey 
solution. Using a glass-wool plug, the strongly alkaline solution was 
filtered from undissolved impurities. Neutralization (pH paper) while 
cooling in an ice-bath using 6 B_ HCl gave a grey-tan precipitate; this 
was collected by cooling the solution in a refrigerator and filtration 
of the solid obtained by suction filtration. Crude pyrazole (diol) 218 
-
thus obtained weighed 0.35 g. (51%)1 m.p. 248-252°. Purification by sub-
limation gave a colorless product, pyrazole (diol) 218~m.p. 256-8°. 
-
Anal. Calcd. for c21H15N202F: N, 8.09; F, 5.50. 
Found: N, 8.10; F, 5.42. 
Spectral analysis (IR and NMR, Plates XLII and LXXXIX) gave support 
for the suggested structure for pyrazole (diol) 218. 
Preparation of 10,ll-Dihydro-7,8-dirnethoxyphenanthro[2,l-~]isoxazole 
(190). Hydroxyrnethylene ketone 237 (1.3 g., 0.005 mole) was boiled with 
- --
a mixture of HONH2 ·HC1 (0.8 g., 0.012 mole) and sodium acetate trihy-
drate (0.8 g., 0.006 mole), all suspended in 25 ml. of acetic acid and 
3 ml. of water. Boiling of the mixture was allowed to continue for 1.5 
hour with gentle magnetic stirring (N2). A brown color developed on 
boiling. This brown solution was cooled to room temperature and 10 ml. 
of water was added. The flask then was stored in a refrigerator for 12 
hours. Shiny golden-yellow crystals separated out upon cooling. Fil-
tration by suction removed these crystals (crude isoxazole 190) from the 
.-
acidic solution; the crystals were washed (cold water) and dried. The 
acidic mother liquor gave a second crop of crude isoxazole 190 upon ,,,_ 
dilution with water until turbidity began to persist; the mixture was 
chilled at o0 c. The second crop was darker in color than the first 
201 
product, and after washing with cold water and drying, the total yield 
amounted to 1.20 g. (85%), m.p. 192-193°. IR and NMR spectra (Plates 
XL and LXXXVII) were consistent for the structure of'isoxazole 190. A 
sample of isoxazole 190 sublimed 0 -3 194-195°. at 180 /10 mm., m. p. 
-
Anal. Calcd. for Cl7Hl5N03: c, 72. 60; H, 5.34. 
Found: c, 72. 52; H, 5.40. 
Preparation of l-S-Q-Glucopyranosyl-4,5-dihydro-7-methoxy-l~-benz-
[_g_]indazole Tetraacetate (ester) (206). 118 The modified procedure for 
--
the chloromercurio derivative was used in this experiment. (A): Prepa-
ration of the c hloromercurio derivative of 4-, 5-dihydro-7-methoxy-l~-benz-
[~]indazole (205): A solution of indazole 247 (5.0 g., 0.025 mole) in 
- -
150 ml. of hot 50% ethanol containing an equivalent of NaOH (1.0 g., 
0.025 mole) was treated with one equivalent of HgC12 (6.79 g., 0.025 
mole). The latter was previously dissolved in 50 ml. of boiling 95% 
ethanol. A white precipitate formed immediately. After cooling to room 
temperature, the white precipitate was collected by suction filtration 
using a medium-sized, sintered glass funnel. The solid was washed with 
cold water and with 5 ml. of cold, 95% ethanol and finally with 25 ml. 
of cold ether. After drying 2 days under a hood, the product had a con-
stant weight. This experiment gave 8.6 g. (88%) of chloromercurio inda-
zole 205. In order to maximize the yield, the mode of addition of reac-
-
tants was reversed to prevent the formation of R2Hg which could con-
ceivably reduce the yield of chloromercurio indazole 205. Thus in a 
--
second run the alkaline-ethanolic solution of indazole 247 (same quan-
-
tities as before) was added dropwise to a boiling ethanolic solution of 
HgC12 . By use of this simple reverse addition, the yield of chloro-
mercurio derivative was almost quantitative; 9.7 g. (98%). 
202 
(B): Condensation of chloromercurio indazole 205 with tetra-0-
-
acetyl-a-D-glucopyranosyl bromide (238): A suspension of chloro-
- --
mercurio indazole 205 (4.0 g., 0.009 mole) in 400 ml. of dry xylene 
-
(dried over sodium) was stirred vigorously by a magnetic stirrer for 
10-15 minutes. About 100 ml. of xylene was distilled off azeotropically 
to remove traces of water. The distillation apparatus was protected by 
a CaC12 tube. Tetra-Q-acetyl-a-glucopyranosyl bromide (238) (4.0 g., 
-
0.0098 mole) was added into the cooled, xylene suspension of chloromer-
curio indazole 205. 
-
Another 100 ml. of xylene was azeotropically dis-
tilled from the suspension with vigorous magnetic stirring. The dis-
tillation condenser was disconnected and the reaction mixture was boiled 
for 3 hours and allowed to cool overnight (all under N2). Filtration by 
suction removed the dark-brown, inorganic by-products from the xylene 
solution. Evaporation of the xylene solution was effected (rotary 
evaporator) and light-brown syrup was obtained. Dissolving that syrup 
in chloroform and allowing it to stand overnight in a refrigerator re-
sulted in formation of a precipitate (inorganic by-products and unchang-
ed reactants). Gravity filtration of the chloroform solution was 
carried out. Remaining mercury salts and complexes were removed by 
washing the chloroform solution with water, with 30% Nal solution, and 
again with water. A dried (Mgso4) solution was passed through a neutral 
alumina column (2 x 60 cm.) which was eluted with HCC13 . There were 
afforded almost colorless fractions. Evaporation of the HCC13 from 
various fractions (rotary evaporator) resulted in the isolation of an 
amber-colored syrup. Trituration with hot hexane initiated solidifica-
tion. Crystallization occurred after several washings with hot hexane 
followed by the addition of cold ether. An off-white, crystalline 
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product N-glycoside 206 was obtained; weight 1.4 g. (25% based on 247), 
- - -
m.p. 148-150°. Recrystallization from petroleum ether (b.p. 30-60°)/ 
diethyl ether (1:2) afforded a colorless product, m.p. 155-156°. A 
0 -4 0 
sample of a sublimed product (140 /2 x 10 mm.) melted at 159-160 . 
Anal. Calcd. for c26H30N2o10 : C, 58.87; H, 5.t6; N, 5.28. 
Found: C, 59.03; H, 5.60; N, 5.25. 
IR and NMR (Plates XLIII and XCI) data agreed well with the struc-
ture proposed for N-glucoside 206. 
- -
(C): Cleavage of the Acetate Groups in 206; Formation of the de-
-
acetylated N-glucose derivative of 4,5-dihydro-7-methoxy-l_!!.-benz[~]inda­
zole: Anhydrous methanol [(Mallinckrodt) (250 ml.)] was placed in 
500-ml., round-bottomed flask chilled in an ice-salt bath. Ammonia gas 
from a commercial lecture-bottle (Matheson Co.) was bubbled into the 
cooled methanol for about 2 hours to effect saturation. Blocked N-
glycoside 206 (0.9 g., 0.002 mole) was transferred into the methanolic 
-
ammonia solution and the flask was stoppered. The reaction flask was 
stored (24 hours) in a refrigerator (ca. s0 c.) and for another 24 hours 
0 
at room temperature (ca. 23 C.). Excess methanol and ammonia were 
evaporated (rotary evaporator); a yellowish-brown syrup was obtained. 
Acetamide (a by-product) was removed by washing the syrup with 1 ml. 
HCC13 and 10 ml. of hot hexane. Purification was accomplished by 
allowing a chloroform solution of the syrup to pass through a neutral 
alumina column (2 x 50 cm.) and then· eluting with methanol. Solidi-
fication did not occur by evaporating of the organic solvents to dry-
ness. Trituration with cold CH30H-(C2H5) 2o (1:9) and boiling in ex-
cess ether (ca. 250 ml.) followed by slow evaporation of the ether solu-
tion at room temperature did not initiate crystallization. Many attempts 
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were made using various solvents and combination of solvents, all being 
unsuccessful in giving a crystalline product. The crude syrup (in 
HCC13) was again caused to pass through a column of neutral alumina 
(4 x 50 cm.) which was washed thoroughly with HCC13 . The HCC13 frac-
tions were evaporated separately and again attempts at crystallization 
were resumed. However, they were also unsuccessful. The only proof 
that the compound was the free sugar-pyrazole came from NMR and IR 
analyses of the syrup. These spectra were very similar to those obtain-
ed on the dimethoxy analog. . The latter was successfully recrystalliz-
ed. 
N-Glycosidation Using Hg(CN) 211 , 397 • The procedure used was simi-
lar (but with modifications) to that of Yamaoka~97 4,5-Dihydro-7-
methoxy-1!!_-benz[~]indazole ('l!!J) (2.0 g., 0.011 mole) was dried by 
azeotropic distillation of its solution in nitromethane (Fisher Scien-
tific Co.). About 50 ml. of distillate was collected from an original 
volume of about 250 ml. of nitromethane. The rei;naining nitromethane 
solution was cooled; the acetobromoglucose ( 232) ( 6 .15 g. , 0. 015 mole) 
.,,......, 
was added cautiously followed by 5.0 g. (0.037 mole) of anhydrous caso4 
(commercial-grade "Drierite"). To this mixture was added 2.7 g. (0.01 
mole) of Hg(CN) 2 (Ventron), and the reaction mixture was vigorously 
stirred by a magnet and allowed to boil for 4 hours under N2 . Filtra-
tion was carried out while the mixture was still hot with a medium-mesh, 
sintered glass funnel (150 ml. capacity). Warm CH3No2 (ca. 20 ml.) was 
used to wash the residue in the funnel. Combining the original filtrate 
and washings and evaporating all the nitromethane (rotary evaporator) 
gave a light-brown syrup. Chloroform (about 100 ml.) was added to the 
syrup in the evaporating flask,which was then stored in a refrigerator 
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for 1 day. Complex Hg and Ca salts deposited upon cooling the solution 
and were filtered out and discarded. The clear, amber-colored chloro-
form filtrate was washed with H20, with 30% NaI, and with H20; it was 
dried (MgS04) and evaporated to a very viscous straw-yellow syrup. Re-
peated trituration of the syrup with petroleum ether (b. 40-60°) with 
cooling in ice-bath gave a pasty, off-white product. Cold ether was 
added dropwise during the trituration; the pasty product in petroleum 
ether solidified and was filtered out and dried (23 g., 42%~m.p. 158-
1600. Spectral analyses (NMR and IR, Plates XLIII and XCI) were in 
agreement with the proposed structure of acetylated ~-glycoside 206. 
Mixed m.p. determination with the product of the HgC12 method showed no 
appreciable depression in m.p. (150-155°). 
Preparation of 1-8-D-Glucopyranosyl-4,5-dihydro-7,8-dimethoxy-l!!-
benz[g]indazole (202). (I): The chloromercurio derivative of pyrazole 
- ,.....__., 
200: 
--
A suspension of pyrazole 193 (S.O g., 0.02 mole) in 100 ml. of 
-
50% aqueous ethanol was boiled to complete solution. One equivalent of 
NaOH (0.8 g., 0.02 mole) was added to that boiling solution. While hot, 
this alkaline solution was added dropwise to another boiling solution 
made from dissolving HgC12 (5.43 g., 0.02 mole) in 50 ml. of 95% ethanol. 
A creamy-white precipitate formed at once. This mixture was heated for 
an additional 3 to 4 minutes to complete digestion; heat was stopped, 
and the flask was cooled under a hood. A white precipitate (chloro-
mercurio derivative 200) was collected by suction filtration in a sinter-
-
ed glass funnel (medium-pored, 150 ml. capacity). Crude chloromercurio 
compound 200 was allowed to dry thoroughly in air under a hood for many 
--
hours;9.3 g. (100%). 
(II): Chloromercurio compound 200 (9.3 g., 0.02 mole) was further 
-
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dried azeotropically by distillation with xylene. Thus a suspension of 
the chloromercurio derivative 200 in 300 ml. of dry xylene (dried over 
-
Na) was stirred vigorously and distilled until about 70-80 ml. of 
xylene had been coliected. The residual xylene suspension was cooled 
and the acetobromoglucose (238) (8.2 g., 0.02 mole) was added. Distilla-
-
tion was resumed to dehydrate the mixture. There was collected another 
70-80 ml. of xylene as distillate. Boiling was then continued in the 
residual xylene mixture (under N2) for 14 hours with vigorous magnetic 
stirring. Cooled to room temperature, the reaction mixture deposited 
solid, presumably some brown inorganic complexes as .by-products. The 
latter were removed by filtration and the xylene solution (yellow in 
color) was evaporated to a brown syrup which was dissolved in chloroform 
(approximately 30 ml.). Undissolved substances (presumably some sort 
of inorganic compounds) were filtered out. Washing the chloroform 
solution free of excess Hg salts was accomplished with H20, 30% NaI 
solution, and H20 consecutively; the final solution was dried (Mgso4). 
Passing the dried solution through a neutral alumina column (4 x 60 cm) 
and evaporating the chloroform gave a honey-colored syrup. Trituration 
0 
with petroleum ether (b.p. 30-60 ) and adding a few ml. of cold diethyl 
ether gave 7.4 g. (66%) of !!_-glycoside acetate 201, m.p. 142-146°. 
,,._ 
0 -3 Sublimation at 150-160 /5 x 10 mm. gave a colorless glycoside acetate 
0 201, m.p. 170-171 . 
,__ 
Anal. Calcd. for c27H32N2o11 : N, 5.00. 
Found: N, 4.97. 
IR and NMR spectra (Plates XLIV and XCII) support the structure 
for !!_-glycoside acetate 201. 
-
(III): Removing the acetate moieties on N-glycoside 201 with 
- .-... 
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NH3/cH30H: The tetraacetyl compound~ (3.0 g., 0.006 mole) was added 
. to 250 ml. of methanol saturated with ammonia gas at o0 for 2 hours. The 
resulting yellowish solution was stored in a refrigerator for 24 hours 
and for another 24 hours at room temperature. Excess NH3 and CH30H 
were volatilized on a rotary evaporator to leave a syrupy residue. This 
was washed with 5 ml. of hot hexane and 2 ml. of HCC13 to remove aceta-
mide the main, by-product of hydrolysis. The resulting syrupy compound 
was purified on a neutral alumina column (70 x 3 cm.). The eluent HCC13 
was evaporated to leave an oil which solidified after trituration several 
times with a methanol-ether mixture. Recrystallization (ether) gave a 
solid. (m.p. 162-165°))• yield 1.0 g. (45.6% based on acetate .YV- and 30% 
based on pyrazole 193). The sugar-pyrazole product 202 did not sublime. 
,....... ~
Therefore, one recrystallization (ether) of a sample was considered 
(m.p. 163-165°) pure to submit for analysis.and spectral characteriza-
tion. IR and NMR spectra (Plate XLV and XCIII) agreed with the struc-
ture for free N-glycoside 202. 
- -
Anal. Calcd. for c19H24N2o7 : N, 7.14. 
Found: N, 6.87. 
Preparation of l-8-~-Glucopyranosyl-10,11-dihydro-7-methoxy-3~-
phenanthro[l,2-c]pyrazole Tetraacetate (ester) (220). (A): Chloro-
- ,,.--
mercuric derivative (219): 10,11-Dihydro-7-methoxy-3~-naphth[l,2-~]in-
-dazole (249) (1.5 g., 0.006 mole) was dissolved in 200 ml. of boiling 
~ 
80% ethanol. One equivalent of NaOH (0.24 g., 0.006 mole) was added to 
the previous solution, which was boiled for five minutes. This solution 
was added dropwise to 2.0 g. (0.0073 mole) of HgC12 dissolved in 25 ml. 
of boiling 95% ethanol. An immediate white precipitate appeared. This 
was cooled and filtered out with a medium-sized sintered glass funnel. 
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The precipitate was washed successively with cold water, cold ethanol, 
and finally ether and dried in air, yield 2.91 g. (100%). 
(B): ~-Glycosidation of the chloromercurio derivative: a suspen-
sion of chloromercuriopyrazole 219 (3.4 g., 0.007 mole) in 400 ml. of 
-
dry xylene (dried over sodium ribbon) was distilled to remove water 
azeotropically. About 100 ml. of xylene was distilled, and the mixture 
cooled to room temperature. Tetra-Q-acetyl-a-~-glucopyranosyl bromide 
(4.1 g., 0.01 mole) was added to the cooled xylene suspension. Another 
100 ml. of xylene was added and the suspension was again distilled with 
vigorous magnetic stirring. The reaction mixture was boiled 8 hours 
(N2 atmosphere). A brown precipitate was filtered off from the cooled 
reaction mixture and discarded (this was presumably 'some inorganic by-
products). Xylene was completely evaporated by using a hot water bath 
and rotary evaporator. Chloroform was added (about 50 ml.) to redissolve 
the syrup obtained. Another fine brown solid inorganic complex was re-
moved by filtration. The chloroform filtrate was washed with H2o, 10% 
NaI, and H20 successively, and dried (Mgso4). Purification of the sol-
ution was carried out by passing it through a neutral alumina column 
(3 x 50 cm.). Chloroform was also used as the eluent. Evaporation of 
the chloroform left a light-yellowish syrup which crystallized via 
trituration using first boiling hexane and then cold ether. The tech-
nique also involved boiling the syrup in hexane; the solution was 
cooled and ether was then added while chilling in ice-bath and stirring 
vigorously; yield was 2.1 g. (52%), m.p. 110-114°. Recrystallization 
0 from hexane-ether gave pure, white N-glycoside 220, m.p. 116-7 . 
- -
IR and NMR (Plates XLVI and XCIV) were consistent with the struc-
ture proposed for N-glycoside 220. 
- -
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(C): A methanolic ammonia solution effected hydrolysis of the 
acetylated N....:glycoside 220. Anhydrous methanol (Mallinckrodt) (ca. 200 
- -
ml.) was placed a in 500....:ml.' round-bottomed flask which was cooled in 
ice-sodium chloride bath. Ammonia gas from a commercial lecture bottle 
(Matheson Gas Co.) was bubbled very slowly into the cooled methanol for 
about 2 hours to effect saturation. Blocked N-glycoside 220 (1.5 g., 
- -
0.0026 mole) was added to the saturated methanolic ammonia, and the 
flask was stoppered tightly. The flask in that condition was kept for 
0 24 hours at about 5 (refrigerator temperature) and for another 24hours 
at room temperature. Excess methanol and excess NH3 were removed by 
evaporation (rotary evaporator). A honey-like residue was obtained. 
Washing the residue with 5 ml. of hot hexane followed by 2 ml. of HCC1 3 
was performed in order to remove acetamide (by-product). The syrup was 
evaporated until free from solvents and triturated with anhydrous CH30H 
until solidification occurred. Thus, crude deblocked N-glycoside 221 
- -
melted at 210-212° and weighed 0.15 g. [14% based on 220, 7.3% based on 
-
pyrazole 249]. Sublimation (200° /10-4 mm.) gave a highly pure compound, 
-
m.p. 219°-220°. IR and NMR analysis (Plates XLVII and XCV) agree well 
with the structure proposed for N-glycoside 221. 
- --
Anal. Calcd. for c22H24N2o6 : C, 64.08; H, 5.82; N, 6.80. 
Found: C, 64.35; H, 5.86; N, 6.84. 
Attempted Condensation of ~-Glucose With 7-Methoxy-4,5-dihydro-l~­
benz[g]indazole (247) Using Polyphosphoric Ester (PPE): 312 •345 An at-
- --
tempt to condense the title compound using PPE according to the method 
of G. Schramm312 •345 (1962) was not fruitful. Thus indazole 247 (3 g., 
-
0.017 mole) was dissolved with magnetic stirring in 100 ml. of DMF 
312 345 [water content (0.1-0.2%) was necessary according to Schramm ' ]. 
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Concentrated HCl (ca. 1.2 ml.) was added to the solution. PPE (10 g.) 
312 345 prepared according to Schramm ' was added in one lot. Anhydrous 
g-glucose [1.5 g., 0.008 mole (Mallinckrodt)] was dissolved in 70 ml. of 
DMF and added dropwise to the ac-, die (pH 3) indazole solution. The 
solution was heated at 50-60° in an oil bath for 22 hours with continu-
ous magnetic stirring. DMF was distilled off with a rotary evaporator 
and the moist residue was brought to pH 7 (pH paper) with 5% NH40H solu-
tion. A solid precipitated but it was identified by m.p., mixed m.p., 
NMR, and IR as unchanged indazole 247 recovered material(z.85 g.). 
-
An Attempted One-step Synthesis of ~-Glycoside of 7-Methoxy-4,5-
dihydro-1~-benz[~]indazole (247) With Acetobromoglucose (238) in Dry 
- -
Dioxane: Indazole 247 (1.5 g., 0.008 mole) was dissolved in 40.0 ml. 
-
of dry dioxane, and the solution was mixed with 1.0 g. (0.003 mole) of 
99 
acetobromoglucose. The resulting mixture was boiled for 2 hours 
under N2 . A solid substance (crystalline, off-white) appeared in the 
reaction flask. This was filtered off after cooling the reaction mix-
ture to room temperature. 0 This solid, m.p. 270-3 (decamp.), was pre-
sumed to be the hydrobromide of 247. Dioxane was removed (rotary 
-
evaporator) whereby a white solid deposited on the inside walls of the 
evaporation flask. Ether (20 ml.) was added and t~e suspension was 
filtered. Comparing the m.p. of the crude product 0 (150-155 ) and 
mixed m.p. with the starting indazole (pure m.p. 162-164°, mixed m.p. 
158-160°) made it evident that reaction had not taken place. This was 
supported by an NMR analysis of the recovered indazole (78.5%). This 
experiment might usefully be repeated on a larger scale with higher-
boiling aprotic solvents like DMSO or DMF. 
The Reaction of 6,7-Dimethoxy-l-tetralone (182) and 95% hydrazine 
-
211 
in Methanolic Sodium Methoxide Medium: the Isolation of an Unknown Com-
pound: . 174 6,7-Dimethoxy-l-tetralone (182) (4.12 g., 0.02 mole) was dis-
solved in 100 ml. of absolute CH 30H containing 1.35 g. (0.025 mole) of 
sodium methoxide (reagent grade, Fisher Scientific Co.). The mixture 
was boiled for 3 hours under N2 and allowed to cool. More CH30H (ca. 
30 ml.) was added to dissolve the precipitate and the clear light-brown 
solution was stored in the refrigerator (1 day). Hydrazine [(95%, 3.0 
g., 0.094 mole), Eastman Organic] was added to the cold reaction solu-
0 tion which was warmed to 60 (1 hour). It was cooled to room temperature 
and stored in the hood and exposed to air for slow evaporation of sol-
vent [cH30H and excess reactants (H2NNH2)]. Acidification with HCl (6 
!!) was done dropwise to a neutral pH (pH paper). A brown oil settled 
out; this was extracted with benzene (2 x 50 ml.) and then ether (1 x 
25 ml.). The organic solutions were combined, washed with H20, and 
dried (Mgso4). Evaporation of solvents gave an oily product which when 
triturated with cold 95% ethanol solidified. There was obtained a 
bright-yellow crystalline product, m.p. 218-220°. Recrystallization 
from THF-c2H50H (95%) yielded a canary-yellow, crystalline compound, 
m.p. 220-2°; weight 1.5 g. Microanalysis gave the following results: 
Anal. Calcd. for c26H30N202 : C, 69.44; H, 6.88; N, 6.45. 
Found: C, 69.28; H, 6.49, N, 6.29. 
Two strong contenders for the structure of this unknown solid were 
(a) and (b), both of which had the identical calculated analyses. Spec-
-1 tral data were as follows: IR(KBr), cm , 1570-1580 (C=C or C=N), 1240-
1250 (C-0); NMR (DCC13), 2 singlets (2H), o 6.60 and 7.84 (Ar.!i_), 2 
singlets (6H), 0 3.88 and 3.90 (Aro C.!i_3), 2 multiplet (6H), 0 1.95 and 
2.80 (C.!i_2C.!i_2C.!i_2); MS, ~/~ (M+) 408. 
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Structures (a) or (b) were thus considered to be possible candi-
dates for the unknown compounds. Both have a molecular weight of 408. 
OCH 
3 
(a) (b) 
There was no H-D exchange (with n2o) in the NMR spectrum, however, to 
support (b). Furthermore, from the integration of the NMR spectrum of 
the compound, (a) might be expected to give a pattern consistent with a 
synnnetrical anti isomer. Isomer (b) would not be expected to give such 
a spectral pattern. Thus, taken on the whole, the data supported struc-
ture (a). 
Reaction of Veratrole, 3-Carbomethoxypropanoic Acid and 115% PPA 
at 100°: Veratrole (239) (138.0 g., 1.0 mole) was mixed with 3-carbo-
-
methoxypropanoic acid84 (242) (198.0 g., 1.5 mole) and the mixture was 
-
added to 500 g. of 115% PPA. 366 Manual stirring was used while the vis-
cous reaction mixture was warmed to 80-90°. Stirring became more facile 
as the temperature rose. A deep-violet color developed upon heatingand 
persisted throughout the 2-hour period allowed for the reaction at 90-
100°. The reaction mixture was cooled with continuous stirring to 
room temperature and poured onto about 2 kg. of crushed ice. Vigorous 
stirring resulted in the deposition of an oily substance which soon 
solidified to a white precipitate. The precipitate changed, after 
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several hours of cooling in the aqueous acidic medium, to a gummy mater-
ial. Water was decanted and the gummy material was washed carefully by 
NaHC03 solution and then with water until neutral (pH paper). Ethanol 
(95%, ca. 200 ml.) was added to the gummy product and the mixture·was 
triturated several minutes in the cold. This formed a crystalline pre-
cipitate. The product was filtered and recrystallized from boiling 95% 
0 
ethanol, m.p. 220-2 . The undissolved substance, obtained from the 
ethanol recrystallization, was recrystallized from acetone, m.p. 128-130°. 
The ratio of products by weight was 1:5. Mass spectral analysis of the 
0 + . 
ethanol fraction (m.p. 220-222) gave an IE_/~ 340 (M ), while the acetone 
fraction (m.p. 128-130°) gave an~/~ 252 (M+). Both compounds had C=O 
-1 . 
absorption bands in the IR spectrum at 1739 cm and were very similar. 
Since both compounds appeared to give identical NMR spectra, the two 
products may only be different crystalline forms; Further studies to 
identify that unusual reaction of hot 115% PPA with veratrole and 3-car-
bomethoxypropanoic acid were terminated at that stage. The compound of 
+ IE_/~ 252 (M ) was, of course, not methyl 4-(3 ,4 -dimethoxyphenyl)-4-
butanoate (222) but we cannot rule out a 1,2,3-substituted benzene ana-
-
log. 
Condensation of Hydroxymethylene Ketone 232 With Methylhydrazine; 
-
Formation of Isomers: In similar fashion to the condensation of hydroxy-
methylene ketones with substituted arylhydrazines, this experiment was 
carried out using methylhydrazine. The hydroxyrnethylene compound 232 
-
(1.6 g., 0.007 mole) was dissolved in 50 ml. of CH30H and 2 drops of 
acetic acid were added. To that solution was added 8.0 ml. (8.4 g., 
0.183 mole) of 98% CH3NHNH2 (Aldrich Chemical Co.), and the mixture mag-
netically stirred and boiled (3 hours) under N2 . Concentration to dry-
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ness (rotary evaporator) gave a crude product (creamy-white) which was 
recrystallized from 50% c 2H50H; weight 1.45 g. (ca. 85%), m.p. 90-105°. 
Sublimation (100°/10-4 mm/Hg) gave a pure material (lighter in color) 
but the m.p. was unchanged. NMR analysis revealed four OCH3 (singlets 
12 protons) at o 3.7-3.95. An obvious conclusion was that an 1-.!:I_ methyl 
and 2-N isomeric mixture of methyl pyrazoles was present. No attempt 
was made to separate the isomers or study the mixture further. 
Attempted Bromination of the Allylic Position of Alkene 242 .Qy 
~
Bromine in the Presence of Light. In a 250-ml., round-bottomed flask 
fitted with a condenser, a dropping funnel and a trermometer was placed 
a solution of alkene ~ (5.0 g., 0.029 mole) in 20 ml. of pure CC14 . 
Bromine [(reagent-grade, Fisher Scientific Co.); 4.6 g., 0.058 mole] was 
dissolved in 50 ml. of pure cc14 , and the solution was charged to the 
dropping funnel. The source of light used in this experiment was a 150-
watt, frosted, tungsten lamp (Westinghouse Electric Corporation). The 
reaction was initiated by adding the bromine solution dropwise into the 
magnetically stirred cc14-alkene solution with the light directed at 
the reaction flask. The bromine color disappeared during the addition 
period (1 hour). A few droplets of CC14 condensed as the temperature 
rose to about 60-70°. Evaporating the CC14 solvent (after 2 hours) from 
the colorless solution yielded a crystalline product. Recrystalliza-
tion from 95% ethanol gave a highly pure bromo compound (2.5 g.), m.p. 
122-3°. An NMR analysis of the bromo compound showed a multiplet (cen-
tered at o 7.6) corresponding to five aromatic protons; a singlet at 
o 3.89 due to ArOC.!!_3 (with 3 protons); and a singlet at o 2.6 due to 
Arc~3 (with 3 protons) (CC14). + Mass spectral data showed M at a m/e 
251. It was concluded that a single bromine atom was introduced in one 
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position. However, dehydrogenation of the 3,4-positions possibly had 
taken place (presumably via a bromination-dehydrobromination process). 
Apparently, two simultaneous undesired side-reactions occurred and no 
further studies of the process were conducted. 
Preparation of 6-Methoxy-l-methyl-3,4-dihydronaphthalene53 (242). 
-53 The procedure was a modification of that of Bhattacharyya Thus, 
6-methoxy-1-tetralone (240) (50.0 g., 0.312 mole) was dissolved in 200 
--
ml. of a solution of dry benzene-dry ether (3:1). This solution was 
added dropwise (under N2) to a Grignard reagent prepared from 57.0 g. 
(0.400 mole) of CH3I and 9.7 g. of pure Mg (0.400 g. at.) in 200 ml. of 
dry ether. After all the ketone had been added, the reaction mixture 
was stirred (3 hours) at room temperature (under N2). A white complex 
precipitated out after boiling the reaction mixture for 1 hour. Stirring 
was allowed to continue overnight at room temperature. Cold concentrated 
H2so4 (ca. 20 ml.) was dropped in cautiously with continuous stirring 
while the reaction flask was cooled in an ice-bath. Decomposition with 
cold water (ca. 100 ml.) was performed by careful addition using a 
dropping funnel (and mechanical stirring). Cold water was allowed to 
drip into the mixture until most of the white complex disappeared. The 
organic layer was separated, and the aqueous layer was extracted with 
benzene. Combining the organic solutions and washing successively with 
H2o, saturated NaHC03 , and H20 and then drying (MgS04) and evaporating 
the solvents gave an amber-colored oil (crude alkene 242). Distillation 
-
of that crude alkene at 85-90°/0.2 mm. (lit. 53 b.p. 128-30°/6 mm.) gave a 
slightly yellowish liquid; weight 28 g. (52%). IR and NMR spectra were 
indicative of the presence of alkene 242. 
--
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3-B-D-Glucopyranosyl-10,ll-dihydro-7-methoxy-3H-phenanthro[l,2-c]pyrazole (221) , KBr Pellet 
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Solvent ... DCC1 3 O.F. .100.1 MHz F.B ..... 2 Hz R. F. • 6 7 db 
s. w. . . 1000 Hz S. T. 250 sec s.o. . 83701 Hz S .A. • • • 8 N ...._, 
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4,5-Dihydro-lH-benz[g]indazole-7,8-diol (194) 
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4,5-Dihydro-7,8-dimethoxy-.,.l-phenyl-lH-benz[g]indazole (195) 
- - --
Solvent. . DCC13 
S.W .•.. 1000 Hz 
0 .F. 
S.T. 
• • 100 .1 MHz 
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F.B ..... 2 Hz 
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4 ,5-Dihydro-1-phenyl-lH-benz[g]indazole-7 ,8-diol (196') 
- - --
. c5D5N 
1000 Hz 
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4, 5-Dihydro-7, 8-dimethoxy-1-(p-methoxyphenyl)-lH-benz[g]indazole (1977 
- . - - ,,.,..__ 
Solvent. . DCC13 
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O.F. .100.1 MHz F.B ...•. 2 Hz R. F. • 65 db 
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4,5-Dihydro-l-(p-hydroxyphenyl)-lH-benz[g]indazole-7,8-diol (198) 
- ...- - ,,__..., 
Solvent. . DMS0-~6 O.F. . . .100.1 MHz F.B. . . . . 2 Hz R.F. . 67 db 
s .w. . . . 1000 Hz S.T. . . . 500 sec s.o. . . 83701 Hz S .A. . . . 8 N 00 
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4 ,5-Dihydro-7, 8-dimethoxy-1-(p-tolylsulfonyl)~lH-benz[g]indazole (199) 
- - - .,,...__,,, 
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4,5-Dihydro-1-phenyl-lH-benz[g]indazol-7-ol (204) 
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4,5-Dihydro-7,8-dimethoxynaphth[2,l-~]isoxazole (lBS) 
Solvent. DCC1 3 
S.W •••• 1000 Hz 
O.F ••.. 100.1 MHz 
S. T. • 250 sec 
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Solvent ..• DCC13 
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4,5-Dihydro-7,8-dimethoxynaphth[l,2-c]isoxazole (186) 
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2,3a,4,5-Tetrahydro-7-methoxy-3H-benz[g]indazol-3-one (233) 
Solvent. 
s.w ... 
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2, 3a, 4 ,5-Tetrahydro-7, 8-dimethoxy-3H-benz[g]indazol-3-one (207) 
Solvent •• DMS0-~6 
S.W ...• 1000 Hz 
O.F •••• 100.1 MHz 
S.T. 500 sec 
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2,3a,4,5-Tetrahydro-7,8-dimethoxy-2-phenyl-3H-benz[g]indazol-3-one (208) 
- - ----
Solvent. DMS0-~6 
S.W .... 1000 Hz 
0. F. . 
S. T. • 
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2...-(p-Fluorophenyl)-2, 3a,4 ,5-tetrahydro-7 ,8-dimethoxy-3H-benz[g]indazol-3-one (209) 
- - - .--
Solvent. • DMS0-~6 O.F •• . .100.1 MHz F.B •• . . . 2 Hz R.F •• 61 db 
s .w. . . • 1000 Hz S.T. . . . 500 sec s.o. . • 83701 Hz S .A •• • 3.2 N 
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2,3a,4,5-Tetrahydro-7,8-dimethoxy-3a-methyl-3H-benz[g]indazol-3-one (~) 
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2-Amino-4,5-dihydro-7,8-dimethoxynaphtho[l,2-d]thiazole (211) 
- --
Solvent .... DMS0-~6 O.F .. •• 100.1 MHz F.B. . . . • 2 Hz R.F • . 61 db 
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2-Anilino-4,5-dihydro-7,8-dimethoxynaphtho[l,2-d]thiazole (212) 
- -
Solvent. DMS0-~6 
S.W •••• 1000 Hz 
O.F .••• 100.1 MHz 
S.T. • . • 500 sec 
F.B ••••• 2 Hz 
s.o. 83701 Hz 
R. F. • 61 db 
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2-(Allylamino)-4,5-dihydro-7,8-dimethoxynaphtho[l,2-d]thiazole (213) 
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4,5~P~hydro-7,8-dimethoxy-2-methylnaphtho[l,2-d]thiazole (214) 
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Solvent .•. DCC13 
S .W. • • • 1000 Hz 
O.F. 
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. 1(2H) Y . ( ) Methyl 3,4-dihydro-6,7-dimethoxy-~ - ' -naphthalenecrotonate ~
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6, 7-Dimethoxy-1-naphthalenebutyric Acid (236) 
--
O.F •••• 100.1 MHz F.B ..... 2 Hz 
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3,4-Dihydro-6,7-4imethoxy-1(2H)-phenanthrone (188) 
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3,4-Dihydro-2-(hydroxymethylene)-6,7-dimethoxy-1(2H)-phenanthrone (237) 
- -
Solvent •.• DCC1 3 O.F .•.• 100.1 MHz F.B. •• 2 Hz R.F .. 67 db 
s .w. . . 1000 Hz S. T •• 250 sec S.O ..• 83701 Hz S.A ••• 3.2 N l.O 
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10,ll-Pihydro-7,8-dimethoxy-3H-phenanthro[l,2-c]pyrazole (215) 
- - --
>-H~ 
"' 
S.olvent ... ·c5n5N O.F •••• 100.1 MHz F.B ••••• 2 Hz R.F •. 71 db 
S .W. • • • 1000 Hz S.T. 250 sec S .0. • • 83701 Hz S.A •• · 20.0 w 0 
0 
PLATE LXXXVI 
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"c~ I PPM '1' 
Solvent. 
s. w. . . 
10-11-Dihydro-3H-phenanthro[l,2-c]pyrazole-7,8-diol (216) 
- - ---
DMS0-~6 
1000 Hz 
0 .F. 
S.T. 
. .100.1 MHz 
500 sec 
F.B. • • 2 Hz 
s. 0. . 83701 Hz 
R.F •• 70 db 
S .A. . 8.0 w 0 
t-' 
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"a J I 
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1000 " ' 1 " I ' >-H~ 
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~· -
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~~ I I 
10,11-Dihydro-7,8-dimethoxyphenanthro[2,1-~]isoxazole (190) 
.,...__,. 
Solvent. . . DCC1 3 O.F. . . .100.1 MHz F.B. . . . . 2 Hz R.F . . 65 db 
s. w. . . . 1000 Hz S. T. . . . 500 sec s .o. . . 83701 Hz S .A. . 2.0 w 0 
N 
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10,ll-Dihydro-l-(p-fiuorophenyl)-7,8-dimethoxy-3H-phenanthro[l,2-c]pyrazole (217~ 
- - - -
Solvent .• DMS0-~6 
S .W. • •• 1000 Hz 
O.F. 
S.T. 
.100.l MHz 
500 sec 
F.B. • • 2 Hz R.F. • 69 db 
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0 
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10 ,11-Dihydro-l-(p-fluorophenyl)-3H-phenanthro[l ,2-c]pyrazole =·7, 8-diol (218) 
- - - ,,,,,-......,,, 
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2,3,4,6-letra-0-acetyl-a~D-giucosyl bromide (238~ 
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l-S-E_-Glucopyranosyl-4,5-dihydro-7-methoxy-1!!,-benz[~]indazole tf~traacetate (ester) (3.2.§,) 
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l-~-D-Glucopyranosyl-4,5-dihydro-7,8-dimethoxy-lH-benz[g]indazole Tetraacetate (ester) (201) 
~ - -
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3~B..,.J)-Glucopyranosyl-10,ll-dthydro-7-methoxy-3H-phenanthro[l,2-c]pyrazole ~etraacetate 
(e';'ter) (220) - -
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3-S-D-Glucopyranosyl-10,11-dihydro-7-methoxy-3H-phenanthro[l,2-c]pyrazole (221) 
;.:;::::;. - - ,,_.,__ 
Sol vent. • Acetone-~ 0 .F. . .100 .1 MHz F.B •••.• 1 Hz R.F. 73 db 
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w 
f---' 
0 
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